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Autism spectrum disorders, intellectual disabilities and childhood epilepsies have a preval-
ence of about 1-3% in the western child and adolescent populations with mutations in single
genes being responsible for more than 60% of the more severe, low-functioning cases. However,
the biological mechanisms underlying autism spectrum disorders and intellectual disabilities
(ASD/IDs) remains largely unknown. Over the course of my PhD, I have used transgenic rats
to model one such single-gene associated ASD/ID, SYNGAP1-mediated ID. The use of a labor-
atory rat as a pre-clinical model for this disorder will help us gain a better understanding of the
cellular and molecular processes that cause altered behaviours observed in humans with this
condition.
Neurons, the most abundant cell type in the brain, communicate with each other through
short, electrical pulses at specialised junctions called synapses. Most neurons continually adapt
the volume, speed, and frequency with which they communicate in response to external and
internal cues. They do so by modulating some of their own features, including the number of
incoming electrical pulses required before a neuron will conduct its own pulse to the next cell.
This feature, termed ‘cellular excitability’, is very tightly regulated and is often found to be
altered in ASD/ ID, including in rat models of SYNGAP1-mediated ID. One key regulator of
cellular excitability is the site where these electrical pulses are generated, called the axon initial
segment (AIS). The AIS controls cellular excitability by altering its length and its distance
from the main body or ‘soma’ of the cell in response to incoming information. Thus, the key
hypothesis explored in this thesis is that alterations in AIS length underlie the alterations in
cellular excitability observed in the rat models of SYNGAP1-ID.
In order to test this hypothesis, first a characterisation of AIS lengths across six different
brain regions was undertaken in rats that model SYNGAP1-ID and compared to control anim-
als. The brain regions chosen included two sensory regions as well as four brain regions used
for higher cognitive function as individuals with SYNGAP1-ID present with impaired cognit-
ive function and altered responses to sensory stimuli including increased sensitivity to sound.
Second, the ability of the AIS to adapt its length in response to stimuli was tested. This was done
by subjecting SYNGAP1-ID and control rats to an anxiety-associated learning task followed
by measuring and comparing changes in AIS lengths in two brain regions that are involved
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in modulating fear and anxiety. An anxiety-associated learning task was chosen as fear and
anxiety-related behaviours are known to be altered in individuals with SYNGAP1-ID.
Lastly my thesis has also explored the idea that different genetic causes of ASD/ID converge
to result in similar changes to cellular function. As such, I hypothesize that alterations to AIS
lengths might underlie alterations in cellular excitability across other single gene or monogenic
causes of ASD/ID. In order to test this, I have examined AIS lengths in the same brain regions
studied in the Syngap1-ID rat in six additional rat models of monogenic forms of ASD/ID.
Convergence is a particularly attractive hypothesis because, if true, it would mean that the
same drug might be beneficial to individuals with genetically distinct mutations that cause
their ASD/ID. The results indicate that in almost all the brain-regions studied the AIS length
remained unchanged between animals modelling ASD/ID and control animals. My thesis,
therefore rejects the hypothesis that alterations in AIS length is a common pathway underlying
changes in excitability across these models. However, the work documented here provides the
first evidence of anxiety-induced alterations in AIS length in models of SYNGAP1-ID as well




Monogenic mutations in synaptic proteins are known to cause severe and low functioning
cases of autism spectrum disorder and intellectual disability (ASD/ID) (Wright et al., 2018).
One of the most prevalent monogenic causes of moderate to severe non-syndromic and syn-
dromic ID with a high co-morbidity of seizures and altered sensory processing is SYNGAP1
haploinsufficiency (Hamdan et al., 2009; Hoischen et al., 2014). Resulting from de novo trun-
cating or frameshift mutations in the SYNGAP1 gene on human chromosome 6, SYNGAP1
haploinsufficiency leads to a 50% reduction of the encoded synaptic GTP-ase activating protein
(SynGAP) (Hamdan et al., 2009).
Pre-clinical models of Syngap1 haploinsufficiency have provided an invaluable tool to under-
stand the underlying pathophysiology resulting from a reduction of SynGAP. The heterozygous
mouse model of Syngap1 haploinsufficiency (Syngap1+/-) demonstrates a range of cellular,
physiological and behavioural abnormalities from early development to adulthood (Chen et al.,
1998; Kim et al., 1998; Komiyama et al., 2002; Rumbaugh et al., 2006; Muhia et al., 2010).
Key among these phenotypes is brain region and cell-type specific hyper- and hypo-excitability,
causing an excitation/inhibition imbalance which manifests as disrupted circuit function (Clem-
ent et al., 2012, 2013; Ozkan et al., 2014; Aceti et al., 2015; Berryer et al., 2016; Katsanevaki,
2017).
Neuronal excitability is defined as the probability of action potential (AP) generation in
response to a given current. The site of AP generation is a specialised cellular compartment
located between the somatodendritic and axonal compartments of a neuron, called the axon
initial segment (AIS). The AIS is a dynamic structure, shown to alter its length and position
along the axon in response to altered physiological and pathological conditions (for review
see Rasband (2010)). Prolonged increase in neuronal activity causes shortening and a distal
shift of the AIS (Evans et al., 2015; Grubb and Burrone, 2010) while extended periods of
decreased neuronal activity result in lengthening and proximal shift of the AIS (Kuba et al.,
2006; Kuba, 2012). The functional consequence of this morphological plasticity is altered
intrinsic excitability such that neurons with distally located, shorter AISs exhibit increased
AP threshold with subsequent production of fewer APs in response to a given current while
neurons with longer, proximal AISs exhibit decreased AP threshold and increased frequency
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of AP firing (Kuba et al., 2006; Grubb and Burrone, 2010; Kuba et al., 2010; Kuba, 2012;
Evans et al., 2015). Given this ability of the AIS to alter cellular excitability and the evidence
of altered excitability in pre-clinical models of SYNGAP1 haploinsufficiency, this thesis tests
the hypothesis that alterations in AIS length will underlie some the altered cellular excitability
observed upon reduction of SynGAP.
In order to test this hypothesis, first a characterisation and comparison of AIS lengths
between Syngap1+/- and control juvenile rats was undertaken across six brain regions previously
known to exhibit altered cellular excitability or be involved in behaviours that are altered in
Syngap1 haploinsufficiency. These brain regions include the prelimbic medial prefrontal cortex
(mPFC-PL), somatosensory cortex – barrel fields (S1BF), Cornu Ammonis 1 and 3 (CA1, CA3)
sub-fields of the dorsal hippocampus, the lateral (LA) and basal (BA) nuclei of the amygdala
and the primary visual cortex 1 (V1). Juvenile animals were chosen to reflect the developmental
underpinnings of this disorder as Syngap1+/- mice exhibit alterations in synaptic physiology at
this age (Barnes et al., 2015) and it coincides with the developmental critical period for some of
the brain regions analysed, including the V1 and BLA. Further, the AIS has been shown undergo
developmentally regulated alternations in its morphology during this time-period. Statistical
analysis of results and post-hoc interactions of brain-region and genotype were analysed using
a linear mixed modelling (LMM) approach to account for the non-normal distribution of the
data-sets. Subsequently, the effects of Syngap1 haploinsufficiency on morphological plasticity
of the AIS was tested. This included analysis and comparison of genotype specific changes
in AIS lengths over development and following a cued fear conditioning associative-learning
paradigm. Lastly, as cell-type specific differences in cellular excitability have been noted in
the Syngap1+/- mouse, AIS lengths were compared across genotypes in cells of the mPFC and
BLA with specific projection targets. In addition to studying the difference of AIS length in
rat models of SYNGAP1 haploinsufficiency, a similar study was undertaken in this thesis in rat
models of Fragile-X syndrome, Cowden’s syndrome, NLGN3-associated non-syndromic ID,
NRXN1 and CNTNAP2 associated ASD/ID. This work was undertaken to study the hypothesis
that diverse genetic causes of ASD/ID converge onto common cellular pathways, and, as pre-
clinical models of these disorders all exhibit evidence of altered cellular excitability, alterations
in AIS length might underlie some of these changes.
The work documented in this thesis provides the first characterisation of AIS lengths across
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pre-clinical models of Syngap1 haploinsufficiency as well as across multiple monogenic rat
models of ASD/ID. The results indicate that in almost all the brain-regions and models stud-
ied, AIS morphology remained unaltered between heterozygous/homozygous animals and their
wild-type littermate controls, causing a rejection of the hypothesis that alterations in AIS mor-
phology is a common cellular pathway underlying changes in cellular excitability across these
models. However, provided here is the first evidence of AIS morphology in the mPFC-PL
being differentially altered in Syngap1 haploinsufficiency compared to control animals when
subjected to a cued fear conditioning paradigm as well as alterations in AIS morphology in the
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1.1 Autism spectrum Disorder, intellectual disability & childhood
epilepsy
Pervasive developmental disorders (PDDs), including autism spectrum disorders (ASD),
intellectual disabilities (ID), attention deficit hyperactivity disorder (ADHD) and childhood
epilepsies affect about 2-5% of the general western population (Chelly et al., 2006; Cooper
et al., 2009; Shevell et al., 2003). Prevalence of these PDDs is estimated to be higher in low
and middle-income countries where diagnosis, management, and support options are limited
(Samadi and McConkey, 2011; Akhter et al., 2018).
As per the World Health Organisation’s International Statistical Classification of Diseases
and Related Health Problems (ICD-10), intellectual disability is defined as:
‘A condition of arrested or incomplete development of the mind, which is especially char-
acterized by impairment of skills manifested during the developmental period, skills which
contribute to the overall level of intelligence, i.e. cognitive, language, motor, and social abilit-
ies’ (World Health Organization, 1992).
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Figure 1.1: Diagnoses and Causes of Intellectual Disabilities (Left) A diagnosis of intellectual disabilities (ID)
is classified using intelligence quotient (IQ) tests into mild (IQ 50-69), moderate (IQ 35-49), severe (IQ 20-34) or
profound (IQ <20) (Right) The causes of ID are highly heterogeneous and include environmental, chromosomal
and single gene mutations. Monogenic causes of ID are further divided in to syndromic and nonsyndromic forms of
ID. Syndromic causes of ID are characterised by physical, metabolic and biological features and include Tuberous
Sclerosis, Fragile X syndrome which are caused by mutations in the TSC1/2 and FMR1 genes respectively. In
contrast, the only clinical manifestation associated with non-syndromic causes of ID is cognitive dysfunction,
examples of which include mutations in SYNGAP1 and NLGN3 that encode the synaptic GTPase activating protein
(SYNGAP) and NEUROLIGIN-3 that are crucial for normal synaptic functions.
Traditionally, ID severity was estimated using standardised intelligent quotient tests, with
a positive diagnosis made in individuals presenting with an IQ score of <70 and onset before
the age of 18. The diagnosis is further classified into mild (IQ 50-69), moderate (IQ 35-49),
severe (IQ 20-34) or profound (IQ <20), and into syndromic (S-ID) or non-syndromic (NS-ID)
intellectual disability (fig 1.1). In S-ID, patients present with one or multiple clinical features
such as morphological (cranial, facial, and skeletal dysmorphisms), radiologic or metabolic
abnormalities in addition to ID whereas patients with NS-ID present with intellectual disability
as the sole clinical feature (Kaufman et al., 2010). More recently, the criteria for ID diagnosis
has evolved to include the development of conceptual, social and practical skills, grounding its
diagnosis in adaptive functioning.
ASD is characterised by deficits in social communication and social interaction, with re-
stricted, repetitive patterns of behaviour, interests or activities (Harper, 2014). About 30% of
individuals diagnosed with ASD also present with ID. While approximately 20% of individuals
diagnosed with both ASD/ID present with epilepsy and 90% report altered sensitivity to various
sensory and tactile stimuli (fig. 1.2) (Marco et al., 2011; Besag, 2018). An epilepsy diagnosis
is applied to patients exhibiting two unprovoked seizures greater than 24 h apart (Fisher et al.,
2014) with subsequent severe perturbations in neurobiological, cognitive, psychological, and
social function (Scheffer et al., 2017). An epileptic seizure is a transient symptom state resulting
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Figure 1.2: Neurodevelopmental Disorders Schematic Venn diagram of neurodevelopmental disorders (NDD)
including autism spectrum disorders, intellectual disabilities (ID) and childhood epilepsies. Where these disorders
overlap, the most severe, low functioning cases are found. Monogenic mutations have been found to be the predom-
inant causative factor in these cases.
from abnormal, excessive, or synchronous neuronal activity in the brain and is characterized by
abrupt and involuntary skeletal muscle activity (Klitten et al., 2011).
The impact on the life-span and quality of life for the individuals living with these disorders
presents a major challenge to clinicians, geneticists and neuroscientists (Patja et al., 2001; Tyrer
et al., 2007; Emerson and Baines, 2011; Dieckmann et al., 2015; Baxter et al., 2015). Current
therapies focus on symptomatic relief of co-morbidities including seizures, anxiety, ADHD and
mood disorders. Therefore, in order for us to better treat individuals with these disorders it is
vital to understand its aetiology and pathophysiology.
1.1.1 Causes of ASD/ID
ASD/IDs present with complex aetiology, with causes being highly heterogeneous. These
include both genetic and environmental factors that disrupt key neurodevelopmental processes
during pre-, peri- and early post-natal life (Figure 1.1) (Chelly et al., 2006; Chiurazzi and Pirozzi,
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2016). Acquired and environmental causes include maternal intoxication with alcohol or drugs
(e.g. foetal alcohol syndrome), foetal infection (e.g, CMV, meningitis), vascular accidents
and asphyxia. Genetic causes span chromosomal abnormalities and monogenic causes, with
some studies suggesting they account for 25-50% of all ID cases (McLaren and Bryson, 1987;
Kaufman et al., 2010). Chromosomal abnormalities include microdeletions, trisomy 21, and
deregulation of imprinted genes causing syndromes such as Prader F Willi and Angelman
syndrome. A recent Deciphering Developmental Disorders study (DDD) (Wright et al., 2018),
has found that 42% of individuals of their 1,133 cohort with the most severe cases of ASD/ID
all presented with mutations in a single gene. This is a 15% increase from the reported 27% in
their initial 2011 study (Firth and Wright, 2011).
Despite the ever-increasing identification of genetic and environmental causes of ASD/ID,
the underlying pathophysiology of these disorders remains poorly understood. Monogenic
disorders are particularly attractive to study as not only do they account for the most severely
affected individuals, but they can also be easily modelled in the lab in vivo (e.g. rodent models),
in vitro (cell culture) and in silico (computational models). This allows for extensive pre-clinical
examination and thus furthers our understanding of disease pathology.
SYNGAP1 haploinsufficiency, occurring in 0.75-1% of individuals with either epileptic
encephalopathy (Carvill et al., 2013) or ID (Fitzgerald et al., 2015) and characterised by de-
velopmental delay (100% of individuals carrying pathogenic mutations), generalized epilepsy
(~84%) and ASD (≤50%) (Asadi, 2018), is one such single-gene disorder and forms the primary
focus of this thesis.
1.2 Syngap1 Haploinsufficiency linked to S-ID and NS-ID
The human SYNGAP1 gene is present on chromosome 6p21.3 and encodes the ~135 kDa
Synaptic GTP-ase Activating Protein (SynGAP). SynGAP is one of the most abundant proteins
present in the post-synaptic density (PSD) of mammalian neurons, making up nearly 1-2% of
all PSD-proteins (Kim et al., 1998). It is predominantly known for its negative regulation of
the Ras/Rap pathway as part of the N-methyl-D-aspartate receptor (NMDAR) complex. The
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structure and function of the SYNGAP1 gene, and resulting protein, are further elaborated in
section 1.3.
De novo mutations in the SYNGAP1 gene were first identified as causative of NS-ID in 3
patients in Montreal by Hamdan et al. (2009). These mutations resulted in haploinsufficiency:
The loss of one functional copy of the SYNGAP1 gene and a consequent 50% reduction in
protein level. Since then, mutations in SYNGAP1 in patients with ID has been reported in over 18
studies (Vlaskamp et al., 2019). Hoischen et al. (2014) reported SYNGAP1 as one of the most re-
current mutated genes with de novo mutations, in the form of truncating, missense, chromosomal
translocations and micro-deletions, presenting in one of 8 patients with ID, ASD, schizophrenia
and developmental and epileptic encephalopathy (fig. 1.3). The Deciphering Developmental
Disorders (DDD) study led by Fitzgerald et al. (2015) identified SYNGAP1 as one of the
top 5 recurrently mutated genes in individuals with genetically-undefined developmental brain
disorders. Lastly, the Simons Foundation Autism Research Initiative (www.sfari.org) listed
SYNGAP1 as one of 23 ‘high confidence’ autism risk genes.
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Figure 1.3: Schematic presentation of SYNGAP1 mutations and micro-deletions previously published in the literature Chromosome 6p21.32 microdeletions including SYNGAP1,
are presented as gray bars with «and »indicating that their breakpoints were outside the region presented here. Patient mutations include translocations, mirodeletions, truncating variants,
splice-site variants, missense variants and inframe mutations. Colors of the lines represent the epilepsy syndrome phenotype: moderate to severe developmental and epileptic encephalopathy
(red), moderate to severe developmental encephalopathy with epilepsy (orange), moderate to severe developmental encephalopathy with no epilepsy (blue), mild developmental and epileptic
encephalopathy (light green), mild developmental encephalopathy with no epilepsy (dark green), and unknown/unclassified epilepsy (gray). Chromosomal coordinates were based on
National Center for Biotechnology Information Build 37 [hg19] and SYNGAP1 mutations, protein domains, and exons on the longest isoform 1 (NM 006772.2) Image from Vlaskamp et al.
(2019).
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Until 2015, SYNGAP1 haploinsufficiency was linked solely to NS-ID. However, a study
by Parker et al. (2015) presented the first evidence of 10 individuals with SYNGAP1 haploin-
sufficiency presenting with clinically syndromic ID. A more recent study by Vlaskamp et al.
(2019) identified 57 new patients with de novo mutations in SYNGAP1, 56 of whom presented
with developmental and epileptic encephalopathy with eyelid myoclonia (65%), atonic seizures
triggered by eating (25%) and ataxia and gait abnormalities (51%). 55 of the patients presen-
ted with ID (50 patients with moderate to severe ID), expanding the number of SYNGAP1
haploinsufficiency individuals with S-ID.
Across multiple clinical case reports, the most recurrent pathologies reported in individu-
als with SYNGAP1-ID include: moderate to severe-ID, hyperactivity with ADHD, elevated
anxiety, moderate to severe speech impairment, aggression towards care-givers, seizures in-
cluding myoclonic seizure, absence seizures, drop attacks, generalised tonic-clonic seizures
and photosensitive epilepsy. Parents and care-givers also note anecdotal evidence of increased
pain-threshold, altered sleep patterns, gait abnormalities and hyperacusis (heightened sensitivity
to sound) (Hamdan et al., 2009, 2011; Pinto et al., 2010; Parker et al., 2015; Krepischi et al.,
2010; Zollino et al., 2011; Pinto et al., 2010; Klitten et al., 2011; De Ligt et al., 2012; Rauch et
al., 2012; Berryer et al., 2013; Carvill et al., 2013; Writzl and Knegt, 2013; Redin et al., 2014;
Von Stülpnagel et al., 2015; Mignot et al., 2016; Prchalova et al., 2017; Vlaskamp et al., 2019;
Jimenez-Gomez et al., 2019).
Despite the increase in patient numbers presenting with autosomal dominant mutation-
linked ID the numbers are quite small, partly due to the lowered reproductive fitness associated
with these conditions, occluding linkage analysis. Therefore, pre-clinical models offer an
excellent platform to gain a better understanding of complex pathophysiology underlying these
disorders and new potential therapeutic targets.
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1.3 SynGAP Protein: Expression, Structure and Function
1.3.1 Protein Expression
SynGAP was first identified in 1998 by two independent groups (Kim et al., 1998; Chen et
al., 1998) in the PSDs of the rat forebrain. Found in a large complex with synapse associated
protein (SAP102), PSD-95 and NMDARs, SynGAP protein expression was initially thought
to be limited to the excitatory PSDs of mice (Kim et al., 1998; Chen et al., 1998; Knuesel et
al., 2005; Clement et al., 2012, 2013; Ozkan et al., 2014). However, SynGAP was later shown
to also be present in the PSDs of inhibitory GABAergic neurons of mice (Zhang et al., 1999;
Moon et al., 2008; Ozkan et al., 2014; Berryer et al., 2016).
The earliest reported expression of Syngap1 mRNA in mice is at embryonic (E) day 8.5
with whole-mount embryos showing expression throughout the developing neural tube, somites
and heart (Porter et al., 2005). By E10.5 Syngap1 mRNA expression extended to the developing
limb-buds while expression in the cortex, basal ganglia and thalamus reported at E14.5. At
E16.5, following the completion of neurogenesis, Syngap1 expression is reported in the hip-
pocampus and hypothalamus. In the cortex, protein expression peaks in the second week of
post-natal development ( P14) before being restricted to L2/3 and the boundary of L4/5 in the
adults (>P60) (Barnett et al., 2006; Clement et al., 2012; McMahon et al., 2012). Lastly, in
adult animals SynGAP protein is also expressed in the striatum, amygdala and olfactory bulbs
but not in the thalamus, cerebellum, midbrain or brain stem (Porter et al., 2005).
1.3.2 Protein Structure
A highly-conserved gene, SynGAP has multiple amino- (N-) and carboxyl-terminal (C-)
isoforms. The N-terminal isoforms include A, B, C and E and arise from alternative transcription
start site while the C-terminal isoforms, arising from alternative splicing, include α1, α2, β1-4
and γ (Li et al., 2001; McMahon et al., 2012) (Figure 1.4). The different SynGAP isoforms show
differential localisation, with the α1 isoform being found solely in excitatory neurons whereas
the β isoform is found in both excitatory and inhibitory neurons. The β isoform is also found to
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be distributed more along the dendritic tree compared to the α1 isoform in neuronal cell culture
(Moon et al., 2008). Both the N- and C-terminal isoforms exert differential activity dependent
functions, elaborated below (see section 1.3.3). Additionally, the C-terminus also acts as a
classical small protein binding SH3 domain, mediating the formation of protein complexes via
a proline-rich region (770 - 800) (Cohen et al., 1995).
The Pleckstrin Homology (PH) domain is a 100 amino acid region that binds the phos-
phatidylinositol of biological membranes. This domain is complete in the A, B and E isoforms,
with a truncated domain present in the C isoform. The calcium dependent lipid binding (C2)
domain forms part of the core-domain of the protein that is shared by all the isoforms. A study
by Pena et al. (2008) showed that the C2 domain was crucial for the activity of SynGAP as a
Rap-GTPase. The enzymatic ‘GAP’ domain of SynGAP defines it as a guanosine triphosphate-
ase–activating protein and mediates the effect of SynGAP on downstream signalling pathways.
This function is further elaborated below.
Figure 1.4: SynGAP Protein Structure (Top) Syngap1 gene adapted from the online ENSEMBL database showing
the exons coding for the PH, C2 and GAP domain (Bottom) SynGAP Protein showing the various N- and C-terminal




As previously stated, SynGAP forms part of the NMDAR protein complex. Its interactions
as part of this complex affects downstream signalling cascades and synaptic plasticity in a
GAP-domain dependent and independent manner.
Yeast two-hybrid screening studies revealed that SynGAP binds directly to the PDZ struc-
tural domains of membrane-associated guanylate kinases (MAGUKs) such as SAP102 and
PSD-95. The same system also showed that PSD-95, via it’s PDZ domain, directly binds to
the GluN2B sub-unit of NMDARs (Kim et al., 1998). As the PSD-95 interaction provided
a direct link between SynGAP and NMDARs, it was thought to be the main binding source
localising SynGAP to the PSD. This binding is facilitated by the QTRV motif found in the α1
C-terminal isoform, making it the most studied of all SynGAP isoforms. However, experiments
by Vazquez et al. (2004) showed that a mutation in the QTRV motif did not alter the presence of
re-combinant protein in the spines and the β isoform, lacking the QTRV motif, is also isolated
in the PSD fraction. These findings by Vazquez et al. (2004) can be partially explained by
SynGAP’s interaction with Ca2+/calmodulin-dependent protein kinase (CamKII) (Kim et al.,
1998; Chen et al., 1998). Indeed, SynGAP α1, α2 and β isoforms are all shown to directly
interact with the α isoform of CamKII (Kim et al., 1998; Chen et al., 1998; Li et al., 2001).
Additionally, in neurons of the CA1 and CA3 sub-unit of the hippocampus, SynGAP is
shown to interact with the ubiquitously expressed scaffolding protein MUPP1 (Krapivinsky
et al., 2004). MUPP1 facilitates a direct physical interaction with CamKII, forming another
link to NMDARs via CamKII’s interaction to the GluN2B receptor sub-unit. This interaction,
however, was shown to not be crucial for SynGAPs localisation to the PSD. Disruption of the
MUPP1-SynGAP complex, using TAT-PDZ13 fusion protein, failed to alter SynGAP clusters
at the PSD of cultured hippocampal neurons.
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Activity Dependent Regulation
The regulation of synaptic strength by SynGAP is dependent on neuronal activity. McMa-
hon et al. (2012) show that in mouse neuronal cultures, enhancing and inhibiting network
activity produced differential expression of its N-terminal isoforms. Bath application of net-
work enhancer bicuculline, a γ-amino butyric acid (a) (GABAA) receptor agonist, increased
mRNA levels of SynGAPs N-terminal B and C isoforms while reducing mRNA levels of the
A isoform. Conversely, inhibiting network activity, via application of tetrodotoxin (TTX), re-
versed these changes. This form of network manipulation was not found to affect the mRNA
levels of the C-terminal α1 or α2 isoforms. However, expression of α1, in combination with
either A, B or C N-terminus, showed a 73% increase in the presence of ‘silent synapses’, meas-
ured as cells lacking mEPSCs. Expression of α2 did not show a similar increase, maintaining
silent synapse percentages similar to wildtype levels of about 11%. Finally, α2 over-expression
in combination with either the B or C N-terminal resulted in increased mEPSC amplitude and
frequency whereas over-expression of α1 with the A N-terminal isoform resulted in decreased
mEPSC amplitude.
In addition to regulating its synaptic strength, SynGAP localisation to the PSD is also regu-
lated in an activity dependent manner. Typically SyNGAP expression is found in the PSD-core,
the first 40 nm from the post-synaptic membrane, with more sparse expression 40-120 nm from
the membrane (Yang et al., 2011). Yang et al. (2011, 2013) showed that upon depolarisation
induced by application of K+ or activation by application of NMDA, SynGAP α1 and α2 are
relocated away from the PSD-core to the 40-120 nm region in PSD-fractions isolated from adult
rat brains. This re-location is reversible and mediated by CamKII. Additionally, Araki et al.
(2015) showed that during and following induction of chemical long-term potentiation (LTP)
using glycine in cultured hippocampal neurons, CamKII mediates rapid dispersal of SynGAP
away from spines. This is blocked if you inhibit CamKII or mutate its phosphorylating sites on
SynGAP.
The predominant function of SynGAP is mediating synaptic plasticity via regulation of
downstream signalling cascades and is discussed in the following section.
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Downstream Signalling Cascades and Synaptic Plasticity
Upon activation of CamKII, either by Ca2+ entry to the PSD (predominantly via NMDAR
activation) or Ca2+ independent auto-phosphorylation, CamKII binds to the phosphorylation
sites present on the C-terminus of SynGAP (Oh et al., 2004). Phosphorylation of SynGAP
activates the GTP-ase function of the protein. It acts in conjunction with guanine exchange
factors (GEFs) to enhance the hydrolysis of GTP by de-phosphorylation of GTP-binding pro-
teins. These GTP-binding proteins comprise of the Ras, Rap or Rho family of proteins and are
known to activate multiple downstream signalling pathways (Palsson et al., 2000).
SynGAP was originally identified as an HRas-GAP (Chen et al., 1998; Kim et al., 1998)
due to sequence and 3-D conformation homology with Ras-GAPs p120 and neurofibromin.
Upon activation, SynGAP de-phosphorylates Ras from a GTP bound ‘active’ state to a GDP-
bound ‘inactive’ state. GTP-bound Ras activates the extracellular-signal regulated kinases
1-and-2 (ERK 1/2) / mitogen-activated protein kniase (MAPK) pathway. Activation of the
ERK1/2 / MAPK results in the phosphorylation of translation inhibitor 4E-BP, dis-inhibiting
protein translation. Indeed, models of SynGAP haploinsufficiency including heterozygous
(het) (Syngap+/-) mice (Carlisle et al., 2008) and knock down neuronal cultures (Araki et al.,
2015) show increased levels of Ras. Rumbaugh et al. (2006) showed increased phosphorylated
(activated) ERK in cultures from Syngap1-/- mice while Komiyama et al. (2002) showed
similarly high p-ERK levels in Syngap+/- adult mice. Both studies also found an increase in this
elevated p-ERK level upon stimulation of NMDAR. Kim et al. (2003) showed that knock-down
of SynGAP down using RNAi results in a sustained increase of p-ERK levels after NMDAR
stimulation, instead of its typical transient activation. However, Ozkan et al. (2014) upon
activating the NMDAR pathway showed no increase in elevated p-ERK levels. One possible
explanation for this discrepancy, might be the stimulation protocols used. Ozkan et al. (2014)
used a theta burst stimulation while Rumbaugh et al. (2006) used a low Mg2+-high glycine
media whereas Komiyama et al. (2002) bath applied NMDA. Further evidence of negative
regulation of the ERK pathway by SynGAP was provided in a study by Berryer et al. (2013),
in which neurons in organotypic slice cultures were transfected with either wild-type (WT) or
mutated SYNGAP1 with mutation loci matched to mutations found in patients. They found that
upon transfection with WT SYNGAP1, the levels of p-ERK decreased whereas transfection
with mutated SYNGAP1 showed no change in p-ERK levels. Finally, Barnes et al. (2015) found
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elevated levels of basal protein synthesis in juvenile Syngap+/- mice can be reversed to control
levels by blocking the ERK1/2 pathway using U0126.
In addition to HRas, SynGAP also acts as a Rap1-GAP (Krapivinsky et al., 2004; Pena
et al., 2008; Walkup et al., 2015). In fact, Krapivinsky et al. (2004) showed that in cultured
rat hippocampal neurons SynGAP, as part of the MUPP1-SynGAP-CamKII complex, showed
10-fold stimulation of its Rap-GTPase activity compared to a two-fold stimulation of its Ras-
GTPase activity. Rap is upstream of and shown to inhibit the p38-MAPK pathway (Palsson
et al., 2000), therefore one would expect that loss of SynGAP would result in decreased p38-
MAPK activity whereas increased SynGAP expression would cause the opposite. Indeed,
Rumbaugh et al. (2006) showed that inducing SynGAP expression, by activation of NMDAR,
resulted in increased p38-MAPK and these levels are reversed on knockdown of SynGAP using
siRNA. Controversially, Krapivinsky et al. (2004) found that calmodulin mediated activation
of CamKII led to a de-phosphorylation of SynGAP and attenuated the phosphorylation activity
of p38-MAPK with no change in ERK activity. One possible explanation for this discrepancy
is the use of different isoforms. The Rumbaugh et al. (2006) study specifically states the use of
SynGAPα1, whereas the study by Krapivinsky et al. (2004) simply states the use of SynGAPα .
Given the differential effect of α1 and α2 isoforms on synaptic strength, there is a possibility
that the Krapivinsky et al. (2004) study used α2 and uncovered an isoform specific function.
Recently, Walkup et al. (2015), showed that the Ras-GAP versus Rap1-GAP activity of a
recombinant SynGAP protein (r-SynGAP lacking 102 residues at the N-terminal) depended on
its phosphorylation by cyclin-dependent kinase-5 (CDK-5) and CamKII. The study showed that
phosphorylation of the C-terminal of r-SynGAP by CDK-5 preferentially promoted its Ras-GAP
activity (98% compared to 25% Rap1-GAP activity) whereas phosphorylation by CamKII pref-
erentially promoted its Rap1-GAP activity (76% to 25% Ras-GAP activity). This study provides
the first evidence of SynGAP switching its Ras/Rap GTP-ase activity in a phosphorylation-
partner dependent manner.
Ras and Rap are known to differentially control synaptic plasticity through control of α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor insertion dynamics
at the post-synaptic membrane (Zhu et al. (2002)). Ras, through activation of the ERK1/2
pathway, drives long-cytoplasmic tail containing AMPA-R delivery to the membrane, enhancing
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Figure 1.5: Downstream Signalling cascades mediated by SynGAP The Schematic shows the various Ras, Rap
and Rac pathways activated by phosphorylation of SynGAP. Glutamate receptors, such as NMDAR and AMPAR,
are clustered at the postsynaptic active zone with a dense matrix called PSD. Upon NMDAR activation, Ca2+
enters the postsynaptic cytosol, triggering phosphorylation of CaMKII, which in turn phosphorylates SynGAP.
SynGAP regulates Ras-GTPases controlling actin dynamics and AMPARs insertion into the postsynaptic membrane.
In Syngap1 Heterozygous mutation, the inhibition of Ras activation by SYNGAP1 is lost, which increases Ras
activity, thereby increasing AMPAR exocytosis to the postsynaptic membrane. Phosphorylation of SynGAP by
cyclin-dependent kinase 5 (CDK5) activates Rap1 that increases endocytosis of AMPAR. This schematic was made
using Biorender software.
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synaptic activity and facilitating LTP. In contrast, Rap promotes removal of short-tailed AMPA-
Rs through the p38-MAPK, promoting activity induced synaptic long-term depression (LTD).
Given its dual HRas and Rap1 function, one would expect loss of SynGAP to result in altered
AMPAR mediated transmission, LTP and LTD. Komiyama et al. (2002) show that under
basal conditions in Syngap1-/- mice, AMPAR transmission is unaffected. However, stimulation
of LTP affects recruitment of AMPARs to the PSD, resulting in impaired LTP in the CA1
of the heterozygous mice. Given that this impairment in LTP is driven by Ras, one would
expect HRas-/- mice to mimic this impairment. HRas-/- mice, infact, show enhanced AMPAR
transmission following an LTP stimulation protocol. There appear to be two explanations for
this observation: First, the loss of HRas maybe compensated for by other Ras subtypes and
second, Ras-independent forms of LTP have been reported. Clement et al. (2013) measured an
increased AMPA/NMDA ratio with decreased LTP in L4 stellate cells of the somato-sensory
barrel cortex of P5 het mice. Ozkan et al. (2014) showed that tamoxifen-induced reversal
of SynGAP levels in adult mice rescued the LTP deficit and lowered Ras and p-ERK levels.
While the LTP deficits have been widely reproduced, studies on the surface expression of
AMPA-R sub-units (GluR1, 2 and 3) has been more controversial. Rumbaugh et al. (2006)
report decreased surface expression of GluR1 but increased number and size of GluR1 clusters
in cultures from Syngap1-/- mice. Muhia et al. (2010) found a similarly increased size of
GluR1 clusters in a conditional Syngap1-knockout mouse. However, Krapivinsky et al. (2004);
Vazquez et al. (2004); Carlisle et al. (2008), and Araki et al. (2015) all report an increase in
AMPAR concentration upon loss of SynGAP. Kim et al. (2003), further showed that transfecting
cells lacking SynGAP with the full length SynGAP protein actively reduces surface AMPAR
expression by about 33%.
In addition to impairments in LTP, models of Syngap1 haploinsufficiency have also presen-
ted with altered LTD in a stimulation protocol-dependent manner. Upon chemical induction of
LTD, using a high Ca2+ solution, reduced levels of LTD were reported in the CA1 region of 6-12
week old Syngap1+/- mice (Carlisle et al., 2008). Whereas LTD induction using a low-frequency
paired-pulse protocol in the CA1 of similarly aged Syngap1+/- mice produced no LTD deficit
(Kim et al., 2003). Induction of LTD by stimulating the metabotropic glutamate receptor-5
(mGluR5) using DHPG showed exaggerated LTD in the CA1 of juvenile (P25-32) het mice
(Barnes et al., 2015). Thus, while the exact mechanics are debated, SynGAP appears to me-
diate synaptic plasticity in an NMDAR-dependent manner through manipulation of AMPA-R
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trafficking.
The studies so far discussed all report the influence of SynGAP on AMPAR trafficking via
downstream signalling cascades, a GAP-domain dependent function. A study by Walkup et al.
(2016) suggests an alternative C-terminus domain dependent mechanism by which SynGAP
might influence AMPAR trafficking. At the post-synaptic membrane, AMPARs undergo a three-
step immobilisation process that allows the docking of these receptors at the membrane. The
three steps include insertion into the membrane, diffusion into the synapse and ‘trapping’ at the
membrane (Opazo and Choquet, 2011). AMPAR trapping is mediated by proteins present in the
post-synaptic density (PSD) including transmembrane AMPAR regulatory proteins (TARPs)
and leucine rich repeat transmembrane proteins (LRRTMs). The PSD is a complex composed
of signaling and scaffolding proteins present just below the post-synaptic membrane. The most
abundant of its scaffolding proteins is PSD-95 that binds multiple PSD proteins, including
TARPS, LRRTMs and SynGAP, via multiple PDZ protein domains. The Walkup et al. (2016)
study postulates that since each PSD-95 molecules has a predefined number of PDZ binding
domains, PSD proteins must compete with each other to fill these PDZ ‘slots’. They further
report that SynGAP, via its C-terminus QTRV motif, competes with PSD proteins like TARPs
and LRRTMs to preferentially bind the PDZ slots of PSD-95, thereby restricting AMPAR
docking at the PSD. Phosphorylation of SynGAP by CamKII and Polo-like Kinase 2 (PLK2)
reduces its affinity to bind the PDZ domain of PSD-95, thereby freeing up PDZ-slots for other
proteins, resulting in increased AMPARs at the PSD.
During synaptic plasticity, PSD size and composition are dynamically regulated with changes
to synaptic strength. This change is thought to form the biophysical basis of LTP and LTD with
recent in vitro super-resolution studies proposing a liquid–liquid phase separation (LLPS) model
for this modulation. In the LLPS model, proteins are constantly diffusing between the dense
LLPS ‘core’ structure formed by the protein-enriched cellular compartments beneath the post-
synaptic membrane, and the less concentrated aqueous cytoplasm in synaptic spines (Feng et
al., 2019; Zeng et al., 2016). SynGAP binding of PSD-95 induces phase separation, causing
dispersion of the protein from the PSD complex into the cytoplasm, allowing for the recruitment
and stabilization of AMPA receptors to the PSD thus controlling synaptic plasticity (Lautz et
al., 2019). However, analysis of SynGAP protein concentrations from neurosynaptosomes and
whole cell homogenates in rat models of Syngap1 haploinsufficiency (S Nawaz, upublished)
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found no differences in protein concentration, suggesting that altered protein phase does not
underlie the aberrant synaptic plasticity in this model.
Both GAP-dependent and GAP-independent models of SynGAP function highlight the im-
portance of this protein in controlling synaptic plasticity. However, it is still not known which of
these modes of function is disrupted in individuals presenting with SYNGAP1 haploinsufficiency
mediated ID.
Lastly, SynGAP is also thought to mediate synaptic plasticity by regulating spine morpho-
logy. Actin regulation and dynamics can have both a physiological as well as a morphological
effect on spines. The former is mediated by control of AMPA-R trafficking whereas the later
through changes in architecture of spine shape, size, and turnover dynamics. F-actin is down-
stream of Ras and Rac-GTP and also associates with N-Cadherin which is downstream and
activated by the AMPA-R subunit GluR2. Vazquez et al. (2004) first showed that cultures of
Syngap1+/- neurons have increased spine number with larger head width. Carlisle et al. (2008)
showed that at steady state, SynGAP regulates phosphorylation of the actin-binding protein
cofilin in a Rac-PAK 1,3 kinase dependent manner. In Syngap +/- mice, levels of Rac-GTP,
activated PAK and inactive (phosphorylated) cofilin were elevated. The same mice failed to
show transient de-phosphorylation of cofilin upon activation of NMDARs and presented with
increased spine number and spine head-width in the CA1 sub-region of the hippocampus. Clem-
ent et al. (2012) also show the similar increases in spine length, number and head width in the
dentate gyrus (DG) of the hippocampus. Barnes et al. (2015) however, found no difference in
either spine density or head width in the CA1 of the hippocampus using super-resolution STED
microscopy. The study did, however, find an increase in spine neck length in the Syngap1+/-
mice compared to WT controls, indicating an increase in compartmentalisation factor. The com-
partmentalisation factor shows the impact of morphological change on biochemical diffusion
coupling and is calculated as head volume x head neck length / area of spine neck cross-section
(Wijetunge et al., 2014). In the case of Syngap1+/- mice it would indicate altered biochemical
coupling of the spine to the parent dendritic shaft. McMahon et al. (2012) also found no effect
of specific isoforms on spine, density, width or length in SynGAP knockout neuronal cultures.
The discrepancies between the studies maybe accounted for by a few reasons. First, all studies
were done at different ages, Carlisle et al. (2008) at 3-6 months, Clement et al. (2012) at P14
and Barnes et al. (2015) at P35. Secondly, the Clement et al. (2012) study was performed
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at a different sub-region of the hippocampus, the DG, compared to the CA1 in the Barnes et
al. (2015) study. Third, spines on different dendrites were chosen for analysis: Barnes et al.
(2015) measured apical dendrites whereas Carlisle et al. (2008) measured spines on the basal
dendrite. However, the most pronounced reason for the discrepancies in the findings reported is
the use of a spine categorisation system employed in the Carlisle et al. (2008) and Clement et
al. (2012) studies. This system differentiates spines into ‘stubby’, ‘mushroom’ and ‘filopodia’
depending on on its morphology, and both studies state that the differences reported are for the
‘mushroom’ spines. However, spine morphology is shown to cover a continuum of shapes and
sizes uncorrelated to function, making the rather simple classification obsolete (Wijetunge et al.,
2014), and it therefore is unclear if genotype differences would persist with this categorisation
removed. Additionally, Clement et al. (2012) use spine number (ranging from 2383 to 2788
spines) as their independent metric or ‘n’ for statistics. Spine numbers are dependent on the an-
imal, therefore using it as the ‘n’ conflates statistical significance. Another study by Aceti et al.
(2015) found an increase in spine length and density in L5 of the primary somato-sensory cortex
of Syngap1+/- mice at P21 that is lost by P60. Using time-lapse microscopy they also show
decreased spine turnover at P21-23 and P30-32 suggesting accelerated maturation. Clement et
al. (2012) show increased spine motility in the DG of Syngap1+/- mice at P14. This evidence
suggests that SynGAP has a role in altering spine turnover dynamics during critical periods of
development, but these might be distinct across brain regions.
1.4 Modelling SYNGAP1 haploinsufficiency
In order to understand the pathophysiology of complex disorders, it is vital that we are able
to successfully model them in a pre-clinical setting. The original definition of an ‘ideal’ pre-
clinical model of human psychiatric disorders was coined by (McKinney and Bunney, 1969).
They required that for a model to be relevant to human pathology it must show analogous of
symptoms with existence of observable and measurable behavioral changes, that was agreed
upon amongst multiple observers. The model must also be reproducible and show similar
response to treatments. The original 5-point criteria has since been adapted to three core criteria
of validity (Belzung and Lemoine, 2011):
18
Construct validity refers to the human-model similarity of the genetic predisposition that
participates in the etiology of the disease. In the case of SYNGAP1 haploinsufficiency this
would require that the animal model present with a 50% reduction in SynGAP protein resulting
from loss of one copy of the Syngap1 gene.
Face validity is the similarity of observable ethologically-relevant pathological behaviours
in the model compared to the human disorder. In modelling social isolation of individuals with
ASD/ID, one would look for altered social behaviours in the animal model. Face validity is
sometimes extended to also include ‘biomarker’ validity, wherein functionally-related biological
markers of the modeled condition are present in the pre-clinical model. For example, when
modelling post-traumatic stress disorder in rodents, a surge in glucocorticoids is measured
despite the fact that they do not come in the same form in human subjects (cortisol) and in
rodents (corticosterone).
Predictive validity refers to the ability of the model to predict both behavioural and pharma-
cological outcomes of the condition it is modelling. In cases of epilepsy, a model with predictive
validity would inform the experimenter of the efficacy of an anti-epileptic drug being tested.
The most widely used model of SYNGAP1-ID at present is a heterozygous mouse model
while in this thesis, I use two novel monogenic rat models of Syngap1 haploinsufficiency.
However, as behavioural, circuit and electro-physiological characterisation of the rat models
occurred concurrently with the work outlined in this thesis, the behaviour and circuit deficits
of only the Syngap1 mouse model and how it compares to patient co-morbidities is outlined
below.
1.4.1 Mouse Model of SYNGAP1 haploinsufficiency
Cellular and Synaptic Deficits
The first knock-out mouse model of Syngap1 was published by Komiyama et al. (2002).
They noted that mice homozygous for the Syngap1 deletion (Syngap1-/-) died between P2 to
P5. However, Kim et al. (2003) and Barnett et al. (2006)) found that reducing litter sizes
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by selective removal of litter-mates allowed Syngap1-/- to survive till P7. The lethality of the
deletion may explain why no individuals with a homozygous deletion in SYNGAP1 have been
reported.
One of the most reported features of individuals with SYNGAP1 haploinsufficiency is pres-
ence of cortical generalized seizures (Carvill et al., 2013; Berryer et al., 2013). To analyse the
presence of spontaneous seizures, Ozkan et al. (2014) performed video-monitored electroen-
cephalography (EEG) in adult (>12 weeks) WT and het mice. While no seizure-like motor
events were observed in the video recordings, high amplitude cortical discharges were recorded
in the EEG from the het mice but not from the WT littermates. These epileptiform discharges
were intermittent, ranging in frequency from 1 to 681/hour (mean of 81/hr). They also found a
decreased threshold of flurothyl induced clonus and tonic-clonic seizures in the het mice. Addi-
tionally, Clement et al. (2012) reported an increased incidence of audiogenic seizures at P21-25
in the het mice. 100% of the hets in their behaviour cohort showed wild-running, consisting
of intense running mixed with high jumps, compared to 50% of the WTs, and 66% of the hets
had seizures. While both these studies are encouraging of the face validity of the mouse model,
the data should be interpreted with caution as the power of the experiments is low. The Ozkan
et al. (2014) study employed an n=3 and n=2 for the het and WT mice respectively while the
Clement et al. (2012) study used an n=6 per genotype.
A significant number of individuals with SYNGAP1-ID present with altered sensory percep-
tion, predominantly increased sensitivity to sound (hyperacusis) and photosensitive epilepsy
(Parker et al., 2015; Klitten et al., 2011). While the exact biomechanics underlying these altera-
tions is yet to be elucidated, they are thought to result from impaired connectivity and processing
within neuronal networks. This typically manifests as an impaired excitatory/inhibitory (E/I)
balance and given the abundance of SynGAP at glutamatergic synapses, its loss is hypothesised
to result in increased excitatory activity (Lee et al., 2017). In support of this, Clement et al.
(2012) showed that photostimulation-evoked signals, measured using fast voltage-sensitive dye
imaging, originating in the dentate gyrus (DG) of het mice were amplified, instead of attenuat-
ing, as they spread through the hippocampus. Using a similar imaging approach Ozkan et al.
(2014), also reported increased excitability in the medial-prefrontal cortex of adult (8-10 weeks)
het mice. While both these studies have focused on increased glutamatergic neuronal activity,
another possible explanation for increased excitability is the loss of inhibition. Berryer et al.
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(2016) used an optogenetic approach with a conditional mouse line to selectively knock-out
Syngap1 from GABAergic inhibitory cells derived from the medial ganglionic eminence. They
found that Syngap1 haploinsufficiency significantly reduced the formation of perisomatic innerv-
ations by parvalbumin-positive basket cells, impairing their connectivity and reducing inhibitory
synaptic activity and cortical gamma oscillation power in the somatosensory cortex. The studies
so far present evidence of a shift in the E/I balance towards increased excitation, either by a
direct increase of glutamatergic activity or reduced GABAergic inhibition. Recent evidence by
Michaelson et al. (2018) suggests that these shifts might be circuit specific. They report reduced
cortical activity in the upper lamina of the somatosensory cortex-barrel field (S1BF) of adult
Syngap1+/- mice. This suggests a circuit hypo-excitability might underlie altered thigmotaxis
(altered movement of an animal in response to a touch stimulus (Simon et al., 1994; Walz et
al., 2016)) which has been reported in 20 of 48 patients in the same study. These deficits are
particularly confounding as a previous study by Aceti et al. (2015) found accelerated matura-
tion of dendritic spines and synaptic pruning during critical periods in the S1BF of het mice.
Additionally, Barnett et al. (2006) showed that while complete loss of SynGAP resulted in more
serious barrell-loss phenotypes, het mice show normal but delayed formation of barreloids in
L4 of the S1BF. They found partial segregation of the thalamocortical afferents (TCA) from
the whiskers into barreloids in the thalamus in P5-7 Syngap1-/- mice. These afferents further
made it into L4 of the S1Bf but lost cellular segregation, resulting in a lack of barrels in the S1.
The discrepancies between the studies can, to some extent, be attributed to the difference in age
between the studies. The study by Aceti et al. (2015) used animals between P14-21 while the
Michaelson et al. (2018) study used adult mice.
Sensory hypersenstitivites may also arise from an inability to filter or prioritize incoming
sensory stimuli, thus leading to a ‘overload’ of sensory information. This process, termed
‘sensorimotor gating’, is tested using the ‘Pre-pulse inhibition’ (PPI) test and is known to rely
on fore-brain circuitry (Braff et al., 2001). The PPI test is based on the principle that pre-
exposure to weaker stimulus, the ‘pre-pulse’, dampens the response to an immediately followed
(within 150 ms) stronger stimulus. Guo et al. (2009) performed an acoustic PPI and startle
test in Syngap1 het mice and WT controls using a pre-pulse sound of 4KHz presented at 4-16
dB above background noise followed by a 120ms delayed startle sound of 120 dB. For the
general startle response, naïve mice were subjected to increasing amplitudes of white noise
ranging form 70-120 dB. They found that the het mice presented with both reduced inhibition
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to the startle response and a generally heightened startle response, measured as amplitude of
the evoked potential using an EEG.
Behavioural Deficits
In addition to altered excitability in models of Syngap1 haploinsufficiency, a number of
cognitive and behavioural deficits have also been observed in these mice. These deficits have
been observed in both lines with complete germline mutations (Komiyama et al., 2002; Muhia
et al., 2009, 2010; Clement et al., 2012; Ozkan et al., 2014; Berryer et al., 2016) as well as lines
where SynGAP has been deleted in a cell-type and age dependent manner (conditional mutants)
(Muhia et al., 2012; Ozkan et al., 2014; Berryer et al., 2016).
Hyperactivity & Anxiety
One of the most consistent behavioural findings reported in Syngap1 het mice is increased
locomotor activity (Guo et al., 2009; Muhia et al., 2009, 2010, 2012; Clement et al., 2012;
Berryer et al., 2016). Hyperactivity is measured by calculating total distance travelled and
moving speed of the mouse when exposed to an open field environment (Guo et al., 2009;
Muhia et al., 2010; Ozkan et al., 2014; Berryer et al., 2016). This increased locomotion is
suggested to be due to increased glutamatergic activity, rather than loss of inhibitory activity,
with a resultant disruption in the E/I balance of the circuit. Evidence for this comes from the
Berryer et al. (2016) and Ozkan et al. (2014) studies, where no increase in locomotion was
observed in mice where SynGAP was conditionally deleted in GABAergic neurons arising from
the MGE, while hyperactivity was observed in mice with SynGAP conditionally knocked out
in glutamatergic neurons of the fore-brain. The Ozkan et al. (2014) study also performed a
‘rescue’ experiment, wherein they found that reversing SynGAP levels in the adults rescued the
cellular phenotypes outlined in section 1.3.3 but did not alter the increased locomotion levels
observed in these mice. Suggesting that reversal of cellular and synaptic abnormalities does
not reverse the pleiotropic compensatory changes which together contribute to the pathology of
SYNGAP1-ID. Guo et al. (2009) also noted an increase in ‘stereotypy’ behaviours in the het
mice, a characteristic widely reported in individuals with autism and schizophrenia (Randrup
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and Munkvad, 1974). Scored as bouts of repetitive movements without purpose, presence of
these behaviours in the het mice confers further face validity to this model.
In addition to hyperactivity, a decrease in anxiety-related behaviours is also widely reported
in the Syngap1 het mice. Most endogenous measures of anxiety utilize the rodent instinct to
preferentially spend time in shaded/covered regions as opposed to open/exposed regions. In the
open field arena, anxiety levels are scored by comparing the amount of time the mouse spends
in the walled periphery to the amount of time spent in the exposed (arbitrarily defined) centre.
Another widely used behavioural task to measure anxiety in rodents is the elevated plus maze
(EPM). The arena for the EPM consists of safe ‘closed’ arms with high side walls crossed with
unsafe ‘open’ arms without any side walls to form a plus shaped elevated platform. Anxiety in
this task is measured as amount of time spent in the closed arm compared to time spent in the
exposed open arm (Lister, 1987; Peier, 2000). In addition to time spent in the open arms/centre,
another measure of anxiety is the number of entries into the centre (open field) or the open arm
(EPM). In both tasks, Syngap1 het mice show reduced anxiety with increased amounts of time
spent and entries into the ‘centre’ of the open field (Guo et al., 2009; Muhia et al., 2010) as well
as the ‘open arms’ of the EPM (Muhia et al., 2010; Ozkan et al., 2014; Berryer et al., 2016).
Contrary to the observations made in mice, most individuals with SYNGAP1-ID show elevated
levels of anxiety (Krepischi et al., 2010; Klitten et al., 2011). Given that the above described
tasks used to measure anxiety levels in the rodent models are dependent, to some degree, on the
animal’s movement, the hyperactivity observed in the het mice might offer an explanation for
the discrepant anxiety phenotypes between the mouse model and human patients.
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Social Function
Impaired social interaction and communication are key features observed in individuals
with ASD. To test if the Syngap1 het mice present with similar social impairments, studies used
the 3-chamber social interaction task to assess social interaction, social isolation and preference
for social novelty (Guo et al., 2009; Berryer et al., 2016). The 3-chamber task utilizes the wild-
type rodent preference for sociability, the choice of spending more time with another rodent as
opposed to an object, and social novelty, preferentially investigating a new intruder placed in the
arena compared to a familiar one (Nadler et al., 2004; Bolivar et al., 2007). Accordingly, time
spent in the central ‘neutral’ chamber as opposed to chambers with rodents in them is scored as
‘social isolation’. Both studies found that Syngap1 het mice showed decreased preference for
social novelty without any change in social interaction. Guo et al. (2009) also report increased
social isolation. Social interaction is scored by counting the number of entries into the specific
chamber as well as time spent ‘sniffing’ the con-specific animal. Therefore, one explanation
for decreased social novelty memory might be impaired olfactory processing in the het mice.
However, Guo et al. (2009) found no olfactory deficits in these mice, suggesting that the
observed phenotypes were in fact social deficits. These studies indicate that reduced SynGAP
function results in a significant cognitive defect altering social interactions.
Cognition & Memory
Most individuals with SYNGAP1-ID present with moderate to severe ID (for review see
Vlaskamp et al. (2019)), therefore testing cognition and memory in the Syngap1 het mice
is crucial for the face validity of the model. A brain structure vital for the acquisition and
consolidation of spatial memory is the hippocampus (Hodges, 1995) and the Syngap1 het mice
show impaired NMDAR mediated LTP and exaggerated mGluR5 mediated LTP in the CA1 sub-
region of the hippocampus. These impairments have previously been associated with deficits
in spatial reference memory. As such, Komiyama et al. (2002) and Muhia et al. (2010) tested
hippocampal-dependent spatial memory in these mice using the Morris Water Maze (MWM). A
spatial reference-memory version of the task was used wherein the latency of the animal to find
a platform using distal visual cues was measured. Both tests reported mildly impaired spatial
memory retrieval in the het mice with no difference in memory acquisition or extinction. Muhia
et al. (2010) also reported a decrease in time spent in the ‘correct’ platform quadrant by the het
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mice when the platform is removed. However, this deficit was only found in the first 15 s of the
60 s testing period.
Muhia et al. (2010) also assessed reference and working memory in the Syngap1 het mice
using a baited version of the dry-land radial-arm maze. In this test, alternate arms of the maze
were ‘baited’ with reward food pellets. Following an initial training phase where a ‘reference
memory’ (RM) was acquired, RM errors were defined as initial entry into an unbaited arm.
Following this phase, the number of re-entries into a baited arm after reward consumption and
entries into a never baited arm were assessed as errors in ‘working memory’ (WM). They report
that the het mice showed impaired acquisition and retrieval of RM as well as increased WM
errors.
The most widely reported spatial memory deficit in the Syngap1 het mice is the loss of spon-
taneous alternation in the T-maze. Rodents innately explore novelty in their environment. The
unforced T-maze, which is dependent on a pre-frontal cortex-hippocampus network, assesses
this exploratory behaviour by measuring the entries of the rodent into each arm of the maze
(Deacon and Rawlins, 2006). While WT mice naturally alternate between the arms entered, the
Syngap1 het mice fail to do so above chance (Guo et al., 2009; Muhia et al., 2010; Berryer et al.,
2016). Given that this task involves the recognition of novelty (un-entered arm) over familiarity
(just entered arm), novel object recognition was also assessed in thees animals. However, no
deficits were observed in this task (Muhia et al., 2010).
In addition to spatial reference memory, the Syngap1 het mice have also been tested in
associative memory paradigms. Clement et al. (2012) showed that Syngap1 het mice exhibit
lowered freezing compared to WT mice in a hippocampal-dependent contextual fear paradigm.
In this paradigm, rodents are exposed to an aversive context ‘A’, where they receive aversive
stimuli like footshocks, followed by exposure to a neutral context ‘B’. The animals are then
returned to context ‘A’ and their aversive behaviour (typically presenting as freezing behaviour
in mice) is scored as a % of time. A similar result was reported by Ozkan et al. (2014) but only
in a conditional mutant where SynGAP was deleted from GABA-ergic neurons, using a Gad2-
cre driver line, and not in the mutant where SynGAP was deleted from excitatory glutamatergic
neurons. Guo et al. (2009), however found no differences in freezing behaviour of the Syngap1
het mice when using contextual fear conditioning. This result is unsurprising as the WT mice
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in the study by Clement et al. (2012) showed very little reduction in % time spent freezing over
the course of the entire protocol, suggesting a generalised fear response as opposed to the more
widely reported reduction in freezing over time. Guo et al. (2009), however, did report reduced
freezing in Syngap1 het mice following a cued-fear conditioning paradigm. In this paradigm, a
specific cue (called the conditioned stimulus or CS), like a tone, is associated with an aversive
stimulus (called the unconditioned stimulus or US), like a foot-shock, and is dependent on a
pre-frontal cortex-amygdala interaction as opposed to hippocampal interactions.
Un-modelled Alterations
While a majority of the neurological and behavioural presentations of SYNGAP1-ID have
been modelled in the mice, others have not been as extensively characterised. Increased pain
tolerance has been reported in individuals with SYNGAP1-ID, but the Syngap1+/- mice show
no altered sensitivity to thermal stimulation (Muhia et al., 2010). Individuals also present with
altered sleep patterns, but circadian rhythm abnormalities yet to be studied in the Syngap1+/-
mouse model.
1.4.2 Using Rats to Model ASD/ ID
A number of factors have led to mice being the most widely used model organism in
biomedical research (Mayford et al., 1997). These include the availability of a diverse genetic
toolbox to create transgenic lines with precise spatial and temporal control of loss of function
mutations as well as rescue experiments (Lipp and Wolfer, 1998), a short reproductive cycle
making them more cost-effective to maintain in the lab (Siglin and Baker, 2001) and better
performance, compared to other rodent models, on tasks involving touch-screens (Bussey et
al., 2008). However, within the framework of ‘bench top to bedside’ translational medicine,
modelling ASD/IDs in mice presents with some limitations. Behaviourally, mice show limited
cognitive flexibility, thereby restricting the battery of tests that can be used to study a disorder
that predominantly presents as deficits in cognition (Ellenbroek and Youn, 2016). They also
show increased impulsivity, introducing greater variability in datasets of more challenging tasks
Ellenbroek and Youn (2016). Ethologically, male mice show limited social interactions, living
in single-male territorial structures (called ‘demes’) that is founded by an alpha that mates
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with multiple females (Van zegeren, 1979). As a result, interactions between males are much
rarer and, when they occur, are more aggressive and territorial in nature (Schmid-Holmes et
al., 2001). In accordance with this observation, studies investigating home-cage relations in
WT mice have revealed aggressive behaviour between con-specifics. This presents a challenge
when modelling disorders where impaired social interaction is at the diagnostic core.
Using the Norway rat, Rattus norvegicus, as a model organism mitigates a few of these
limitations. First, rats offer greater cognitive flexibility as witnessed in operant tasks to self-
administer drugs (Parker et al., 2014). They also perform better, with smaller reported variability,
in a number of cognitive flexibility and attention tasks including attention shifting, delayed at-
tention and delayed (non) matching to sample tasks Ellenbroek and Youn (2016). Given that
ADHD is a highly reported co-morbidity of ASDs (Leitner, 2014), it is crucial that the model
used is able to perform complex attention tasks, especially when testing drug efficacy. Specific-
ally for mood disorders, another common comorbidity to ASD/ ID, rats and mice show distinct
neurochemical profiles, with the rat profile being more closely matched to human physiology.
For example, in a restrained-stress paradigm Konstandi et al. (2000) showed that rats and mice
evoked differential transmission of noradrenaline, dopamine and serotonin. Further, Larm et
al. (2003) performed a comparative study looking at the expression profiles of serotonergic
neuropeptide galanin and its receptor GalR1 (Misane et al., 1998). Galanin and Galr1 have
been implicated in regulating cellular processes underlying anxiety and depression. The study
showed that mice lack these molecules in the dorsal raphé nucleus, a brain region key for reg-
ulating mood disorders. Consistent with this finding, studies by Blanchard et al. (1997) and
Griebel et al. (1997) found that drugs acting on the serotonergic pathway had anxiolytic and
panicolytic effects in rats but not in mice. These neurochemical differences between rats and
mice extend to the effect of corticotropin releasing factor (CRF). CRF expression in the brain
stem is a key regulator of fear and anxiety (Van’T Veer et al., 2012) whereas its expression in
the cortex is associated with cognition and stereotyped motor behaviours (Binder and Nemeroff,
2010; Crawley et al., 1985; Dunn and Swiergiel, 2008) showed intra-cerebroventricular admin-
istration CRF lead to a reduction of depression like behaviours in rats but not mice. Given the
potential pharmacological implications of species choice on the predictive value of the model,
efforts must be made to find a balance between high-throughput models with human-relevant
physiology.
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Specifically for ASDs, the aspect where rats most prove their superiority over mice as
the model of choice is social cognition and behaviour. Ethologically, rats live in complex
hierarchical colonies but dominance structure amongst the males is less rigid, with all males
often mating with all females. This fluid structure acts to reduce aggression and territorial
instincts between males (Blanchard et al., 1997) and increases natural social interaction. The
increased sociability of rats, compared to mice, is supplemented by observations of juvenile
rats in ‘rough and tumble’ play and wrestle behaviour (Siviy and Panksepp, 2011). In humans,
peer-play is an integral part of childhood development, and children with ASD and ADHD often
experience social isolation. Play behaviour in rats typically comprises of non-serious chasing,
fighting and rolling around together accompanied by emission of high frequency (50kHz) ultra-
sonic vocalisations (USVs). Play has been shown to promote growth factor expression in the
brain (Gordon et al., 2003), with rats that were isolated showing increased play behaviour
upon restoration of sociability (Burgdorf et al., 2013). Social interaction was also found to
be the preferred reward, compared to a cocaine reward, in rats (79%) when compared to mice
(22%) (Kummer et al., 2014; Zernig and Pinheiro, 2015). In addition to play rats also exhibit
‘empathy’, another sophisticated and nuanced behaviour. Sato et al. (2015) tested the presence
of altruistic intentions in rats using a witness to distress paradigm. In this setting, rats were
placed in a plexiglass box divided into two compartments with entry between sides restricted by
a hatch. In one half of the compartment, the rat was subjected to a forced swim test with steadily
rising water levels. The only way for the ‘forced-swim’ rat to escape was if the observer rat
released the hatch separating the two sides. The results from the experiments showed that the
observer rat only released the hatch when the ‘forced-swim’ rat was in distress. Additionally, if
the observer had previously been subjected to the forced swim paradigm the rat learnt to release
the hatch, and save the cage-mate, faster than one that had never been soaked. These, more
sophisticated, empathy experiments have so far only been possible in rats compared to other
laboratory rodents. Thus, when modelling disorders like ASD/ID where impairments in social
cognition and interaction is a key feature of the diagnosis, using the rat over the mouse might
be preferred.
Rats also provide a number of auxiliary benefits. They weigh about 10 times more than
mice, with the rat brain weighing 4 times more than the mouse brain (Ellenbroek and Youn,
2016). This increased size leads to larger tissue samples and increased blood volume, reducing
the number of animals needed, particularly when measuring low-abundance molecules. The
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increased size also aides technically complicated procedures like surgeries, allowing better
targeting of smaller brain structures, like the thalamus, and implantation of in vivo micro-
electrodes as early as P14 (Langston et al., 2010). The latter is particularly advantageous
when studying NDDs as it allows for longitudinal studies within the same animal, providing
unique insights into the developmental trajectory of these disorders. In addition to the rat
brain weighing more than the mouse brain, the cortex is 40% thicker. This allows for about 10x
improved spatial resolution in non-invasive imaging studies using positron emission tomography
(PET) (Zheng et al., 2016). Another popular imaging technique widely used to study brain
dynamics is resting state functional magnetic resonance imaging (rsfMRI). While rats and mice
show similar spatial resolution in this technique, the variability in the acquired datasets is much
lower in the rat (Jonckers et al., 2011). Finally, rats are also shown to better recapitulate gender
differences of human clinical conditions including inflammatory diseases and cardiovascular
diseases (Paul et al., 1994; Taurog et al., 1999).
The predominant drawback of using rats, compared to mice, is the limited availability of
sophisticated genetic manipulation tools and the increased cost of maintenance. However, recent
advances in zinc-finger nuclease and CRISPR/Cas9 technology have allowed for the generation
of rat knock-out models of ASD/ID including Fmr1, MeCP2, Nlgn3, Nrxn1, GRM5, Pten and
CNTNAP2 (Horizon Discovery). The use of these models is already expanding our current
understanding of these disorders (Engineer et al., 2014; Till et al., 2015).
Given the improved translational attributes of rats outlined above, this thesis uses two novel
rat models to study SYNGAP1 haploinsufficiency mediated ID. The first shares construct validity
with the human and mouse models, being heterozygous for the entire protein (Syngap1+/-). The
second model has a specific deletion of the GAP domain (Syngap1+/∆GAP), seeking to delineate
what attributes of the disorder are specifically contributed to by the loss of the GAP domain.
1.5 Convergence in models of ASD / ID
Despite the genetic heterogeneity of ASD/ID the disorders manifest with substantially over-
lapping behavioural abnormalities. This, in turn, might indicate mutually affected molecular
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pathways and circuits in the pathophysiological axis of these disorders. Indeed, bioinformatics
analysis of common and rare variants of genes causative of ASD/ID has identified biological
sub-networks where a significant number of these genes cluster (Hormozdiari et al. (2015), De
La Torre-Ubieta et al. (2016)). One such predominant cluster is genes involved in synaptic
function (Figure 1.6). This cluster includes modulators of biochemical pathways that control
protein turn-over including protein translation (SYNGAP1, FMR1, TSC1/2, PTEN) and degrad-
ation (UBE3A) as well as adhesion (NRX and NLGN) and cytokeletal (CNTNAP2) molecules
that control synapse formation, maintenance and neuronal conduction. The net effect of these
mutations is altered synaptic strength, which, in turn affects circuit excitability (Lee et al., 2017).
Figure 1.6: Synapse schematic A schematic of an excitatory pre and post-synaptic compartments showing proteins
implicated in ASD/ ID that will be investigated in this thesis highlighted in bold.
Experimental evidence of this idea of biochemical and molecular convergence is found
in a number of animal models of ASD/ ID (Auerbach et al., 2011; Baudouin et al., 2012;
Zoghbi and Bear, 2012; Costa-Mattioli and Monteggia, 2013; Krumm et al., 2014; Pinto et
al., 2014; De Rubeis et al., 2014; Barnes et al., 2015). One such node of convergence is
dysregulation of local protein turnover, wherein mouse models of fragile-X syndrome (FXS),
SYNGAP1-haploinsufficiency, Eif4ebp2-deletion show exaggerated protein synthesis (Osterweil
et al., 2010; Barnes et al., 2015; Gkogkas et al., 2013), models of tuberous sclerosis (TS) show
reduced protein synthesis (Auerbach et al., 2011) and models of Angelman’s syndrome show
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enhanced protein degradation (LaSalle et al., 2015). Another node of convergence is altered
synaptic function leading to exaggerated or impaired LTP and LTD associated with changes in
cellular and circuit excitability. Group 1 metabotropic glutamate receptor (mGluR1/5) mediated
LTD is found to be exaggerated in mouse models of FXS (Huber et al., 2002), SYNGAP1-
haploinsufficiency (Barnes et al., 2015), Angelman’s syndrome (hui Jiang et al., 1998) and
occluded in models of TS (Auerbach et al., 2011), NLGN3 associated NSID (Baudouin et al.,
2012), Cowden syndrome (Butler et al., 2005). Similarly LTP is found to be impaired in models
of FXS, Noonan syndrome, Neurofibromatosis 1 and SYNGAP1-haploinsufficiency while LTP
is enhanced in Costello syndrome (Louros and Osterweil, 2016).
From a therapeutic standpoint, mechanistic convergence is a particularly attractive hypo-
thesis. If true, this would save considerable time and resources in drug-safety and clinical
trial studies as the same drug could be administered to individuals with genetically distinct
causes of ASD/ID. Pre-clinical evidence of this was shown in Barnes et al. (2015), where they
found that acute application of drugs that have previously been used to ameliorate phenotype in
mouse models of FSX including CTEP (mGluR5 inhibitor), lovastatin (indirect Ras inhibitor)
and U0126 (ERK1/2 inhibitor), successfully lowered basal protein synthesis levels in a mouse
model of SYNGAP1-haploinsufficiency.
Given that altered cellular excitability provides another possible avenue of convergence, this
thesis looks at a key controller of this excitability - the axon initial segment.
1.6 The Axon Initial Segment
Neurons, the most abundant cell type in the brain, are composed of two functionally distinct
compartments (Figure 1.7): The somatodendritic compartment which is composed of the cell
body and dendritic arbor, receives inputs from the surrounding cells, and the axonal compart-
ment, the main output compartment, propagates action potentials generated by the neuron to
trigger synaptic release onto downstream projections. At the junction of the two compartments,
just beyond the axon-hillock, sits the axon initial segment (AIS). First described over fifty years
ago, the AIS is the site of action potential (AP) generation (Palay et al., 1968; Peters et al.,
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1968). In the years since, its unique molecular architecture and functions have been extensively
studied.
Described below is a brief overview highlighting the key structural components and func-
tion of the AIS with emphasis on its morphological plasticity in response to physiological
manipulations and pathological conditions.
Figure 1.7: Axon initial segment structure The Axon Initial segment lies between the somatodendritic input
compartment and axonal output compartments of the neuron (Upper panel). AIS membrane is composed of voltage-
gated ion channels (Nav, Kv7) and cell adhesion molecules (CAMs) that are bound to the underlying microtuble
fascicles by anchoring protein Ankyrin-G. The submembrane complex of the AIS consists of α2/β4 spectrin
tetramers that connect actin rings spanning ∼190 nm with Ankyrin-G lying in the middle of this tetrameric complex
(lower panel). This schematic was made using the Biorender software and components are adapted from Leterrier
and Dargent (2014); Leterrier (2018).
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1.6.1 Molecular Composition of the AIS
Studies using electron microscopy first identified the AIS in the rat cerebral cortex as a
structure present along the first 20-60 µm of the axon shaft. Its identification was based on the
presence of three distinct morphological features (Palay et al., 1968; Peters et al., 1968):
• The presence of fascicles: bundles of 3-10 microtubules
• A ~50 nm-thick undercoat lining the plasma membrane, which abruptly disappears at the
onset of myelination
• A complete lack of ribosomes
The AIS has a layered molecular and cytoskeletal scaffold that extends from the microtubule fas-
cicles to the plasma membrane. The organisation of this sophisticated network of submembrane
and transmembrane proteins is predominantly achieved by the anchoring protein Ankyrin-G
(AnkG). Outline below is an overview of two key components that make-up the AIS membrane
complex, AnkG and voltage-gated ion channels.
Ankyrin-G (AnkG)
Ankyrins are peripheral membrane proteins with extensive tissue-specific isoforms arising
from alternative mRNA processing (Lambert and Bennett, 1993; Bennett, 1992). Two serine-
rich nervous tissue specific isoforms, encoded by the gene ankyrin-G or ANK3, of 480 and 270
kDa were first isolated from the human frontal cortex and termed AnkG (Kordeli et al., 1995).
AnkG clusters at the site of AIS formation in the proximal axon between E13.5 and P1 in vivo
or 3-4 days in vitro in neuronal cultures (Galiano et al., 2012; Gutzmann et al., 2014; Le Bras
et al., 2014). Starting at the N-terminus, AnkG comprises of a 24 ankyrin-repeat membrane
binding domain, a spectrin binding domain, a serine rich domain, an unstructured tail and a
carboxyl-terminal. This modular structure allows AnkG to interact with and organise all layers
of the AIS scaffold, earning it the title of ‘master-organiser’ (Bennett and Baines, 2001) and the
most vital constituent of the AIS (Jones and Svitkina, 2016).
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At the surface of the plasma-membrane AnkG, via its membrane-binding domain, forms
the archetypal AIS membrane protein complex consisting of voltage-gated ions channels and
cell adhesion molecules (CAMs) such as neurofascin 186 (NF-186) and Nuronal CAM (Nr-
CAM) (Figure 1.7). Voltage-gated sodium (Nav), potassium (Kv) and calcium (Cav) channels
bind AnkG through their ankyrin targeting motifs. The expression, distribution and function
of the various channel sub-types is further discussed in section 1.6.1. The spectrin binding
domain of AnkG binds to the underlying actin/spectrin sub-membrane complex, thus inserting
its entire amino-terminal, including the membrane-protein complex, into the plasma membrane.
Details of the arrangement of this complex were resolved using a combination of platinum
replica electron microscopy and stochastic optical reconstruction microscopy (Leterrier, 2018;
Vassilopoulos et al., 2019). The actin/spectrin sub-membrane complex is composed of actin
rings, ~190 nm apart, connected by spectrin tetramers. This complex presents along the entire
length of the axolemma, conferring structural rigidity to the axons (Xu et al., 2013; D’Este et
al., 2015; Leterrier et al., 2015). The spectrin tetramer composes of 2 α and 2 β sub-units,
with β4 being the predominant isoform in the AIS and β2 being the predominant isoform in
the distal axon. AnkG recruits β4-spectrin to the AIS in a phosphorylation dependent manner
(Dzhashiashvili et al., 2007; Yang et al., 2007; Jenkins et al., 2015) and binds repeats 14-15
of β4-spectrin (Komada and Soriano, 2002), positioning itself and its bound ion channels and
CAMs midway between the actin rings (Xu et al., 2013; Leterrier et al., 2015; D’Este et al.,
2017). The carboxyl-terminal tail of AnkG extends to a maximum depth of 140 nm into the
intracellular AIS shaft and connects the actin/spectrin complex to the underlying microtubules.
The interaction with microtubules is mediated via microtubule associated proteins including
end-binding protein 1/3 (EB1/3) (Leterrier et al., 2011) and nuclear distribution element-like 1
(Ndel1) (Kuijpers et al., 2016).
The domains and processes resulting in recruitment of AnkG to the AIS are unclear. Schultz
et al. (2006) suggests that AnkG recruitment is dependent on phosphorylation of pIκBα , a
phosphorylation inhibitor of nuclear factor-κB, while He et al. (2012) suggests that AnkG
recruitment and stability is dependent on palmitoylation of cysteine-70 of its membrane binding
domain. Further, Galiano et al. (2012) and Zhong et al. (2014) suggest that, in cortical
neurons, the formation of the AIS is dependent on the distal axon cytoskeletal protein complex
of actin/β2-spectrin and ankyrin-B. While the precise temporal dynamics of AIS assembly
are yet to be revealed, the importance of AnkG in AIS formation and maintenance has been
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demonstrated by a number of groups. Loss of AnkG in vivo (ankyrinG-/-) results in a loss of
‘AIS compartment’ proteins including β4-spectrin, Nav, NF-186 and NrCAM (Zhou et al., 1998;
Jenkins and Bennett, 2001; Jenkins et al., 2015). The cells of ankyrinG-/- mice present altered
physiological proprieties including increased threshold for AP initiation, reduced firing rate
with sporadic firing and decreased gamma oscillations (Zhou et al., 1998; Jenkins et al., 2015).
In vitro silencing of AnkG in hippocampal cultures using short-hairpin RNA (Jenkins et al.,
2015) or RNA-interference (Hedstrom et al., 2008) results in a similar loss of ‘AIS compartment’
proteins along with loss of axonal identity, as observed by the localisation of dendritic post-
synaptic markers including microtubule-associated protein 2 (MAP2), K+/Cl- co-transporter
(KCC2), PSD-95 and ‘spines’ in the proximal axon (Hedstrom et al., 2008; Rasband, 2010;
Jenkins et al., 2015).
Although AnkG is not needed for axon formation (Galiano et al., 2012; Jenkins et al., 2015),
it provides the selective advantage of formation of the AIS, in turn allowing rapid and precise
control over AP generation and neuronal signalling. Given the specialised and vital role of
AnkG in AIS assembly and maintenance of neuronal polarity this thesis uses AnkG as a marker
to identify the AIS.
Ion Channels at the AIS
High-density clustering of voltage-gated ion channels, including sodium (Nav), potassium
(Kv) and calcium (Cav) channels, is the hallmark of the AIS (Rasband, 2010; Kole and Stuart,
2012; Jones and Svitkina, 2016; Nelson and Jenkins, 2017; Leterrier, 2018).
Nav channels are made up of four transmembrane domains and localise to the AIS through
binding of AnkG to a nine amino-acid sequence in the cytoplasmic-loop connecting its trans-
membrane domains II and III (JoséGarrido et al., 2003). Nav1.1, Nav1.2 and Nav1.6 channels
localise along the length of the AIS in a cell-type and developmental age dependent manner
(Kole and Stuart, 2012). Nav1.1 is expressed in GABAergic cells, retinal ganglion cells and
spinal-cord motor neurons (Van Wart et al., 2007; Lorincz and Nusser, 2008; Duflocq et al.,
2008). In retinal ganglion cells, Nav1.2 is expressed in early development while expression of
Nav1.6 coincides with the onset of repetitive firing (Boiko et al., 2003). Whereas in cortical
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pyramidal cells of P14-16 rats, Nav1.2 is located at the proximal (to the cell soma) end of the
AIS whereas Nav1.6 is located at its distal end (Hu et al., 2009). Overall, Nav’s are respons-
ible for the local inward ion current at the AIS where Nav1.6 channels are responsible for AP
generation whereas Nav1.2 are involved in their back-propagation to the soma (Hu et al., 2009).
Kv channels at the AIS suppress neuronal excitability and regulate AP repolarisation, thus
determining AP threshold, inter-spike interval, and firing frequency of the neuron (Brown and
Adams, 1980; Pan et al., 2006). The most abundant Kv channels present at the AIS are the low
threshold Kv1.1 and Kv1.2 channels (Dodson et al., 2002; Goldberg et al., 2008; Inda et al.,
2006; Lorincz and Nusser, 2008; Ogawa et al., 2008; Van Wart et al., 2007). These channels
localise to the distal AIS through binding of PSD-93, instead of AnkG (Ogawa et al., 2008;
Duflocq et al., 2011), and influence AP firing frequency and waveform. Kv channels 7.2 and 7.3
(KCNQ2/3) cluster at the AIS of pyramidal neurons using a Nav-homologous AnkG-targeting
motif present on its C-terminus (Pan et al., 2006). These channels generate a slowly activating
and non-inactivating M-type current which controls spike-frequency adaptation.
Ca2+ sequestering cisternal organelles were identified at the AIS by Peters et al. (1968).
While it was hypothesized that these organelles must sequester local Ca2+ entering via Cav
channels, the presence of these Cav channels at the AIS was not shown until 1996. Callewaert
et al. (1996) were the first to show the presence of P/Q-type Ca2+ (Cav2.1 and 2.2) channels
in the AIS of cerebellar purkinje cells. More recently, Bender and Trussell (2009) showed the
localisation of T- and R-type Ca2+ channels (Cav2.3, 3.1 and 3.2) in the AIS of dorsal cochlear
nucleus interneurons, cortical layer 5b pyramidal cells and cerebellar purkinje cells while Yu
et al. (2006) showed the presence of N-type Ca2+ channels in cortical pyramidal cells. These
channels served to boost membrane depolarization and are essential for the generation and
timing of action potential bursts known as complex spikes.
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1.6.2 AIS Function
Diffusion Barrier and Maintenance of Neuronal Polarity
Directional propagation of action potentials in neurons results from anatomical and func-
tional polarity of its compartments. In the mouse cortex, the onset of this polarity is rapid,
occurring between embryonic day (E) 14-18 (Barnes and Polleux, 2009). The AIS is tasked
with maintenance of this polarity throughout post-natal life (Rasband, 2010). Kobayashi et al.
(1992) hypothesised that it does so by forming a ‘diffusion barrier’. They showed that in cul-
tured hippocampal neurons, fluorescent membrane-bound phospholipids in the distal axon were
unable to diffuse into the somatodendritic compartment. In addition to lipids, lateral diffusion of
membrane-bound proteins NCAM-L1 and THY1 are also restricted at the AIS (Winckler et al.,
1999). Pharmacological disruption of the actin filaments increases mobility of both proteins and
lipids, as observed by single-particle tracking (Nakada et al., 2003). These observations led to
the proposal of a ‘fence and pickets’ model of the AIS diffusion barrier where the ‘pickets’ are
the trans-membrane ion-channels and cell adhesion molecules that are themselves immobilized
by the underlying Ank-G-actin-spectrin ‘fence’.
While the existence of this barrier controls the diffusion of membrane components in
the proximal axon, how does it mediate the trafficking of intra-cellular cargo and distinguish
between axon-destined and dendrite-destined cargo? AIS control of intra-cellular trafficking was
first proposed by Song et al. (2009), who measured the diffusion rates of fluroescently labelled
dextrans of varying molecular weights from the soma to the axons in cultured hippocampal
neurons. They found that dextran movement was restricted in a weight-dependent manner, with
only the smaller dextrans visible in the axonal compartment. This led to the proposal that the
actin-cytoskeleton of the AIS acts as a ‘size sieve’. Indeed, disruption of actin filament poly-
merisation by latrunculin A allowed for rapid dispersion of previously-excluded large-dextran
molecules to the axon. As well, Farías et al. (2015) propose a ‘pre-axonal exclusion zone’, a
TRIM-46 positive region in the axon-hillock at the start of the AIS that actively recruits axonal
cargo while rejecting somatodendritic cargoes. While the formation of this region is shown to
be Ank-G dependent (Van Beuningen et al., 2015), Gumy et al. (2017) showed that pre-axonal
exclusion occurs in Ank-G-lacking neurons of the the dorsal root ganglion. Nirschl et al. (2017)
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propose a retrieval mechanism for mistargeted cargoes within the AIS. This follows a two-step
protocol where mistargeted cargo is first stalled by actin followed by either dynein or dynamin-
mediated retrieval. Evidence for the actin-based stalling comes from the works of Lewis et
al. (2009) and Watanabe et al. (2012). They showed that somatodendritic proteins selectively
bind to the motor myosin V (Lewis et al., 2009) which, in turn, binds to the actin patches at
the AIS, causing cargo immobilisation (Watanabe et al., 2012; Balasanyan et al., 2017; Janssen
et al., 2017). The dynein-mediated retrieval is dependent on CDK5-phosphorylation of dynein
activator NDel1 and its binding partner LIS1 (Klinman et al., 2017), whereas dynamin-mediated
retrieval is controlled by Rab5 and its effector FHF (Guo et al., 2016).
While the hypotheses above propose mechanisms of keeping somatodendritic cargo out,
the AIS is also proposed to recruit axonal cargo via selective binding of AIS microtubules to
anterograde kinesin motors like KIF5 (Nakata and Hirokawa, 2003).
Morphological Plasticity and AP Dynamics
In addition to maintaining neuronal polarity, the AIS is widely implicated in regulating
neuronal excitability in a homeostatic manner (Kuba et al., 2006, 2010; Grubb and Burrone,
2010; Evans et al., 2015). This regulation ranges from modulation of surface ion-channel
expression at the AIS in the short-term (miliseconds to minutes) to morphological changes
including alteration of AIS length and position along the axon in the long-term (hours to days)
(Petersen et al., 2017).
Short-term ‘fast’ modulation of the AIS is mediated either by Ca2+ influx into the AIS (Del
Puerto et al., 2015; Martinello et al., 2015; Benned-Jensen et al., 2016) or by neurotransmitters
acting on receptors located at or near the AIS (Bender et al., 2010; Cotel et al., 2013; Ko et
al., 2016; Yang et al., 2016; Yin et al., 2017). In cultured hippocampal neurons, sustained
glutamatergic stimulation of NMDARs leads to an elevation of intracellular Ca2+, inducing
rapid (5-10 min) endocytosis of Nav1.2 and Kv7.2/7.3 ion-channels at the AIS (Benned-Jensen
et al., 2016). This endocytosis, mediated by calpain, is thought to be neuroprotective against
excitotoxcity as it suppresses AP generation and further glutamate release (Benned-Jensen et al.,
2016). In dentate granule cells from acute brain slices, electrical stimulation (8 x 40 kHz, 125
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ms inter-burst interval) of cholinergic fibres is sufficient to activate the muscarinic M1 receptor
leading to intracellular Ca2+ influx into the AIS via Cav3.2 (Martinello et al., 2015). This
results in a suppression of Kv7 mediated M-current, decreased spike-threshold and increased
priming of cells to fire APs for up to 30 min post-stimulation. Neurotransmitters that affect
AIS ion-channel expression include dopamine and serotonin (Bender et al., 2010; Cotel et al.,
2013; Yang et al., 2016; Ko et al., 2016; Yin et al., 2017). In dorsal cochlear nucleus cartwheel
interneurons, Bender et al. (2010) showed that activation of dopamine receptors specifically
inhibited Cav3 channels at the AIS through activation of protein kinase C (PKC) ultimately
reducing the AP output of these neurons. Yang et al. (2016), similarly show that dopamine
receptor 3 (D3) activation inhibits Cav3 channels at the AIS, through non-canonical β -arrestin
mediated signalling. Cotel et al. (2013) showed that prolonged activation of serotonin receptor
5-HT1A in motor neurons, inhibits Na+ channel mediated spike initiation at the AIS while Yin
et al. (2017) showed that activation of 5-HT1A in pyramidal neurons of the prefrontal cortex
lead to selective inhibition of Nav1.2 channels, decreasing AP back propagation which may
result in sustained neuronal firing through integration of excitatory post-synaptic potentials
(EPSPs). In addition to modulation of Nav channels, serotonin activation also hyperpolarises
HCN channels at the AIS in the principal neurons of the medial superior olive lowering AP
threshold (Ko et al., 2016). Together, activity of these ion-channels work to homeostatically
regulate neuronal excitability, preventing excitotoxicity or prolonged suppression of activity, in
response to incoming stimuli.
Long-term structural plasticity of the AIS presents as modulation of its length and position
along the axon over the course of normal development (Cruz et al., 2009; Le Bras et al., 2014;
Yamada and Kuba, 2016; Gutzmann et al., 2014; Schlüter et al., 2017; León-Espinosa et al.,
2018), in response to altered neuronal activity (Kuba et al., 2010; Grubb and Burrone, 2010;
Chand et al., 2015; Wefelmeyer et al., 2016; Horschitz et al., 2015) or pathology (Yoshimura
and Rasband, 2014; Yamada and Kuba, 2016; Jamann et al., 2018). While this occurs in a
brain-region and cell-type specific manner, all things being equal, longer AISs increase cellular
excitability whereas shorter AISs restrict cellular excitability. Similarly, more distally located
AISs decrease neuronal excitability whereas more proximally located AISs increase neuronal
excitability. While the exact mechanisms for these changes in unknown, elongation of AIS
length is expected to increase the number of ion-channels while relocation of the AIS further
from the soma increases its electrical isolation, allowing synaptic signal processing to occur
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independently of the dendrites and soma.
The modulation of AIS morphology to fine-tune neuronal activity was first shown in the
avian auditory system, specifically in the nucleus magnocellularis (NM) and nucleus laminaris
(NL) of the chicken (Kuba et al. (2006), Kuba and Ohmori (2009)). Neurons in these regions
respond only to sounds of a ‘characteristic’ frequency (CF), and are arranged in a tonotopic
fashion with high-frequency recognising cells present more rostro-medially and low-frequency
recognising cells present more caudo-laterally (Parks and Rubel (1975)). NM cells receive
input directly from the auditory nerve and generate spikes at a particular phase of the sound
wave to convey temporal information to the NL. This system allows for accurate estimation of
interaural time difference and localisation of the sound source. In the NM, neurons detecting
low-frequencies (∼0.2 kHz) have about 2-fold longer AIS length, and increased number of
Nav channels, than those detecting high-frequencies (∼4 kHz) (Kuba and Ohmori (2009)).
Characteristically, high-CF NM neurons receive a single-large input from the auditory nerve
whereas low-CF NM neurons receive multiple small synaptic inputs, with AP being generated by
input summation. The difference in AIS length allows the low-CF NM neurons to compensate
for Na+ current inactivation during this slow depolarisation. Thus, the length of the AIS changes
with the number and size of synaptic inputs and ensures reliable and precise firings in NM
neurons. Unilateral removal of the cochlea resulted in a >50% increase in AIS length, measured
by changes in both Ank-G labelling as well as a pan-Nav marker, and neuronal excitability
of NM neurons compared to the intact side within 7-days (Kuba et al. (2010)). Additionally,
auditory deprivation at any stage of development resulted in a similar elongation of AIS length in
NM neurons. This structural elongation is complemented by a near-simultaneous redistribution
of Kv channels, switching predominant channel subtypes from Kv1.1 to Kv7.2. The slow
activation kinetics of Kv7.2 reduces the shunting conductance during AP initiation at the AIS
and enhances neuronal excitability (Kuba et al. (2015)). In the NL, high-CF neurons continue
to be ∼2-fold shorter than low-CF neurons, but unlike NM neurons the high-CF NL neurons
also show increased distance from the cell soma (Kuba et al. (2006)). This increased distance
electrically isolates the AIS from the capacitive and conductive loads that result from temporal
summation of high-CF inputs to the soma and dendrities, allowing AP generation from small
Na+ conductances and accurate coincidence detection. During early development of NL neurons,
the AIS (stained with Ank-G and pan-Nav markers) appears at E9 and is of comparable length
across neurons of all CF. The AIS elongates until E15, following which a CF-specific shortening
40
occurs. This shortening is shown to be activity dependent as bilateral removal of the otocyst
(precursor to the inner-ear), which ablates afferent inputs to the NL, resulted in longer AIS
lengths in high-CF neurons (Kuba et al., 2014). The distance of the AIS from the soma,
however, was not affected by otocyst removal. Therefore, regulation of AIS length and position
along the axon is regulated developmentally in both an activity-dependent and independent
manner.
In cultures, neurons show specific adaptation of AIS length and location upon chronic de-
polarisation (24-48 h) with either high extracellular K+ or optogenetic manipulation (Grubb
and Burrone, 2010; Evans et al., 2013; Chand et al., 2015; Evans et al., 2015). In dissociated
hippocampal cultures, elevating neuronal activity by 48 h treatment with 15 mM K+ or bursts
of photostimulation (5 flashes at 20 Hz every 5s for 48 h) results in a distal shift, relative to
cell soma, in all AIS components including AnkG, β IV-spectrin and Nav, specifically in excit-
atory neurons with GAD-65 positive GABAergic interneurons showing no such shift (Grubb
and Burrone, 2010). This relocation results in decreased neuronal excitability, as evidenced
by increased current threshold and current threshold density for firing an AP (Grubb and Bur-
rone, 2010). Functionally, this relocation was shown to be dependent on L-type Cav channel
(Cav1) activation, as pharmacological block of Cav1 abolished AIS relocation. Downstream
of Cav activation, AIS relocation is mediated by the Ca2+-sensitive phosphatase calcineurin,
as similar pharmacological blockage of this molecule prevents AIS relocation upon high-K+
or photostimulation mediated depolarisation (Evans et al., 2013). In cultures of dopaminergic
neurons from the rat olfactory bulb, however, chronic depolarisation induced by 24 h treatment
with 15 mM K+, resulted in increased length and proximal relocation of the AIS (Chand et al.,
2015). This inverse plasticity was also found to be Cav1 dependent but is not accompanied by
alterations in AP firing properties. The above studies suggest that perturbed network inputs
induce activity-dependent changes of AIS structure to allow altered axonal transport and/or
axonal growth dynamics (Marik et al., 2010; Chand et al., 2015). Additionally, cell-type spe-
cific AIS plasticity has also been observed in vitro (Evans et al., 2015). Optogenetically and
phamaracologically induced depolarisation over a ‘short’ time-scale (3h) showed significant
reduction in AIS length without any relocation only in neurons from hippocampal dentate gran-
ule cell cultures and not in neurons from hippocampal CA1 or CA3 cell cultures (Evans et al.,
2015). Shortening of the AIS resulted in reduced neuronal excitability, particularly repetitive
firing. This ‘rapid’ shortening was also found to be mediated by calcineurin, and reversed by
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CDK5 and re-phosphorylation of Nav. In addition to Ca2+ signaling, Guo et al. (2016, 2017)
proposed that secretory-signalling molecules, brain-derived neurotrophic factor (BDNF) and
neurotrophin 3 (NT3), underlie AIS structural plasticity. In hippocampal cultures, elevation of
extracellular BDNF or NT3 results in proximal (to the cell soma) relocation of the AIS with
increased neuronal excitability whereas knockdown of neurotrophin receptors TrkB and TrkC
causes distal relocation of the AIS with a reduction in neuronal excitability (Guo et al., 2017).
Thus, while activity-dependent alterations in AIS length and location have been widely reported
the exact signalling cascades underlying this structural plasticity are still being identified. These
studies reveal that the AIS is not just a trigger zone for AP generation, but plays a key role in
regulating the integration of synaptic input and neurotransmitter release resulting in alteration
of intrinsic cellular excitability.
Distinct AIS lengths and structural plasticity are also observed in vivo during normal de-
velopment (Fried et al., 2009; Cruz et al., 2009; Le Bras et al., 2014; Gutzmann et al., 2014),
artificial reduction of sensory input (Gutzmann et al., 2014; Schlüter et al., 2017) as well as
in periods of naturally reduced activity like hibernation (León-Espinosa et al., 2018). In the
New Zealand white rabbit, different sub-types of retinal ganglion cells, with distinct visually-
responsive properties, have AISs of distinct length and proximity to the soma (Fried et al.,
2009). Notably, directionally selective (DS) ganglion cells and brisk transient/alpha (BT) light-
intensity sensitive ganglion cells differed significantly in average AIS length (DS: 28.6 ± 4.8
µm; BT: 40.6 ± 5.39 µm; P= <0.001) while proximity to the cell soma differed significantly
between DS/BT cells and unspecified ganglionic cells (DS: 22.8 ± 6.4 µm; BT 26.9 ± 5.5 µm;
unspecified cells: 0-40 µm). In rhesus macaque monkeys, the AIS of pyramidal neurons in
the prefrontal cortex shortened in length during the first 6 post-natal months, following which
the length remained stable through adolescence and adulthood (Cruz et al., 2009). However,
the AIS lengths of gephyrin-positive GABAergic chandelier neurons in the same region and
model showed marked shortening only during adolescence (2-3 years) (Cruz et al., 2009). Taken
together these studies indicate that not only do cells with distinct spiking properties show differ-
ences in AIS length and location along the axon (Fried et al., 2009) but also that the AIS lengths
of different cell types within the same brain region undergo distinct developmental trajectories
(Cruz et al., 2009). In motor neurons of the mouse embryo, AnkG is observed as early as E9.5
and found to be homogeneously distributed throughout the developing axon, with expression
restricted to the proximal axon by E11.5 (Le Bras et al., 2014). In the mouse primary visual
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cortex, Gutzmann et al. (2014) showed that AIS length is dynamically regulated from E14.5 into
adulthood. From when the AIS first appears at E14.5, a steady increase in its length is observed,
peaking at P10-15, coincidental with eye-opening. This is followed by significant shortening
during the critical period of ocular dominance plasticity (commencing around P21, for review
see Espinosa and Stryker (2012)), with shortest lengths being observed at P28 (Gutzmann et
al., 2014). In the adult visual cortex, AIS lengths were longer than those observed at P28, but
still significantly shorter than those observed at P10-15, providing the further evidence that
neurons of different brain regions show differential developmental trajectories of AIS length.
Dark rearing of mice from birth abolished the dynamic shortening of AIS lengths observed
between P10-15 and P21-28. This shortening was later shown to depend on the presence of
the cisternal organelle (Schlüter et al., 2017), as mice lacking synaptopodin, a marker for the
cisternal organelle, showed AIS shortening at P21-28 despite being dark-reared. Given that
the cisternal organelle is known to mediate Ca2+-trafficking, it maybe speculated that this form
of AIS structural plasticity is Ca2+ dependent, however direct evidence for this remains to be
shown. While there is evidence in the literature of reduced cellular excitability upon dark-
rearing (Fagiolini et al., 1997; Morales et al., 2002; Heinen et al., 2004; Funahashi et al., 2013),
the causal role of dynamic AIS regulation on reduced cellular excitability upon dark-rearing
is yet to be shown. In addition to sensory deprivation, environmental modifications including
enrichment have been shown to shorten AIS length in the murine frontal cortex (Nozari et
al., 2017). Lastly, León-Espinosa et al. (2018) showed that during innate prolonged states of
reduced neuronal and metabolic activity, like hibernation, the AIS in the somatosensory cortex
and CA1 regions of the Syrian hamster elongate. This elongation is likely compensatory for
the reduced states of synaptic and neuronal activity, though there is speculation that it serves a
neuroprotective function to ishaemic insults as a results of hibernation accompanied hypother-
mia (León-Espinosa et al., 2018). However, the direct effects of elongates AIS lengths during
hibernation on cellular excitability are yet to be shown.
Given that AIS structure is influenced by network input, Gulledge and Bravo (2016) pro-
posed that neurons intrinsically optimise their excitability by modifying AIS location and length
in a manner that is closely correlated with neuronal morphology. Using a computational model
of realistic somatodendritic morphologies, they showed that small neurons (like dentate granule
cells) exhibited maximal excitability when AIS is of intermediate length (60-65µm) and located
adjacent to the soma. While larger cells (like pyramidal neurons) were maximally excitable
43
when the AIS was long (100µm) and located more distally. They also altered the capacitance
and conductance of the dendritic compartment and found that the former played a more central
role in influencing AP generation at the AIS. Their results also suggest that alterations to AIS
length, rather than location - when paired with corresponding changes in Na+ conductance -
modified neuronal excitability more effectively.
In addition to physiological changes during development, the AIS is also shown to be
modified during various pathological conditions, particularly epilepsy and ischaemia/ stroke.
These alterations are discussed below.
1.6.3 AIS in Disease Pathology
Altered network activity is a hallmark of multiple nervous system disorders. Given that
the AIS influences cellular excitability, it is unsurprising that aberrant AIS morphology and
plasticity is implicated in neuronal disorders and injury (Fig.1.8). Discussed below are some
such findings.
Epilepsy
AIS function, particularly its control of neuronal excitability is heavily dependent on the
density and composition of ion-channels present at this site. Malfunction of these channels, par-
ticularly Na+, GABAA and K+ channels, have been associated various forms of epilepsy (insert
all the reference). Thus, Wimmer et al. (2010) proposed that the AIS was a ‘common node’ in
the pathophysiology of epilepsy, where heterogeneous mutations converge, alter AIS structure
and influence neuronal excitability. The first evidence of the ‘common node’ hypothesis comes
from a study by Ribak (1985). NF-186, a cell-adhesion molecule found at the AIS, is shown to
target axo-axonic GABA-ergic synapse formation at the AIS (Ango et al., 2004; Kriebel et al.,
2011). The Ribak (1985) study found that in primate models of temporal lobe epilepsy, there
was a loss of GABAergic inhibition targeting the AIS. This loss resulted from degeneration of
axo-axonic chandelier cells in the epileptic foci and resulted in reduced inhibition of cortical
pyramidal cells.
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Figure 1.8: Structural changes to the AIS in Plasticity and Pathology (A, B) The AIS alters its length and
position along the axon, measured as altered distance from the soma, in an activity dependent manner (C) There
is evidence of elongated AIS lengths mouse models of Fragile-X Syndrome (Booker et al., 2019) and Angelman’s
syndrome (Kaphzan et al., 2011) (D) Evidence of increased number of ion-channels present at the AIS as well as
decreased number of functional ion-channels at the AIS have been presented in cases of epilepsy (Rasband, 2010)
(E) In cases of stroke and traumatic brain injury degradation of the AIS and the axon have been indicated (Schafer
et al., 2009). This schematic was made using the Biorender and scidraw softwares and parts were adapted from
Rasband (2010).
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Moving on to ion-channels, the most prominent AIS localising single-channel mutation
associated with epilepsy is Nav1.1. Mutations in this channel cause a phenotypic spectrum
of epilepsy from mild febrile seizures (Wallace et al., 1998) to severe myoclonic epilepsy of
infancy (Dravet syndrome) (Scheffer et al., 2009, 2007). Nav1.1 is coded by the gene SCN1A
and localises exclusively to the AIS of GABAergic neurons. Mouse models of Dravet syndrome
(Scn1a-/-) exhibit loss of Na+ current with significantly reduced firing of GABAergic neurons
in the hippocampus without altered activity in excitatory neurons (Yu et al., 2006; Ogiwara et
al., 2007; Kalume et al., 2007). Suggesting that reduced inhibition might underlie neuronal
hyperactivity in this model. Missense mutations in Nav1.2 are causative of a milder form of
childhood epilepsy, benign familial neonatal-infantile seizure (BFNIS) as well as refractory
seizures (Berkovic et al., 2004; Ogiwara et al., 2009). Whereas mutations in Nav1.6, encoded
by SCN8A, are thought to be neuroprotective against development of epileptic phenotypes.
Evidence for the neuroprotective function is two-fold. First, in heterozygous knock-out mouse
models of Scn8a+/-, animals exhibited reduced seizure susceptibility (Blumenfeld et al., 2009),
whereas double-knockout Scn1a-/-;Scn8a+/- ameliorated seizure severity and lethality of the
Scn1a-/- mice (Martin et al., 2007). The mutations discussed above are in the pore-forming α
sub-unit of Na channels, and typically Na channels also comprise of two auxiliaryβ sub-units
(Catterall, 2000). Mutations in β1 (SCN1B) have been reported in patients with generalised
epilepsy with febrile seizures as well as in some patients with Dravet’s syndrome (Wallace et
al., 1998; Scheffer et al., 2007; Patino et al., 2009). However, neurons in mice with complete
loss of Scn1b (Scn1b-/-) were found to be hypoexcitable (Brackenbury et al., 2010).
In addition to Nav channels, mutations in Kv expressed at the AIS have also been associated
with epilepsy. Mutations in Kv1.1 is associated with episodic ataxia. Given that this channel
controls AP waveform and synaptic efficiency, epilepsy mutations could result in increased
firing by altering axonal AP (Kole et al., 2007). Mutations in Kv7.2 and 7.3 lead to reduced
surface expression of these channels, with reduced M-current generation, in patients with benign
familial neonatal seizures (Browne et al., 1994; Jentsch, 2000; Chung et al., 2006; Miceli et al.,
2009).
Finally, gain of function mutations in Cav3.2, resulting in increased Ca2+ influx, is associ-
ated with idiopathic generalised epilepsy with absence seizures (Chen et al., 2003; Heron et al.,
2004, 2007; Khosravani et al., 2004, 2005; Vitko et al., 2005). While loss of Cav2.3 increased
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limbic seizure resistance (Weiergräber et al., 2006).
Thus, while multiple ion-channels present at the AIS are implicated in epileptic etiology,
direct evidence of altered AIS structure or function in the above stated models is still required.
Stroke and Traumatic Brain Injury
Ischaemic injury following stroke results in widespread neurological dysfunction. A major
contributor to this dysfunction is excito-toxicity resulting from a sudden and large influx of
Ca2+. Schafer et al. (2009) showed that in in vivo and in vitro models of stroke this increase
in intracellular Ca2+ activates the protease calpain and results in irreversible breakdown of
the AIS cytoskeleton and loss of Nav clusters. This breakdown occurs independently of and
prior to wide-spread cell death that is also characteristic of stroke. Loss of the AIS results in
loss of neuronal polarity with somatodendritic markers like MAP2 being found in the former
axon while pharmacological inhibition of calpain blocks AIS disassembly following neuronal
injury (Schafer et al., 2009). Concomitant with this increased excitation at the site of injury,
areas adjacent to it (the peri-infarct cortex) increase GABAergic mediated tonic-inhibition in
an attempt to curb excito-toxicity. Hinman et al. (2013) showed that neurons in the peri-
infarct cortex reduce their AIS length along with a loss of axo-axonic synapses resulting in
reduced cellular excitability. Counter intuitively, blocking this increased inhibition either by
blocking GABA mediated downstream signalling or stimulating glutamate signalling aides
recovery post-stroke. Together, the data suggests that structural changes to the AIS are a core
pathophysiology of stroke, its morphological plasticity may contribute to poststroke changes
in neuronal excitability and this may provide a potential pharmacological target to enhance
recovery from stroke.
Autism Spectrum Disorders
The first evidence of altered AIS morphology in a model of ASD comes from the works of
Kaphzan et al. (2011). They report that in the CA1 of a mouse model of Angelman’s syndrome
the AIS is elongated along with increased expression of Nav1.6 at the AIS. The altered AIS
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morphology was accompanied by changes to the intrinsic electrophysiological properties in
these cells including increased action potential amplitude and increased threshold potential.
Additionally, studies using genome wide association (GWAS) and whole exome sequencing
have identified mutations in AIS protein coding genes as causative for ASD/ID in a number of
cases. Sanders et al. (2012) performed whole exome sequencing in 928 individuals including
200 discordant sibling pairs. In their pool of 279 de novo coding mutations they identified two
independent nonsense variants in the gene SCN2A, encoding the AIS channel Nav1.2, present
in probands but not in the siblings. Bi et al. (2012) performed whole exome sequencing on
67 individuals with ASD and identified three different missense mutations in ANK3, which
codes the AIS master organiser ankyrin-G, from four unrelated individuals with ASD. Iqbal et
al. (2013) report one case of a chromosomal translocation causing heterozygous disruption of
ANK3 in a patient with ADHD and ASD as well as a familial cases of autosomal recessive ID,
hypotonia, spasticity and sleep disturbances resulting from a homozygous frameshift mutation
in ANK3. RNAi silencing of the Drosophila homolog of ANK3 resulted in short-term memory
loss, supporting the importance of this gene in cognition (Iqbal et al., 2013). Most recently,
Kloth et al. (2017) used trio-whole-exome sequencing to identify a heterozygous de novo
nonsense mutation in ANK3 in an individual presenting with speech impairment, intellectual
disability, macrocephaly, chronic hunger and an altered sleeping pattern.
While AIS dysfunction is yet to be reported in these cases, the presence of these mutations
in AIS specific proteins underscores the importance of this structure in cognition and makes it
an attractive structure to study in the the context of ASD/ID.
Other Neuropsychiatric Disorders
In addition to the above stated disorders, mutations in ANK3 have been associated by GWAS
to patients with bipolar disorder (Ferreira et al., 2008; Leussis et al., 2012; Wang and Miller,
2018). In schizophrenic patients with reduced GABA activity, a upregulation of the AIS specific
α2 subunit of GABAA receptors is observed in pyramidal cells of the prefrontal cortex (Lewis et
al. (2005)). While in patients with multiple sclerosis, there is evidence of increased antibodies
against the AIS-CAM NF-186 (Mathey et al., 2007).
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1.7 Aims of this thesis
Two groups of studies were critical to the formulation of the hypothesis tested in this thesis:
First, an increase in AIS length was observed in pyramidal cells of the stratum radiatum in the
CA1 of mouse models of Angelman’s syndrome (Kaphzan et al., 2011) and Fragile-X syndrome
(FXS) (Booker et al., 2019) with the increased length underlying cellular hyperexcitability
(Booker et al., 2019). Second, mouse models of FXS and SYNGAP1 haploinsufficiency show
convergent cellular and molecular deficits (Barnes et al., 2015) with cellular deficits observed in
the FXS mouse model persisting in a rat model of FXS (Till et al., 2015). Given the extensive
cellular excitability deficits reported across multiple brain-regions upon reduction of SynGAP,
reports of convergent synaptic pathophysiology between models of FXS and SYNGAP1-ID as
well as the ability of AIS morphology to influence cellular excitability the chief hypothesis
tested in this thesis is:
Haploinsufficiency of Syngap1 will result in alterations of AIS length. These altera-
tions may be one underlying mechanism for the altered cellular excitability observed in
animal models of Syngap1 haploinsufficiency.
Further studies show that a reduction in the levels of SynGAP alters spine maturation
dynamics (Aceti et al., 2015; Clement et al., 2012). Spines are the first point of information
input in the neuron, with the density and functionality of spines playing a critical role in shaping
intrinsic cellular excitability and shaping the properties of the axon initial segment (Kole and
Stuart, 2012; Wefelmeyer et al., 2016; Bolós et al., 2019), lending support to the hypothesis
that the AIS length maybe altered in models of Syngap1 haploinsufficiency.
In order to test this hypothesis, in chapter 3, I undertake a comprehensive a characterisation
and comparison of AIS lengths between Syngap1+/- and control juvenile (P28-35) rats was
undertaken across six brain regions previously shown to exhibit altered cellular excitability
or be involved in behaviours that are altered in Syngap1 haploinsufficiency (for review see
Jeyabalan and Clement (2016)). These brain regions include the prelimbic medial prefrontal
cortex (mPFC PL), somatosensory cortex – barrel fields (S1BF), Cornu Ammonis 1 and 3
(CA1, CA3) sub-fields of the dorsal hippocampus, the lateral (LA) and basal (BA) nuclei of the
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amygdala and the primary visual cortex 1 (V1). Juvenile rats were chosen for the experiments
as the convergent pathhophysiology between the FXS and Syngap1 mouse models as well as
the alteration in AIS length in the FXS mouse model were observed at this age. Additionally,
this developmental period coincides with the critical window for some of the brain regions
being studied including the V1 and BLA. The first model, Syngap1+/-, shares construct validity
with the heterozygous mouse model and most patient mutations of SYNGAP1-ID, a similar
characterisation is undertaken in a second model which selectively lacks the GAP enzymatic
domain and models patients with point mutations that selectively remove GAP domain function,
Syngap1+/∆Gap. This dual approach allows delineation of the function of the GAP domain versus
the scaffolding function of SynGAP in particular cellular and behavioural processes.
In chapter 4, I test the hypothesis that reduction in SynGAP alters in vivo morphological
plasticity of the AIS. Specifically, analysis and comparison of genotype specific changes in
AIS lengths over development was undertaken in neurons of the mPFC PL and the BLA. Sub-
sequently, adaptation of AIS length following a cued fear conditioning associative-learning
paradigm was analysed in both models of Syngap1 haploinsufficiency compared to controls.
Lastly, as cell-type specific differences in cellular excitability have been noted in the Syngap1+/-
mouse and reciprocal mPFC-BLA projection neurons are crucial for the formation and retrieval
of fear memory, AIS lengths in this specific sub-population were analysed across genotypes.
In chapter 5, I test the hypothesis that genetically heterogenous causes of ASD/ID result
from common alterations in cellular pathways. To this effect, I repeated the analysis performed
in chapter 3 hlwhile expanding the scope of the analysis to include 5 monogenic rat models of
ASD/ID. All five genes chosen are found at the post-synapse and include models of Fragile-X
syndrome (Fmr1-/y), Cell adhesion molecule associated non-syndromic ID (Nlgn3-/y, Nrx1+/-,






2.1.1 Housing and breeding
All animals used were bred and maintained across two different sites: The University
of Edinburgh, Scotland, United Kingdom and the National Centre for Biological Sciences,
Tata Institute of Fundamental Research, Bangalore, India. The Fmr1 ‘knockout’ (Fmr1-/y),
Syngap ‘Gap deletion’ (Syngap1+/∆gap), and Syngap ‘full-knockout’ rats (Syngap1+/-) were
group housed and bred in accordance with the United Kingdom Home office regulations and
Animals (Scientific Procedures) Act 1986 (ASPA 1986). They were maintained in a facility that
was kept on a 12:12 hour light/ dark cycle with food and water ad libitum.
The Nlgn3-/y, Nrx1+/-, Cntnap2+/-, and Pten+/- transgenic rats were bred and maintained
in agreement with ethical guidelines approved by the Institutional Animal Ethics Committee
(National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore,
India). These animals were group-housed and maintained in a facility on a 14:10 hour light/
dark cycle with food and water available ad libitum.
52
For experimental results detailed in chapter 3, rats of both sexes were used whereas exper-
iment and analysis was limited to male rats in chapters 4 and 5. Further, juvenile (P28-35)
animals were used to obtain results detailed in chapters 3 and 5, while adult (P90-120) rats were
used in chapter 4.
2.1.2 Generation of rat models
The transgenic animal models were generated by Sigma Advanced Genetic Engineering
(SAGE) laboratories (St. Louis, MO, USA), now part of Horizon Discovery, using zinc-finger
nuclease technology with the exception of the Syngap1+/- animals, which were generated using
CRISPR-interference. The Fmr1-/y, Syngap1+/∆gap, and Syngap1+/- transgenic animals were
created on a Long-Evan Hooded (LEH) background while the Nlgn3-/y, Nrx1+/-, Cntnap2+/-,
and Pten+/- transgenic animals were created on a Sprague-Dawley (SD) background.
Generation of Fmr1 LEH rats
The Fmr1 knockout (KO) rats were custom generated by insertion of an eGFPnlsSV40pA
cassette in the coding region of exon 1 which resulted in a loss of the FMR protein (Fig. 2.1).
Generation of Syngap1+/∆Gap LEH rats
The Syngap1+/∆Gap mutants were designed by Prof Peter Kind and Dr. Sally Till. Transgenic
animals were generated by selective deletion of 3584 base pairs (bp) and simultaneous insertion
of a ‘CAC’ 3 bp between intron 7 and exon 12 of the Syngap1 gene, resulting in deletion of the
GTPase Activating Protein (GAP) domain of the SynGAP protein (Fig. 2.2).
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Figure 2.1: Generation of the custom Fmr1 rat model (A) Diagram of ZFN left and right homology arms (HA-L,
HA-R) cleavage sites (selection) for the custom made Fmr1 KO LEH rats showing that the open reading frame of
Fmr1 gene was interrupted in exon 1 by a eGFP gene cassette (B) Western blot showing the loss of FMRP in the KO
animals but not at any developmental stage of the wildtype littermate controls. Western Blot experiments performed
by Dr Sally Till.
Figure 2.2: Generation of the custom Syngap1+/∆Gap rat model (A) Schematic of the Syngap1 gene showing
the locations of the two ZFN sites used to create a selective C2 and GAP domain deletion. Arrow indicates the
coding region of the GAP domain from exon 8-12 (B) Gel showing the results of the genotyping strategy used
to identify heterozygous Syngap1+/∆Gap rats, as only these animals showed presence of a 388 bp band that was
absent in the wildtypes. (C) Western blot showing the ~140 kDa wildtype band only in the Syngap1+/+ animals
whereas Syngap1+/∆Gap rats show a reduction in protein level of the ~140 kDa full length protein with the presence
of additional smaller molecular weight GAP-inactivated SynGAP proteins
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Generation of Syngap1+/- LEH rats
The Syngap1+/- mutant animals were also designed by Prof Peter Kind and Dr Sally Till.
Transgenic animals were generated using a single-guide RNA targeted to exon 8 of the Syngap1
gene. This caused a 2 bp deletion and 1 bp insertion, resulting in the generation of a premature
stop codon and loss of Syngap protein (Fig. 2.3).
Figure 2.3: Generation of the custom Syngap1+/- rat model (A) Schematic of the Syngap1 gene showing the
deletion region in exon 8 that was targeted using CRISPR-Cas9 technology. (B) Western blot from P5 hippocampal
lysates showing the ~140 kDa wildtype band in the Syngap1+/+ animals, while the Syngap1+/- rats show a reduction
in protein level of the ~140 kDa full length protein and the full length protein band is completely absent in Syngap1-/-
rats.
Generation of Nlgn3-/y SD rats
The Nlgn3-/y knockout rats were generated by selective deletion of 58 bp of exon 5 of the
Nlgn3 gene resulting in a complete loss of Nlgn3 protein (Fig. 2.4).
Generation of Nrx1+/- SD rats
The Nrx1+/- mutant rats were generated by selective deletion of 16 bp of exon 1 of the Nrx1
gene resulting in a premature stop codon and loss of Nrx1 protein (Fig. 2.5).
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Figure 2.4: Generation of the Nlgn3 rat model (A) Schematic of the Nlgn3 gene showing the location of the ZFN
site targeting exon 5 (B) Gel showing the results of the genotyping strategy used to differentiate between Nlgn3-/y
and wildtype rats, wildtype rats showed a 300bp band while KO rats showed a 252bp band (C) Western blot showing
the 110kDa wildtype band only in the Nlgn3+/y animals whereas Nlgn3-/y rats show no protein band when probed
with the same antibody. Western blots performed by Aiman Kayenaat.
Figure 2.5: Generation of the Nrx1 rat model (A) Schematic of the Nrx1 reverse strand gene showing the location
of the ZFN site targeting exon 1 (B) Gel showing the results of the genotyping strategy used to differentiate between
Nrx1+/- and wildtype rats, wildtype rats showed a 158 bp band while heterozygous rats show the WT 158 bp band
as well as the mutant 142 bp band.
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Generation of Cntnap2+/- SD rats
The Cntnap2+/- mutant rats were generated by deletion of 5 bp of exon 6 of the Cntnap2
gene resulting in a premature stop codon and loss of Cntnap2 protein (Fig. 2.6).
Figure 2.6: Generation of the Cntnap2 rat model (A) Schematic of the open reading frame of the Cntnap2 gene
showing the ZFN site targeting exon 6. Sequencing chromatographs from wildtype (B) and Cntnap2+/- (B’) rats
with the yellow line showing the 5 bp ATGGA site targeted by the ZFN that is altered in the heterozygous animals
(C) Western blot showing a reduction of Cntnap2/Caspr2 in the Cntnap2+/- animals but not in wildtype (Cntnap2+/+)
littermate controls.
Generation of Pten+/- SD rats
The Pten+/- mutants were generated by deletion of 7 bp of exon 7 of the Pten gene resulting
in a premature stop codon and loss of Pten protein (Fig. 2.7).
2.1.3 Genotyping
2.1.4 DNA extraction
Tissue was collected at P14 in the form of ear notches for animal identification and geno-
typing. DNA was extracted using the Qiagen DNEasy Blood & Tissue kit (#69506) for DNA
Isolation. Tissue was lysed in a mixture of extraction buffer ATL and proteinase K by incubating
overnight at 56 ◦C. The lysis reaction was stopped by adding Buffer AL and 100% Ethanol. The
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Figure 2.7: Generation of the Pten rat model (A) Schematic of the open reading frame of the Pten gene showing
the ZFN site targeting exon 7. Sequencing chromatographs from wildtype (B) and Pten+/- (C) rats with the yellow
line showing the 7 bp GCCAGCT site targeted by the ZFN that is altered in the heterozygous animals.
vortexed solution was then transferred to a spin-column and centrifuged at 6000 x g for 1 min to
allow the DNA to bind to the spin-column membrane. The bound DNA was then washed with
wash buffer AW1 by adding and centrifuging at 6000 x g for 1 min. The DNA membrane was
then dried by adding buffer AW2 and centrifuging at 20,000 x g for 3 min. Finally, the DNA
was eluted in 80-100 µl of double-distilled water (ddH2O) at an approximate concentration of
1 µg/µl and stored at -20 ◦C till further use.
2.1.5 Polymerase chain reaction for Syngap1+/∆gap, Nlgn3-/y and Nrx1+/-
The genotype of each animal was confirmed using a PCR containing 6 µl of Thermofisher
Scientific DreamTaq Green PCR Master Mix (#K1081), 1 µM forward primer, 1 µM reverse
primer and 0.8-1 µg of purified DNA. PCR products were then run on a 4% agarose gel. A full
list of primers and thermal cycling conditions are outlined below in Table 2.1 and Table 2.2.
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Table 2.1: Primers for Genotyping








Sm del f1 GCAGCTCAGCTTCTCCATCT















Table 2.2: Thermocycling conditions for Syngap1+/∆gap,
Nlgn3-/y and Nrx1+/- primers
Cycle Step Temp (◦C) Time




 x 35 cycles3 604 68
5 68 5 min
2.1.6 Genotyping for Fmr1-/y, Syngap1+/-, Cntnap2+/-, and Pten+/- animals
Tissue samples from animals were sent directly to Transnetyx (Cordova, Tennessee, USA)
for genotyping. Genomic DNA was extracted, genotyped and sequenced using proprietary




Animals were overdosed with either Isoflurane or Haloethane, released as fumes from liquid
stock, and killed by decapitation. Brains were collected using a spatula in pre-oxygenated ice-
cold artificial cerebrospinal fluid (ACSF) (Table 2.3). 500 µM dorsal hippocampus slices were
dissected using a Stoelting tissue chopper, snap frozen on dry ice and stored at -80 ◦C.
Tissue homogenisation
Each 500 µM slice was lysed in 150 µl Homogenisation buffer (Table 2.3) using a 200 µl
pipette followed by vortexing. 30 mul of the sample was reserved separately for the protein con-
centration assay. 50 µ l of 4x Laemlli buffer (Sigma Aldrich) containing 10% β -mercaptoethanol
was added to the remaining sample to break the disulphide bonds in the proteins and coat them
in a negative charge to facilitate the Western blotting. Samples were then denatured by boiling
at 85 ◦C for five minutes.
Protein concentration assay
The protein concentration of each sample was determined using a PierceTM BCA Protein
Assay Kit (Thermo Fisher Scientific #23227). Initially, BSA standards were made using a 20
mg/ml BSA stock which was diluted with ddH2O to make a 2 mg/ml solution. This 2 mg/ml
solution was serially diluted in ddH2O to give a range of BSA standards from 2 mg/ml to 0.625
mg/ml. For the assay, 5 µl of either BSA standard or protein sample were added to a 96-well
Nunc plate in triplicate. Next, the BCA working reagent was prepared by mixing Reagent
A with Reagent B (50:1) and 200 µl was added to 10µl of each albumin standard and each
diluted protein sample. The plate was incubated for 30 minutes at 37 ◦C and a FluoStar Optima
plate reader (BMG Labtech) was used to read the plate at an absorbance of 570 nm. Protein
concentrations for each sample were then calculated based on the BSA standard curve.
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Running the Western blot
Prior to loading samples were boiled again for five minutes and briefly spun down. 5 µl
of protein ladder (PageRulerPlus Prestained Protein Ladder, Thermo Scientific #26620) and 10
µg of each sample was loaded into a well of 12% Mini-PROTEAN TGX Precast Gels (Bio-Rad
#4561045). The gels were run in running buffer (table 2.3) at a constant voltage of 100 V until
the markers separated (approximately 15-20 min) and then at 200V until the dye front just ran
off the bottoms of the gels (approximately 25-30 min).
Transfer steps
The samples were transferred to nitrocellulose membrane (Bio-Rad #1620112) in transfer
buffer (table 2.3) at either 85 V for 2 hours at room temperature or 35 V overnight at 4 ◦C.
Antibody steps
The nitrocellulose membranes were briefly rinsed in ddH2O and 0.1M Phosphate Buffer
Saline (PBS) (table 2.3) before staining with Pierce Reversible Protein Stain Kit (Thermo Fisher
Scientific, #24580) according to the manufacturer’s instructions to visualise the protein bands
and check the quality of the transfer. The blot was then cut at specific molecular weights (50,
75 or/and 100 kDA) so that multiple proteins could be probed for on the same membrane.
The blots were rinsed further for upto three times with 0.1 M PBS plus 0.1% Tween-20
(PBS-T) and blocked in ‘blocking solution’, a 1:1 mixture of Odyssey Blocking Buffer (Li-COR
Biosciences #927-40000) and 0.1 M PBS-T (Thermo Fisher Scientific, #85113), for 1 hour at
room temperature. Blocking solution was poured off and the blots were incubated overnight at
4◦C in primary antibody diluted in ‘blocking solution’.
The primary antibody was discarded and membranes were washed three times with PBS-
T and incubated in the dark at room temperature in secondary antibody diluted in blocking
solution (Table 4) for 60-90 minutes.
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Table 2.3: Solutions for Western Blotting and Immunohistochemistry
Solutions
ACSF
124 mM NaCl (Sigma Aldrich)
1.25 mM NaH2PO4 (Sigma Aldrich)
3 mM KCl (Sigma Aldrich)
26 mM NaHCO3 (Sigma Aldrich)
10 mM Glucose (Sigma Aldrich)
2 mM CaCl2 (Sigma Aldrich)
1 mM MgCl2 (Sigma Aldrich)
Homogenisation Buffer
10 mM HEPES (Sigma Aldrich)
150 mM NaCl (Sigma Aldrich)
2 mM EDTA (Sigma Aldrich)
2 mM EGTA (Sigma Aldrich)
Phosphatase Inhibitor Cocktail Sets II and III (Merck Millipore)
Running Buffer
25 mM Tris (Sigma Aldrich)
190 mM Glycine (Sigma Aldrich)
0.1% Sodium Dodecylsulphate (2BScientific Ltd)
Transfer Buffer
25 mM Tris (Sigma Aldrich)
190 mM Glycine (Sigma Aldrich)






75.4 mM NaH2PO4 (Sigma Aldrich)
24.6 mM Na2HPO4 (Sigma Aldrich)
Secondary antibody solution was poured off and the blots were washed 2 times in PBS-T
and further rinsed in 0.1 M PBS. Membranes were imaged on an Odyssey infrared imaging
system (Li-COR Bioscience) and bands were visualised on Image Studio Lite v5.0 (Li-COR
Bioscience).
Table 2.4: Antibodies for Western Blotting
Primary Antibodies for Western Blotting
Antibody Name (Supplier) Catalogue Number Animal Dilution
Pan-Syngap (Abcam) AB77235 Rabbit 1:2000
Cntnap2 (Merck Millipore) AB5886 Rabbit 1:1000
Secondary Antibodies for Western Blotting
IRDye 800CW H+L (Li-COR Biosciences) 926-32211 Goat anti-Rabbit 1:5000





Animals were sedated with approximately 2 ml of Haloethane/Isoflurane and terminal an-
aesthesia using either a Ketamine/Xylazine mixture or Sodium pentobarbital was administered
via intraperitoneal (IP) injection (Ketamine 100-200 mg/kg; Xylazine 5-16 mg/kg; Sodium
pentobarbital 27.5 g/kg body weight). Animals were then trans-cardially perfused with ice-cold
PBS followed by 4% paraformaldehyde (PFA) in 0.1 M PB (table 2.3), pH 7.2-7.4 with volumes
approximately equalling the blood volume of the animal. Brains were then removed with a
spatula and post-fixed in 4% PFA for up to 2-3 hours at room temperature. If not immediately
sectioned, brains were washed twice for 10 min in 0.1 M PBS and stored in 0.025% Na-Azide
in PBS at 4 ◦C.
Vibratome sectioning
Brains were sectioned into 50 µm coronal sections using a vibratome (Leica VT 1200S).
Sectioning was performed in 0.1 M PB and the vibratome was set at an amplitude of 1 mm with
a sectioning speed of 0.2-0.3 mm/s. Areas of interest were identified using a rodent brain atlas
(Paxinos and Watson (2007)) and sections were stored in 0.025% Na-Azide in PB at 4 ◦C
2.2.2 Immunofluorescent labelling
Sections were washed 3 times in 0.1 M PBS. Non-specific labelling was blocked with a
solution containing 10% normal goat serum (NGS), 0.3% Triton-X to permeablise cells (Jamur
and Oliver (2010)), 0.05% Sodium Azide for its bacteriostatic qualities, in PBS for 1hr at
room temperature. Sections were then incubated in primary antibodies (table 2.5) in the above
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solution, except NGS concentration was reduced to 5%, for 24-72 hours at 4 ◦C.
Sections were then washed 3 times in PBS and incubated in secondary antibodies (table
2.5) in solution containing 3% NGS, 0.1% Triton-X, 0.05% Sodium Azide in PBS for 3 hours
at room temperature or overnight at 4◦C. Sections were then washed twice in PBS and once
in PB to prevent NaCl crystallisation and subsequently mounted in either Vectashield anti-fade
hard-set mounting medium (Vector Labs #H-1400) or for sections containing retrobeads (see
section 2.3.2) Fluoromount Aqueous Mounting Medium (Merck Millipore, #F4680).
Primary Antibodies for Immunofluorescence
Antibody Name (Supplier) Catalogue Number Animal Dilution
Ankyrin-G (Antibodies Incorporated) 75-146 Mouse 1:500
NeuN (Merk Millipore) 634301 Rabbit 1:500
Secondary Antibodies for Immunofluorescence
Alexa Fluor 405 (Thermo Fisher Scientific) A-31556 Goat anti-Rabbit 1:500
Alexa Fluor 488 (Thermo Fisher Scientific) A-11001 Goat anti-Mouse 1:500
Alexa Fluor 568 (Thermo Fisher Scientific) A-11011 Goat anti-Rabbit 1:500
Alexa Fluor 647 (Thermo Fisher Scientific) A-21235 Goat anti-Mouse 1:500
Table 2.5: Antibodies for Immunofluorescence
2.3 Stereotaxic injections
Surgeries were performed by the author under the supervision of Dr Adam Jackson.
2.3.1 Anaesthesia and preparation
Prior to surgery, 8-10 week old rats were weighed, placed in a plexiglass chamber and
anaesthetised using a mixture of air and isoflurane (5%, 0.4 l/min). When the breathing rate
had slowed to approximately 1 Hz, rats were transferred to a stereotaxic frame (David Kopf,
CA, US) where anaesthesia was continued through a mask (1.5–3.5%, 0.4 l/min). Rats were
placed on a heat-mat to regulate body temperature. Anaesthesia level was constantly monitored
throughout the experiment through observation of breathing rate and loss of toe pinch reflex.
Ear bars were placed into the skull indentation on the inter-aural line to fix the head in place.
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The fur on the head was shaved using an electric razor and the scalp was swabbed with iodine
solution. Viscotears liquid gel (Bausch & Lomb) was added to the eyes to prevent drying and the
following analgesics and anti-inflammatory drugs were injected subcutaneously: Veteregesic,
buprenorphine, 0.1 mg/kg of body weight; Dexamethasone, 2 µg; Carpofen, 0.15 mg. An
additional injection of 1 ml saline solution was administered subcutaneously to prevent dehyd-
ration. All surgical tools were washed and autoclaved prior to surgery. In the event of multiple
surgeries on the same day, instruments were sterilised using a bead steriliser between surgeries.
Injection pipettes were produced from boroscillate glass capillaries (Harvard apparatus, UK)
using a vertical puller (P-1000 Flaming Brown, Sutter Instruments, US).
2.3.2 Stereotaxic surgery
A small incision was made along the medial axis of the scalp and the skull exposed by
clamping the skin with forceps. The skull was cleaned to expose the lambda and bregma with
any ruptured blood vessels cauterised. The skull and surrounding skin was kept hydrated using
saline solution throughout the experiment. Bregma and lambda co-ordinates were established
and the nose bar adjusted to ensure they were in the same horizontal plane. Sterotaxic co-
ordinates for the injection site were adapted from the Paxinos and Watson (2007) atlas and
identified relative to the Bregma. The skull was thinned using a microdrill, following which a
small gauge needle was used to perforate the skull and remove it. Any ensuing blood flow was
cleaned and stemmed before proceeding with the injections.
Red Retrobeads IX (Lumafluor) were diluted 1:4 in saline and infused into the mPFC
(AP +3.00 mm, ML +0.6 mm, DV -2.0 mm) of the right hemisphere. Green Retrobeads IX
(Lumafluor) were used undiluted and infused into the BLA (AP -3.3 mm, ML -5.0 mm, DV -8.1
mm) of the left hemisphere. All DV co-ordinates were measured relative to dura. Retrobeads
were injected using a micromanipulator and a pipette with a 20 µm tip diameter (Nanoject,
Drummond Scientific, PA) at a speed of 9.2 nl/min. After the infusion of 50nl, injection was
stopped and the pipette left in place for a further 10 mins before removing it from the brain.
The skull was sealed using bone wax and the scalp sutured (VICRYL, Ethicon) and treated with
povidone-iodine solution.
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Animals were single-housed post-surgery and allowed to recover for at least 7 days before
perfusion.
2.4 Behaviour
Behaviour experiments of the Syngap1+/∆gap strain of animals were performed in conjunc-
tion with Dr. Sally Till. All other experiments were performed solely by the author.
Figure 2.8: Fear Conditioning Paradigm Schematic showing the fear conditioning behavioural paradigm. An-
imals were habituated for 5 min on two non-consecutive days. Conditioning took place in a different box and
6 presentations of a 10 seconds neutral flashing blue light (CS) co-terminating with a 1s 0.8mA footshock (US).
During Recall, animals were returned to the habituation chamber and presented with 12 iterations of the 30 seconds
of the CS. This figure was made using the Biorender student package.
2.4.1 Handling and habituation
Behaviour was carried out on adult rats (P80-120) that were housed in groups of 2-4 rats
per cage. All animals were handled and tails marked at least 3 days prior to the start of the
experiment and in a separate holding room. Animals were then habituated for 5 min on non-
consecutive days to the testing context in the experiment room. The recall context was a
modified Colbourne box with black and white checked/striped place-mat curved to cover the
clear back and a smooth plastic excrement tray that was cleaned/sprayed with 70% Ethanol.
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2.4.2 Fear conditioning assay
After the two days of habituation, animals were subjected to a classical Pavlovian condi-
tioning paradigm. Conditioning took place in a Colbourne box without any inserts and with an
electrical grid that was cleaned with Distel (Tristel) disinfectant wipes. Animals were allowed
to explore the box for 3 min before being presented with 6 iterations of a 10 second neutral
flashing blue light, the conditioned stimulus (CS), that co-terminated with a 1s 0.8 mA non-
harmful foot-shock, the unconditioned stimulus (US). The interval between the CSs were varied
in length to avoid anticipatory freezing (CS on at 180, 360, 490, 770, 980, and 1280 seconds).
Following conditioning, animals were immediately returned to their home-cage. Additionally,
the first animal of every cage, counter-balanced for genotype, was a CS-only control that was
presented with the flashing light without the presentation of the foot-shock.
2.4.3 Recall
24 hours following conditioning, the rats were put into the testing context, allowed to
explore the context for 2 min and then given 12 presentations of the CS. Each CS ‘light-on’
presentation was 30 seconds and was interleaved with 30 seconds of ‘light-off’. Approximately
2 hours after fear recall animals were terminated by perfusion fixation (see section 2.2.1).
2.4.4 Behavioural analysis
All analysis was done with experimenter being blind to genotype. The primary behaviour
scored was ‘freezing’ defined as: A complete suppression of spontaneous locomotor activity,
and of all movements except those needed for respiration (S. Fanselow (1984)). The animal
had to show 2 seconds of complete immobility following a bout of movement before it was
counted as ‘freezing’. Behaviour was scored manually by the experimenter using a stop-watch
and rounded down to the nearest second.
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Freezing was then calculated as a % of time using the following equation:
%Freezing =
Time Frozen (sec)
Total Time in Interval (sec)
×100 (2.1)
Spearman’s correlation analysis was performed for AIS recall and extinction exhibited per
animal. These were calculated as follows:
%Recall = Mean %Freezing during the first 3 CS presentations (CS1-3) (2.2)
%Extinction = Mean %Freezing CS1-3−Mean %Freezing CS10-12 (2.3)
Intervals for conditioning and re-call were as follows:
Conditioning Intervals Recall Intervals
Pre 180s Pre 120s
Inter-Conditioning Interval (ICI) Trial 1-12 30s
ICI 1 170s Inter-Trial interval




Table 2.6: Conditioning and Recall Intervals
2.5 Imaging
All image acquisition and analysis was done blinded to experiment conditions and genotype.
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2.5.1 Confocal imaging
Immunolabelled slices were imaged using standard multi-channel confocal microscopy.
Experiments performed in Bengaluru (for strains Fmr1, Cntnap2, Nrx1, Nlgn3, Pten) were
imaged on an inverted Leica SP5 confocal microscope while those performed in Edinburgh
(Syngap1) were imaged on an upright Zeiss LSM800 confocal microscope under oil immersion
60x/1.4 or 63x/1.4 objective. Z-stacks of 1 µm steps were taken through the 50µm section and
2 images per region per experimental animal were taken for the CA1, CA3, BA and LA. For the
mPFC, tiles spanning the entire cortical column of the pre-limbic region were chosen. Typically
7 tiles per row and 2 rows were imaged from the midline to layer (L) 6/white matter. Similarly
for the S1BF, the entire cortical column was imaged, ensuring that the images were within the
whisker barrels. Barrels were identified using a lower magnification lens (20x) and tiles were
taken from the cortical edge to L6. Akin to S1, the V1 images were tiled from cortical surface
to L6. Cortical areas were identified using a standard adult rat brain atlas (Paxinos and Watson,
2006).
2.5.2 Image analysis
Images were analysed using FIJI (Image J) software. For cortical tiled images, L2/3, L4
and L5 were identified based on proximity to midline (mPFC) or slice surface (S1BF, V1), cell
density and cell soma size. The latter was identified using a neuronal marker ‘NeuN’ that stains
the perisoma. AISs were identified on the basis of Ankyrin-G (AnkG) staining and measured
from their proximal to distal end (Fig 2.9). Approximately 70-100 AISs were traced per region,
per animal for all the base-line measurements. This value was chosen arbitrarily to allow enough
values for bootstrapping analysis. Bootstrapping analysis was performed by Dr. Owen Dando,
and showed that for a statistically significant difference of approximately 3 µm or higher, a
minimum of 25 AIS measurements were sufficient. In accordance with this, in animals with
retro-bead injections at least 25 AISs were measured per region per animal while for those that
underwent behaviour 50 AISs were traced through the z-stack per region per animal.
Exclusion criteria included AISs that were cuts off either at the top or bottom of the section,
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continued off of the edge of the image or were occluded by blood vessels (Fig 2.9).
Figure 2.9: AIS Analysis Criteria (A) Representative image of a single AIS with arrows pointing to the proximal
and distal ends (scale bar = 5 µm) (A’) Yellow line shows a traced AIS (scale bar = 5 µm) (B) Representative
image of the mPFC showing multiple AISs (scale bar = 20 µm) (B’) Yellow lines showing traced AISs that met the
selection criteria for measurement of representative figure B (scale bar = 20 µm).
2.6 Statistics
All the base-line AIS data was statistically analysed by Zrinko Kozic using a generalised
linear mixed modelling (GLMM) approach. Briefly, using the ‘R’ package ‘lme 4’ differences
in AIS length between genotypes and across brain regions were analysed per model. Further,
using the R package ‘car’ for analysis of deviance, type III ANOVA with post-hoc correction for
multiple comparisons (Tukey’s) was used to identify statistically significant differences. Use of
the GLMM approach allowed for higher statistical sensitivity, when compared to traditional non-
parametric statistical tests, for evaluation of data trends and significance while simultaneously
using animal number as the statistical metric ‘n’ thus avoiding pseudoreplication.
For behaviour, a Two-Way ANOVA with Bonferroni’s correction for post-hoc multiple
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comparisons was used. Comparison to measure statistical significance were differences between
genotypes and condition (CS only VS CS+US) at each ICI during conditioning and at each trial




Characterisation of AIS lengths in juvenile rat models of
Syngap1 haploinsufficiency
3.1 Introduction
SYNGAP1 haploinsufficiency, causing a 50% reduction in levels of the protein SynGAP,
is a leading cause of syndromic and non-syndromic intellectual disability (Hoischen et al.,
2014). Clinically, SYNGAP1-ID is often accompanied by developmental and epileptic enceph-
alopathies including generalised seizures, sensory hypersensitivities, such as hyperacusis and
altered response to tactile-stimuli, and photosensitive epilepsy (Parker et al., 2015; Klitten et
al., 2011; Carvill et al., 2013; Berryer et al., 2013). Pre-clinical murine models of Syngap1 hap-
loinsufficiency present with similar seizure and altered sensory processing phenotypes: Mice
heterozygous for the Syngap1 gene (Syngap1+/-), consequently lacking 50% of the SynGAP
protein, exhibit an average of 81 absence seizure-like epileptoform discharges per hour (Ozkan
et al., 2014), increased incidence of audiogenic seizures and decreased threshold for fluorothyl
induced tonic-clonic seizures (Clement et al., 2012). Abnormal sensory processing in the
Syngap1+/- mice include reduced pre-pulse inhibition, exaggerated startle response to auditory
stimuli and altered thigmotaxis (Guo et al., 2009).
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These seizure and altered sensory processing phenotypes suggests an increase in network
excitability. A long-standing model thought to drive this circuit hyperexcitability in ASD
is a change in the excitation to inhibition ratio (E/I) in the cerebral cortex (Rubenstein and
Merzenich, 2003). Evidence from pre-clinical models for the altered E/I ratio hypothesis
in the field of ASD has been mixed with reports ranging from reduced inhibition (Wallace
et al., 2012; Liang et al., 2015; Mao et al., 2015) to reduced excitation (Dani et al., 2005;
Wood and Shepherd, 2010; Delattre et al., 2013) to increased inhibition (Tabuchi et al., 2007;
Harrington et al., 2016). This altered circuit excitability is itself underscored by alterations in
cellular excitability. In the Syngap1+/- mouse model of SYNGAP1-ID, alterations in cellular
and network excitability appear to be brain-region and cell-type specific. For instance, neurons
in the medial prefrontal cortex (mPFC), a brain region involved in higher cognitive function,
attention and goal-directed behaviour (Ostlund and Balleine, 2005), and the dentate gyrus
(DG), a hippocampal sub-region involved in formation of episodic memory (Kesner, 2007), of
Syngap1+/- mice show increased activity in excitatory glutamatergic neurons (Clement et al.,
2012; Ozkan et al., 2014). Similarly cells in layer (L) 4 of the somatosensory barrel cortex
(S1BF), a primary sensory region, of Syngap1+/- mice were found to be hyperexcitable, due
to reduced synaptic activity of GABAergic inhibitory neurons (Berryer et al., 2016). However,
cells in L2/3 of the S1BF were found to be hypoexcitable in adult Syngap1+/- mice (Michaelson
et al., 2018). While cellular hyperexcitability of the mPFC and DG are thought to underlie the
seizure phenotypes observed in Syngap1+/- animals (Ozkan et al., 2014), hypoexcitability of
S1BF L2/3 cells is thought to underlie their disrupted thigmotaxis (Michaelson et al., 2018).
Defined as a propensity of the neuron to generate, beyond a certain threshold, an action
potential (AP) from a given input signal (usually an excitatory postsynaptic potential or EPSP),
the excitability of a neuron is dependent on a number of intrinsic physiological features includ-
ing the number and type of voltage-gated ion channels present at the dendrites, soma and axon
initial segment (AIS) (Daoudal and Debanne, 2003). Mechanistically, the ion channels of the
somatodendritic compartment serve to amplify (via persistent sodium current and T-type cal-
cium channels) or attenuate (via A-type K+ current and H-type cationic current) the amplitude
of the incoming EPSP (Reyes, 2001) while those at the AIS are responsible for the initiation
of the AP (Kole and Stuart, 2012). This input-output coupling is fundamental to the function
of the neuron, and cells are known to alter AIS location, length and ion-channel density, influ-
encing the threshold and frequency of AP generation, in response to physiological stimuli and
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pathology (Kuba et al., 2006; Rasband, 2010; Kole and Stuart, 2012). Specifically in ASD/ID,
altered AIS morphology has been noted in mouse models of Angelman’s syndrome (Kaphzan
et al., 2011) and Fragile-X syndrome (Booker et al., 2019). In both models, mutant mice ex-
hibited longer AISs in the CA1 sub-region of the dorsal hippocampus compared to wild-type
controls accompanied by reduced AP voltage threshold, reduced minimal current amplitude for
AP generation (rheobase) and increased firing frequency.
Given the extensive excitability deficits reported across multiple brain-regions in mouse
models of SYNGAP1-haploinsufficiency and reports of convergent synaptic pathophysiology
between mouse models of Fragile-X syndrome (Fmr1-/y) and SYNGAP1-ID (Syngap1+/-) (Barnes
et al., 2015), in this chapter I investigate the hypothesis that the convergence of cellular phen-
otypes would translate between the mouse and rat models and, similar to the Fmr1-/y mice,
alterations in AIS length would be observed in rat models of SYNGAP1-ID. Additional support
for this hypothesis comes from studies that show a reduction in levels of SynGAP accelerates
spine maturation and increases dendritic spine length in L5 pyramidal cells of the S1BF Aceti
et al. (2015), while increase in spine motility is noted in the DG (Clement et al., 2012). Spines
are the first point of information input in the neuron, with the density and functionality of spines
playing a critical role in shaping intrinsic cellular excitability and shaping the properties of the
axon initial segment (Kole and Stuart, 2012; Wefelmeyer et al., 2016; Bolós et al., 2019). In
order to address this hypothesis, I undertook a comprehensive characterisation of AIS lengths in
periadolescent rats (P28-35) of Syngap1 haploinsufficiency across neo-cortical and archicortical
regions where excitability deficits have previously been observed in Syngap1+/- mice. Described
below is a brief summary of the brain regions selected, their function and the excitability deficits
observed upon reduction of SynGAP.
The first brain region inspected was the medial prefrontal cortex (mPFC). The mPFC is
associated with a diverse range of cognitive and emotional function, exerting ‘top-down’ control
on attentional processes, visceromotor activity, decision making, goal-directed behaviour, and
working memory (Ostlund and Balleine, 2005). Anatomically the rat mPFC comprises of four
divisions, the medial (frontal) agranular, anterior cingulate, prelimbic (PL), and infralimbic (IL)
cortices, each of which is involved in distinct cognitive processes (Hoover and Vertes, 2007).
Here, I focused on the pre-limbic (PL) division of the mPFC, a brain region implicated in
working memory (Ragozzino et al., 1998; Floresco et al., 1997; Delatour and Gisquet-Verrier,
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2000, 1999, 1997, 1996; Seamans et al., 1995; Brito and Brito, 1990) as increased cellular
excitability has previously been reported in mPFC glutamatergic neurons (Ozkan et al., 2014)
in Syngap1+/- mice, along with marked deficits in working memory tasks (Muhia et al., 2010).
Next, AIS lengths in two primary sensory cortices were measured which included the
barrel fields of the somatosensory cortex (S1BF) and the visual cortex (V1). The primary
somatosensory cortex in rodents is organised into somatotopic maps, wherein peripheral features
such as facial whiskers (mystacial vibrissae) are isomorphically recapitulated onto the cortical
surface (Belford and Killackey, 1979; Woolsey and Van der Loos, 1970). This recapitulation is
driven by thalamocortical afferents (TCAs) and the faithful representation of the rodent whisker
pad is termed the ‘barrel field’ such that each individual whisker is represented by its own
neuronal cluster or ‘barrel’. Normal development of the barrel fields starts with tangential
TCA overlap in L4 followed by activity-dependent developmental events that involve axonal
and dendritic elaboration and synaptic development culminating in barrel segregation (Rebsam
et al., 2002). Microcircuitry within the barrels typically consists of information from the
trigeminal nerve reaching L4 through the TCAs, which is then relayed to L2/3 and finally
to L5/6, the main output layer of the barrel cortex (Chen-Bee et al., 2012; Petersen, 2007).
In mouse models of SYNGAP1-ID, mice lacking SynGAP (Syngap1-/-) failed to show barrel
segregation whereas mice heterozygous for SynGAP (Syngap1+/-) show partial segregation of
the TCAs into barreloids in the thalamus and retarded segregation at L4 (Barnett et al., 2006).
Additionally, in Syngap1+/- mice cells of S1BF L2/3 are hypoexcitable (Michaelson et al., 2018)
while those in L4 are hyperexcitable (Berryer et al., 2016). The primary visual cortex (V1)is
another sensory system that is shaped by experience-dependent synaptic modifications and
shown to be affected in ASD (Frenkel and Bear, 2004). In a clinical setting, individuals with
SYNGAP1 encephalopathy are reported to have photosensitivity (Vlaskamp et al., 2019) while
in a pre-clinical setting neurons in L2/3 of the primary visual cortex (V1) in Syngap1+/- mice
show increased excitability during locomotion (Katsanevaki, 2017), making both the S1BF and
the V1 important target brain regions to study in the context of modified AIS lengths.
Finally, two key brain-regions of the limbic system were chosen for AIS analysis; the dorsal
hippocampus and the basolateral amygdala. The hippocampus is the seat for novel memory
formation, particularly episodic memory and spatial cognition (for review see Hannula and
Duff (2017)). In a ‘typical’ hippocampal circuit, external information from L2/3 of entorhinal
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cortex (EC) is relayed to the CA3 and DG via the perforant pathway. The CA3 subsequently
relays information onto CA1 and CA2 via the schaffer collaterals. Finally, the CA1 closes
the circuit by projecting to L5 of the EC (Hannula and Duff, 2017). Plasticity of CA3-CA1
synapses have previously been shown to be disrupted in models of ASD, including Fmr1-/y
and Syngap1+/- mice (Barnes et al., 2015). These disruptions in Syngap1+/- mice include
attenuated LTP (Komiyama et al., 2002), attenuated NMDAR-LTD (Carlisle et al., 2008) and
exaggerated mGluR-LTD (Barnes et al., 2015) in the CA1. While these are examples of deficits
in plasticity, which typically arise from altered synaptic efficacy (Debanne, 2009), alterations
in the AIS, which in-turn influence AP generation thresholds, may contribute to the altered
plasticity. Accompanying the cellular deficits, Syngap1+/- mice show deficits in long-term
spatial memory tasks (Komiyama et al., 2002; Muhia et al., 2010), further underscoring the
importance of investigating AIS lengths in the dorsal CA1 and CA3.
Altered emotional state, including elevated anxiety and stress levels, is a common co-
morbidity of SYNGAP1 haploinsufficiency (Hamdan et al., 2009; Parker et al., 2015; Jeyabalan
and Clement, 2016; Asadi, 2018). These behaviours indicate a dysfunction in the amygdala,
a part of the limbic system that is involved in the acquisition, expression and storage of fear-
related memories (Forster L. et al., 2012; Davis, 2006). The amygdala comprises of various
nuclei, but the basolateral nucleus (BLA) is believed to play a key role in fear learning across
various species (LeDoux et al., 1990). The BLA comprises of the lateral amygdala (LA), which
receives sensory afferents from the thalamus and cortex and plays a key role in fear acquisition
(Romanski and LeDoux, 1992). The basal amygdala (BA) is involved in memory storage and
fear expression and projects to other cortical and sub-cortical components of the fear circuit in-
cluding the ventral CA1, mPFC and central amygdala (Gale et al., 2004; Anglada-Figueroa and
Quirk, 2005). In rodents, fear memory is classically studied using fear conditioning paradigms
(Marchand et al., 2003). While no direct evidence of altered amygdala function has been re-
ported in the Syngap1+/- mice, these mice do show reduced levels of anxiety in contextual fear
conditioning paradigms (Clement et al., 2012). This evidence in conjunction with the patient
co-morbidities makes the BLA an interesting target to study in the context of altered cellular
excitability and modified AIS lengths.
The AIS length analysis was performed across two distinct rat models of Syngap1 haploin-
sufficiency, one mutant specifically lacking 50% of the GAP domain (Syngap1+/∆Gap) and the
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other lacking 50% of the full length protein (Syngap1+/-) in order to delineate the contribution
of the GAP domain to any observed phenotypes.
3.2 Results
3.2.1 mPFC L2/3 and L5
Within the PL, AIS lengths of neurons from both L2/3 and L5 were analysed as it has
previously been shown that neurons from the different layers have distinct electrophysiological
properties (Song and Moyer, 2018), arguing that they may have distinct alterations in AIS length.
No difference in average AIS length or cumulative distribution of AIS lengths was observed in
neurons of either L2/3 (fig. 3.1 F Syngap1+/+= 28.75 µm ± 0.85 µm n=11, Syngap1+/∆gap=
28.31 µm ± 0.81 µm n=8, Syngap1+/-= 28.73 µm ± 0.69 µm n=11 animals) or L5 of the
mPFC PL between animals of either genotype compared to wildtype littermate controls (fig.3.1
K; Syngap1+/+= 28.99 µm ± 0.55 µm n=11, Syngap1+/∆gap= 29.19 µm ± 0.67 µm n=8,
Syngap1+/-= 28.73 µm ± 0.79 µm n=11 animals).
3.2.2 S1BF L2/3, L4 and L5
As both AIS length and S1BF show experience/activity-dependent alterations, and Syngap1-/-
and Syngap1+/- mice show abnormal barrel segregation as well as altered cellular excitability,
I looked for alterations to baseline AIS lengths across L2/3, L4 and L5 in Syngap1+/∆Gap and
Syngap1+/- rats compared to controls. I found no change in average AIS length or cumulative
distribution of AIS lengths across all layers examined in either model compared to age-matched,
littermate control (fig.3.2; L2/3 (F) Syngap1+/+= 27.48 µm ± 0.76 µm n=13, Syngap1+/∆Gap=
25.98 µm± 0.51 µm n=9, Syngap1+/-= 27.12 µm± 0.58 µm n=12; L4 (K) Syngap1+/+= 21.31
µm ± 0.42 µm n=13, Syngap1+/∆Gap= 21.29 µm ± 0.59 µm n=9, Syngap1+/-= 20.62 µm ±
0.51 µm n=12; L5 (P) Syngap1+/+= 27.56 µm ± 0.74 µmn=13, Syngap1+/∆Gap= 27.94 µm ±
0.53 µm n=9, Syngap1+/-= 28.01 µm ± 0.36 µm n=12 animals).
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Figure 3.1: AIS lengths are unchanged in L2/3 and L5 of the mPFC in P28-35 Syngap1+/∆Gap and Syngap1+/-
rats (A) Schematic of a coronal section of the mPFC. Blue lines highlight the region of the PL imaged. (B)
Representative image of the cortical stack acquired for analysis. Cell bodies visualised using NeuN (red) and
AIS using AnkG (green). White boxes demarcate the regions selected for analysis of L2/3 (left) and L5 (right).
Representative single AISs with arrows representing the proximal and distal ends from L2/3 and L5 of Syngap1+/+
(C, H), Syngap1+/∆Gap (D, I) and Syngap1+/- (E, J) rats. Scale bar=10 µm. (F, G) No change in average AIS length
(Syngap1+/+= 28.75 ± 0.85 µm n=11, Syngap1+/∆Gap= 28.31 ± 0.81 µm n=8, Syngap1+/-= 28.73 ± 0.69 µm
n=11 animals) or cumulative distribution of AIS lengths was observed in mPFC L2/3 between genotypes. (K, L)
No change in average AIS length (Syngap1+/+= 28.99 ± 0.55 µm n=11, Syngap1+/∆Gap= 29.19 ± 0.67 µm n=8,
Syngap1+/-= 28.73 ± 0.79 µm n=11 animals) or cumulative distribution of AIS lengths in mPFC L5 was observed
between genotypes.
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Figure 3.2: AIS lengths are unchanged in L2/3, L4 and L5 of the S1 in P28 Syngap1+/∆Gap and Syngap1+/- rats
(A) Schematic of S1BF. Blue lines highlight the imaged region. (B) Representative image of the cortical stack with
boxes demarcating regions selected for analysis of L2/3 (left), L4 (middle) and L5 (right). Representative single
AISs with arrows representing the proximal and distal ends from L2/3 (C-E), L4 (H-J) and L5 (M-O) of Syngap1+/+
(C, H, M), Syngap1+/∆Gap (D, I, N) and Syngap1+/- (E, J, O) rats. Scale bar=10 µm. No change in average AIS
length was observed in S1 L2/3 (F; Syngap1+/+= 27.48 ± 0.76 µm n=13, Syngap1+/∆Gap= 25.98 ± 0.51 µm n=9,
Syngap1+/-= 27.12 ± 0.58 µm n=12 animals), L4 (K; Syngap1+/+= 21.31 ± 0.42 µm n=13, Syngap1+/∆Gap= 21.29
± 0.59 µm n=9, Syngap1+/-= 20.62 ± 0.51 n=12 µm animals) or L5 (P; Syngap1+/+= 27.56 ± 0.74 µm n=13,
Syngap1+/∆Gap= 27.94 ± 0.53 µm n=9, Syngap1+/-= 28.01 ± 0.36 µm n=12 animals). Cumulative distribution of
AIS lengths was unchanged in L2/3 (G), L4 (L) and L5 (Q) between genotypes.
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3.2.3 V1 L2/3 and L5
Given the evidence of altered cellular excitability in V1 L2/3 neurons by Katsanevaki (2017)
I reviewed the AIS lengths in L2/3 as well as L5 of the rat V1. No change in average AIS length
or cumulative distribution of AIS lengths was found in Syngap1+/∆Gap and Syngap1+/- rats
in either layer compared to controls (fig. 3.3; L2/3 (F) Syngap1+/+= 25.59 µm ± 0.75 µm
n=12, Syngap1+/∆Gap= 24.97 µm ± 0.94 µm n=9, Syngap1+/-= 26.42 µm ± 0.63 µm n=11;
L5 (K) Syngap1+/+= 27.38 µm ± 0.60 µm n=12, Syngap1+/∆Gap= 26.63 µm ± 0.71 µm n=9,
Syngap1+/-= 26.63 µm ± 0.71 µm n=9 animals).
3.2.4 Dorsal Hippocampus CA1 and CA3
AIS lengths were measured in both the CA1 and CA3 sub-regions of the dorsal hippocampus
but no alterations in average length or distribution of lengths were found in either region of
Syngap1+/∆Gap and Syngap1+/- rats compared to controls (fig.3.4; CA1 (F) Syngap1+/+= 31.72
µm ± 0.89 µm n=13, Syngap1+/∆Gap= 33.09 µm ± 0.84 µm n=8, Syngap1+/-= 31.45 µm ±
1.04 µm n=11; CA3 (M) Syngap1+/+= 44.77 µm ± 2.01 µm n=13, Syngap1+/∆Gap= 45.6 µm2
± 1.99 µm n=8, Syngap1+/-= 43.82 µm ± 2.17 µm n=9 animals).
3.2.5 Basolateral Amygdala
Finally, I analysed the average and cumulative distribution of AIS lengths in both the LA
and the BA but found no changes in either parameter in Syngap1+/∆Gap and Syngap1+/- rats
compared to controls (Fig 3.5; LA (G) Syngap1+/+= 24.43 µm± 1.06 µm n=8, Syngap1+/∆Gap=
25.45 µm ± 0.82 µm n=7, Syngap1+/-= 23.71 µm ± 0.96 µm n=6; BA (O) Syngap1+/+= 33.21
µm ± 1.84 n=8, Syngap1+/∆Gap= 32.83 µm ± 1.69 µm n=7, Syngap1+/-= 30.94 µm ± 2.26
µm n=7 animals).
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Figure 3.3: AIS lengths are unchanged in L2/3 and L5 of the V1 in P28 Syngap1+/∆Gap and Syngap1+/- rats
(A) Schematic of V1. Blue lines highlight the imaged region. (B) Representative image of the cortical stack with
boxes demarcating regions selected for analysis of L2/3 (left) and L5 (right). Representative single AISs with arrows
representing the proximal and distal ends from L2/3 (C-E) and L5 (H-J) of Syngap1+/+ (C, H), Syngap1+/∆Gap (D,
I) and Syngap1+/- (E, J) rats. Scale bar=10 µm. No change in average AIS length was observed in V1 L2/3 (F;
Syngap1+/+= 25.59 ± 0.75 µm n=12, Syngap1+/∆Gap= 24.97 ± 0.94 µm n=9, Syngap1+/-= 26.42 ± 0.63 µm n=11
animals) or L5 (K; Syngap1+/+= 27.38 ± 0.60 µm n=12, Syngap1+/∆Gap= 26.63 ± 0.71 µm n=9, Syngap1+/-=
26.63 ± 0.71 µm n=9 animals). Cumulative distribution of AIS lengths was unchanged between genotypes in L2/3
(G) and L5 (L).
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Figure 3.4: AIS lengths are unchanged in the CA1 and CA3 of P28 Syngap1+/∆Gap and Syngap1+/- rats Schem-
atic of CA1 (A) and CA3 (H). Blue boxes highlight the imaged region. Representative low magnification image of
CA1 (B) and CA3 (I). Representative single AISs with arrows representing the proximal and distal ends from CA1
(C-E) and CA3 (J-L) of Syngap1+/+ (C, J), Syngap1+/∆Gap (D, K) and Syngap1+/- (E, L) rats. Scale bar=10 µm.
No change in average AIS length was observed in CA1 (F; Syngap1+/+= 31.72 ± 0.89 µm n=13, Syngap1+/∆Gap=
33.09 ± 0.84 µm n=8, Syngap1+/-= 31.45 ± 1.04 µm n=11 animals) or CA3 (M; Syngap1+/+= 44.77 ± 2.01 µm
n=13, Syngap1+/∆Gap= 45.62± 1.99 µm n=8, Syngap1+/-= 43.82± 2.17 µm n=9 animals). Cumulative distribution
of AIS lengths was unchanged across genotypes in CA1 (G) and CA3 (N).
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Figure 3.5: AIS lengths are unchanged in the BA and LA of P28 Syngap1+/∆Gap and Syngap1+/- rats Schematic
of LA (A) and BA (I). Representative low magnification (B, J) and high magnification (C, K) of the BLA nucleus.
Representative single AISs with arrows representing the proximal and distal ends from LA (D-F) and BA (L-N) of
Syngap1+/+ (D, L), Syngap1+/∆Gap (E, M) and Syngap1+/- (F, N) rats. Scale bar=10 µm. No change in average
AIS length was observed in the LA (G; Syngap1+/+= 24.43 ± 1.06 µm n=8, Syngap1+/∆Gap= 25.45 ± 0.82 µm
n=7, Syngap1+/-= 23.71 ± 0.96 µm n=6 animals) or BA (O; Syngap1+/+= 33.21 ± 1.84 µm n=8, Syngap1+/∆Gap=
32.83 ± 1.69 µm n=7, Syngap1+/-= 30.94 ± 2.26 µm n=7 animals). Cumulative distribution of AIS lengths was
unchanged between genotypes in the LA (H) and BA (P).
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3.3 Discussion
The body of work in this chapter presents the first comprehensive analysis of AIS lengths
across multiple brain regions in a rat model of ASD/ID. However, in all the brain regions ana-
lysed no genotype specific differences in AIS length were observed. Specifically, I have looked
at two complementary models of SYNGAP1 haploinsufficiency that were jointly designed by
Professor Peter Kind and Dr. Sally Till. The Syngap+/- rats carry a point mutation in exon 8 and
share construct validity with protein-truncating nonsense and frameshift mutations observed
in clinical presentations of SYNGAP1-ID, and similar to the Syngap+/- mice, lack 50% of the
full-length protein (fig.2.3). In addition to protein truncating mutations, seven pathogenic de
novo missense mutations have been identified in the SYNGAP1 gene, including 3 in the cata-
lytic GAP domain and 2 in the C2 domain (Berryer et al., 2013; O’Roak et al., 2014; Parker
et al., 2015; Mignot et al., 2016). Introduction of two of these de novo missense mutations
(p.W362R in C2 domain, p.P562L in GAP domain) in cortical organotypic cultures resulted
in the presence of multiple enzymatically inactive proteins in addition to the wildtype (~140
kDa) protein. Enzymatic ability was measured by the extent of inhibition to ERK activation in
transfected cultures (Berryer et al., 2013). Thus, the Syngap1+/∆Gap rats were designed with a
heterozygous deletion of the C2 and catalytic GAP domain of the protein. In hippocampal homo-
genates from these rats, similar to the transfected organotypic cortical cultures and in contrast to
Syngap+/- mice and rats, there is a reduction of the full-length (~140 kDa) protein coupled with
the presence of additional, enzymatically inactive, bands of lower molecular weight (fig.2.2),
a phenomenon not observed in wildtype age-matched and littermate (Syngap1+/+) controls.
Therefore using both Syngap+/- and Syngap1+/∆Gap rat models offers a unique insight into the
phenotypic spectrum associated with domain-specific mutations in SYNGAP1-linked ID.
Due to protein localisation at the PSD (Chen et al., 1998; Kim et al., 1998) and its role in
regulating AMPA-receptor trafficking (Komiyama et al., 2002; Clement et al., 2012), neuronal
excitability alterations in mouse models of Syngap1s haploinsufficiency have traditionally been
attributed to alterations in synaptic properties and plasticity. Conventionally, SynGAP’s control
of synaptic plasticity is mediated through its GTP-ase (GAP domain dependent) activity on
Ras and Rap with subsequent downregulation of ERK1/2 and p38MAPK signalling pathways
(Kim et al., 2003; Krapivinsky et al., 2004; Rumbaugh et al., 2006; Carlisle et al., 2008).
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An additional mechanism of SynGAP’s control of synaptic plasticity proposed that SynGAP
regulates PSD composition, including expression of surface AMPARs, in a GAP-independent
mechanism through its C-terminal PDZ binding domain (Walkup et al., 2016). Thus the use of
both Syngap1+/∆Gap and Syngap+/- rats renders the additional advantage of a direct comparison
of cellular and behavioural deficits elicited by the loss of the enzymatic GAP domain compared
to loss of the full length protein.
The conception of this project was based on two key pieces of evidence: First, an increase
in AIS length was observed in pyramidal cells of the stratum radiatum in the CA1 of a mouse
models of Angelman’s syndrome (Kaphzan et al., 2011) and Fragile-X syndrome (FXS) (Booker
et al., 2019). Subsequently, in the Fmr1-/y mice, this increase was shown to underlie the
hyperexcitability observed in these cells (Booker et al., 2019). Second, a previous publication
showed convergent cellular and molecular deficits between mouse models of FXS and SYNGAP1
haploinsufficiency (Barnes et al., 2015) with cellular deficits observed in the FXS mouse model
persisting in a rat model of FXS Till et al. (2015). Given the extensive alterations in cellular
excitability observed across multiple brain regions in theSyngap1+/- mice, I tested the hypothesis
that these deficits would translate to the rat models of SYNGAP1-ID and an alteration in AIS
length might underlie some of these observed deficits. Additionally, as most current work on
SynGAP function has focused on altered synaptic properties that affect integration of input, the
work in this chapter would be the first to assess for alterations at a site key for generation of
neuronal output. Since previous AIS length analysis in ASD models were conducted in juvenile
animals (P26-32) and is a developmental critical period of sensory cortices (De Villers-Sidani
et al., 2008), I used a similar age range in my project (P28-35).
3.3.1 Rat v/s mouse models of SYNGAP1 haploinsufficiency
In parallel to the work described in this chapter, extensive characterisation of both Syngap1
rat models was undertaken by other members of the lab. While there are some notable sim-
ilarities between the rat and mouse models of SYNGAP1 haploinsufficiency, such as elevated
levels of basal protein synthesis, they also exhibit distinct cellular, molecular and behavioural
phenotypes. Some of these differences in key cellular and behavioural phenotypes across the
models, and the interpretation of my data in the context of these results is discussed below.
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Notably, the comparatively high through-put nature of AIS analysis allowed the examination
of more brain regions than were characterised by electrophysiology. However, no genotype
specific differences in average AIS length were observed in all the regions studied.
Cellular excitability
Characterisation of intrinsic physiology and cellular excitability, including measuring the
firing and associated action potential properties as well as passive membrane properties were un-
dertaken in pyramidal cells of mPFC PL, CA1, BA and LA. Firing and AP properties included
measurement of the minimal current required to elicit an action potential (AP) (rheobase), the
voltage at which AP was elicited (AP threshold) and analysis of the AP waveform including amp-
litude and half-width while passive membrane properties included measuring resting membrane
potential, input resistance, membrane capacitance and sag (a measure of hyperpolarization-
activated cation current Ih). Notably, Booker et al. (2019) found that in CA1 pyramidal cells of
Fmr1-/y mice exhibited increased firing, reduced rheobase and AP threshold compared to con-
trols without alterations in any passive membrane properties. Similarly, Kaphzan et al. (2011)
found that in a mouse model of Angelman’s syndrome, pyramidal cells from the CA1 also show
reduced AP threshold, increased firing and increased AP amplitude with a small hyperpolarisa-
tion of the resting membrane potential. Both studies further showed that this increase in cellular
excitability could be explained by an increase in AIS length found in these cells. Therefore,
in our rat models of Syngap1-haploinsufficiency I was particularly interested in regions that
showed altered evoked firing properties without modifications in intrinsic membrane properties.
While the Syngap1+/- mice exhibit increased evoked excitability in pyramidal glutamatergic
cells of mPFC L2/3 (Ozkan et al., 2014) neither the Syngap1+/∆Gap nor the Syngap+/- rats
exhibited any alterations in firing or AP properties in mPFC PL cells. This lack of altered
single-cell excitability in the mPFC agrees well with the unchanged AIS lengths observed in
both genotypes compared to controls. Similarly, no changes in passive membrane and active
AP properties were found in pyramidal cells of the CA1 in Syngap1+/- rats, in agreement with
the lack of genotype specific alterations in AIS length in these animals. A key objective of
this project was to establish if cellular phenotypes convergent between the mouse models of
FXS and SYNGAP1-ID would extend to altered AIS length and translate to the rat models of
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Syngap1 haploinsufficiency. Both the electrophysiological and AIS data would indicate that
this is not the case for the Syngap1+/- rats. The Syngap1+/∆Gap rats do show a reduction in AP
threshold, however this change is not accompanied by an increased firing rate, alteration in
passive membrane properties or any change in AIS length. While this indicates that perhaps
additional factors, such as axonal diameter (Radivojevic et al., 2017), maybe responsible for
the change in AP threshold observed, the functional consequences of this change remains to be
established.
The final region characterised electrohpysiologically was the basolateral nucleus of the
amygdala. While intrinsic cellular excitability in this brain region has not previously been
characterised in the Syngap1+/- mouse, these mice do present with altered amygdalar-dependent
behaviours, such as decreased anxiety, suggesting altered neuronal and circuit excitability (Guo
et al., 2009; Muhia et al., 2010; Ozkan et al., 2014; Berryer et al., 2016). In our rat models, the
Syngap1+/- rats exhibit increased firing rate in the LA but not in the BA while the Syngap1+/∆Gap
rats exhibit decreased firing rate with increased rheobase in the BA but not in the LA. These
changes in firing properties are not accompanied by any change in passive membrane properties,
indicative of AIS length change mediated dysfunction. However, a lack of statistically signific-
ant change in average AIS length across genotypes would indicate that alterations in AIS length
are not responsible for the observed altered cellular firing. This lack of statistical significance
can partly be explained by the wide range of average lengths across animals observed in the
BLA compared to other brain regions (LA Syngap1+/+ P28-35= 10.14 µm, Syngap1+/∆Gap=
5.81 µm, Syngap1+/- P28-35= 6.23 µm; BA Syngap1+/+ P28-35= 13.77 µm, Syngap1+/∆Gap=
12.54 µm, Syngap1+/- P28-35= 16.54 µm). The BLA projects to, and receives projections from,
multiple brain regions with projection targets known to shape cellular excitability (Song et al.,
2015). A contributing factor to this increased range of AIS lengths maybe the current analytical
approach, which does not distinguish between, thus diluting out, sub-population specific effects.
This idea is further discussed in section 3.3.2 below.
In addition to cellular excitability, both mouse and rat models of SYNGAP1 haploinsuffi-
ciency exhibit impairments in synaptic plasticity. Prominently, Syngap1+/- mice show impaired
long-term potentiation (LTP) in the CA1 sub-region of the hippocampus (Komiyama et al.,
2002), a deficit which is reversed upon restoration of SynGAP to wildtype protein levels in
adults (Ozkan et al., 2014). Impaired LTP is also observed in L4 stellate cell in the S1BF of
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Syngap1+/- mice (Clement et al., 2013). Finally, Syngap1+/- mice also show altered long-term
depression (LTD) in an age and protocol dependent manner (Kim et al., 2003; Carlisle et al.,
2008; Barnes et al., 2015). Similar to the Syngap1+/- mice, Syngap1+/- rats also show impaired
LTP in the CA1 with impaired LTP in the mPFC L5 and thalamic inputs to the amygdala being
observed in both the Syngap1+/∆Gap and Syngap1+/- rats. While there are no direct established
links between altered synaptic efficacy and the axon initial segment, Evans et al. (2015) propose
that calcineurin and CDK5, molecules known to alter SynGAP activity Walkup et al. (2015),
modulate AIS length and may have a marked effect on multiple firing, a feature that is crucial
for LTP.
Behavioural phenotypes
Similar to inconsistencies in cellular excitability deficits, the Syngap1 mouse and rat models
also exhibit differences in behavioural phenotypes. Hyperexcitability with increased locomotion
has been widely reported in Syngap1+/- mice (Guo et al., 2009; Muhia et al., 2010; Clement et
al., 2012; Berryer et al., 2016) and is thought to be driven by increased activity of glutamatergic
neurons (Ozkan et al., 2014). While the Syngap1+/- rats appear hyperactive, the Syngap1+/∆Gap
rats appear to be hypoactive, suggesting distinct alterations to circuit excitability between the
models. In addition to hyperactivity, the Syngap1+/- rats show sustained impaired motor co-
ordination in an accelerating rotarod task, a phenomenon that is not observed in the Syngap1+/-
mice (Muhia et al., 2010). Individuals with SYNGAP1-ID are reported to have an increased pain
tolerance, a feature that is not observed in the Syngap1+/- mice (Muhia et al., 2010). Remin-
iscent of clinical reports, Syngap1+/- rats show an increased threshold for thermal pain while
Syngap1+/∆Gap rats show decreased pain threshold, further suggesting model specific alterations
to underlying circuitry. A point of cross-species conservation of behavioural phenotypes is
deficits in spatial memory. The Syngap1+/- mice show impaired spatial memory in a prefrontal-
hippocampal dependent alternated T-maze (Deacon and Rawlins, 2006) while both Syngap1+/-
and Syngap1+/∆Gap rats show impaired long-term (24 hour delay) hippocampal based spatial
memory in an object location task (Warburton and Brown, 2015). While individuals with SYN-
GAP1-ID show increased anxiety related behaviours, nascent anxiety like behaviours tested in
an open field and elevated plus maze show reduced anxiety levels in Syngap1+/- mice (Guo et al.,
2009; Muhia et al., 2010). Similar to the patient phenotype, both Syngap1+/- and Syngap1+/∆Gap
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rats show elevated levels of nascent and novelty induced anxiety as measured using a marble
interaction paradigm, suggesting hyperactivity of the underlying circuit.
While at present there is no direct evidence linking altered behavioural states to changes
in AIS length, altered behaviour is indicative of underlying circuit hyper- or hypo-excitability
(Nelson and Valakh, 2015). This altered circuit excitability may, in turn, be caused by alterations
in cellular excitability, which is known to be influenced by alterations to AIS length (Kuba et
al., 2006; Grubb and Burrone, 2010). However, as no changes in average AIS length were
observed between rats of either Syngap1 haploinsufficiency genotype and controls in brain-
regions implicated in the altered behaviours, other regulators of learning and memory, such as
altered synaptic plasticity, must underlie the observed behavioural phenotypes. Observed LTP
deficits in the CA1, mPFC and amygdala without alterations in intrinsic cellular excitability
support this conclusion. Of note, AIS length measurements in this chapter were performed at an
age-point earlier than the behavioural characterisation, with the assumption that any alterations
in AIS length and subsequent cellular excitability would precede behavioural abnormalities.
However, the change in cellular excitability and adaptation of AIS length following subjection
to behavioural paradigms has not been assessed.
3.3.2 Limitations in experimental design
Having discussed the sparse cellular excitability deficits in our Syngap1 rat models, it
is unsurprising that the AIS length remained unchanged specifically in mPFC L5, CA1 and
BLA. However, one cannot exclude the possibility that technical and experimental design
choices attributed to the lack of phenotypes observed. Some of these variables include sex of
experimental animal, experimental age and analysis approach and are discussed below.
Sex differences
Animals of both sexes from both models were used in the experiments outlined above. While
there is evidence in literature of differential hippocampal function between male and female
rats, most of these differences are noted in adult animals (>P60), which is outwith the age
of the experimental animals used here (Maren et al., 1994; Oberlander and Woolley, 2016;
Yang et al., 2004; Choleris et al., 2018). One study, however, did find enhanced perforant
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pathway-LTP in male but not female peri-adolescent (P35) rats (Maren et al., 1994), which is
the upper limit of the age range used here. However, within the context of published Syngap1
research both male and female animals have extensively been used to characterise cellular
excitability deficits in the Syngap1+/- mice (Rumbaugh et al., 2006; Clement et al., 2012, 2013;
Ozkan et al., 2014) with only one report of male-specific reduction in mEPSC amplitude in
parvalbumin positive interneurons in the S1 (Berryer et al., 2016). Due to the possibility of
sex-specific alterations in AIS length, ‘sex’ was used as a random variable in the generalised
linear mixed model and separation of data by sex determined no significant contribution of this
variable on observed results. Therefore, it would appear unlikely that the use of rats of both
sexes significantly impacted the results outlined in this chapter. However, as work in subsequent
chapters is performed either in adult animals where sex-specific differences are better delineated
or in animals containing X-linked mutations, work has been restricted to male rats.
Experimental age
The experimental age chosen in this chapter, P28-35, was based off the age at which the AIS
changes in Fmr1-/y mice were found (Booker et al., 2019), the age at which convergence of
cellular and molecular phenotypes was observed between Fmr1-/y and Syngap1+/- mice (Barnes
et al., 2015) and as it is a developmental critical period for sensory cortices (De Villers-Sidani
et al., 2008). However, published literature on cellular and excitability deficits in mouse models
of Syngap1 haploinsufficiency use a wide range of ages. In wildtype mice, expression of
SynGAP increases postnatally, peaking at P14 (Clement et al., 2012; McMahon et al., 2012).
Concomitant with this increase, a number of excitability and spine-turnover deficits in the
Syngap1+/- mice have been noted from P5-P14, especially in the S1BF and the dentate gyrus
of the hippocampus (Clement et al., 2012, 2013; Aceti et al., 2015). Notably, AIS lengths are
most dynamically regulated in the second post-natal week (Gutzmann et al., 2014). Therefore,
P13-15 may have been a more suitable time-point to assess alterations in AIS length. However,
analysis of intrinsic excitability in the CA1 and BLA at P14 of Syngap1+/- and Syngap1+/∆Gap
rats revealed no changes in firing rates in pyramidal cells of these regions (Toft, 2019; Mizen,
2017).
Altered cellular phenotypes have also been noted in adult Syngap1+/- mice, including im-
paired CA1 LTP (Komiyama et al., 2002), increased spine-density (Carlisle et al., 2008) and
increased firing in the mPFC L2/3 cells (Ozkan et al., 2014). Additionally, spontaneous absence-
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like seizures have only been noted at >12 weeks of age in Syngap1+/- mice (Ozkan et al., 2014).
Since cellular excitability alterations have not been characterised in adults in our rat models
of SYNGAP1-ID and there is an increase in AIS length in adults mice compared to juveniles
(Gutzmann et al., 2014), in chapter 4 I investigated alterations to AIS length at in male rats aged
P90-120.
AIS analysis
A key technical limitation of the current analysis is the ‘blanket’ approach, wherein AISs that
met the criteria outlined in chapter 2 were analysed without drawing a distinction between cells
that project to, or receive projections from, specific other brain regions. While this approach is
suitable for areas such as the CA1, CA3, S1 L2/3 and L4 and V1 L2/3, that have fairly conserved
inputs and laminar distribution of connections (Chen-Bee et al., 2012; Petersen, 2007; Hannula
and Duff, 2017; Nowak and Bullier, 1997), it is less suitable for cortical output layers (L5) in
the mPFC, S1, V1 and the BA. This is especially important in the light of circuit-specific long-
range hypoconnectivity in models of ASD/ID (Moseley et al., 2015). This may, to an extent,
explain the increased range of average AIS lengths observed in the BA of our rat models. In
order to address this limitation, in chapter 4 I have focused analysis of AIS lengths on reciprocal
connections between mPFC PL and the BLA.
Lastly, the AIS is also shown to impact cellular excitability by altering its position along
the axon (Grubb and Burrone, 2010; Evans et al., 2013, 2015). However, relative distance of
the start of the AIS from the cell soma were not measured here for a number of reasons. First,
in both the FXS (Booker et al., 2019) and Angelman’s syndrome mouse models (Kaphzan et
al., 2011), no alterations in distance from cell soma (dfcs) were reported. Secondly, in my
analysis of dfcs in other models of ASD/ID, no changes were observed between genotypes (see
appendix fig.S4). In addition, the average observed dfcs in appendix fig.S4 were much smaller
that those previously reported in cultures (Grubb and Burrone, 2010; Evans et al., 2013, 2015).
Thus, while alterations to dfcs may contribute to some aspects of altered cellular excitability,
such as the reduced AP threshold in the CA1 of Syngap1+/∆Gap rats, the significantly smaller
magnitude of any observed changes would make these connections more tenuous.
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Chapter 4
In vivo morphological plasticity of the AIS in rat models
of Syngap1 haploinsufficiency
4.1 Introduction
ASDs have widely been considered a condition lacking central cognitive coherence as a
result of altered neural functional connectivity (Frith, 2003; Belmonte et al., 2004; Barttfeld
et al., 2011; Moseley et al., 2015). Studies using fMRI and EEG have reported a double dis-
sociation in connectivity patterns in individuals with ASD compared to age matched controls:
During ‘rest’, where participants are not engaged in any particular task, long-range connections,
particularly fronto-occipital connections, show functional hypoconnectivity (Assaf et al., 2010;
Barttfeld et al., 2011; Moseley et al., 2015) while short-range connections show hyperconnectiv-
ity (Barttfeld et al., 2011). During periods of attention, however, brain-network connectivity
appears to increase if the target of attention is internal (e.g. focusing on respiration) whereas
connectivity is decreased if the attention target is external (e.g. external auditory stimulus or
task) (Barttfeld et al., 2012). Therefore, functional connectivity defects in ASD appear to be
state dependent. However, individual component analysis has revealed that compared to con-
trols, the mPFC of individuals with ASD appears to be functionally under-connected to multiple
brain regions both at rest (Carper and Courchesne, 2005) and during attention states (Kawakubo
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et al., 2009; Castelli, 2002), making it an interesting target region to study in the context of
ASD/ IDs.
Situated at the rostral tip of the frontal lobe, the mammalian prefrontal cortex (PFC) is a key
player in complex cognitive processes that are known to be disrupted in neurodevelopmental
disorders including decision making, attention states and working memory (Miller, 2000; Testa-
Silva et al., 2012). Studies in Syngap1+/- mice revealed deficits in PFC-dependent working
memory (Muhia et al., 2010) as well as increased glutamatergic activity in the medial prefrontal
cortex (mPFC) of adult (>9 weeks) Syngap1+/- mice compared to controls (Ozkan et al., 2014).
While no such increase in glutamatergic activity was found in the Syngap1+/- rats, impairments
in translaminar long-term potentiation (LTP), a form of hebbian synaptic plasticity that forms
the neural basis for learning and memory (Hebb, 1949; Nabavi et al., 2014; Langille and Brown,
2018), have been found in the mPFC of juvenile and adult Syngap1+/- rats. Anatomically, the
mPFC is divided into four sub-regions each with distinct long-range projection targets (Vertes,
2004). These long-range targets drive the formation of distinct mPFC sub-networks by de-
fining the morphology and intrinsic physiology of pyramidal cells in the chief cortical output
layer of the mPFC, layer 5 (L5), as well as their local inhibitory micro-circuit (Wang et al.,
2006; Brown and Hestrin, 2009; Dembrow et al., 2010). A sub-region of the mPFC crucial
for limbic-cognitive functions, including fear mediated learning, is the pre-limbic cortex (PL)
(Hoover and Vertes, 2007). Fear related behaviours are altered in models of SYNGAP1-ID
such that Syngap1+/- mice exhibit impaired acquisition of fear memory (Clement et al., 2012)
whereas Syngap1+/- rats exhibit exaggerated recall of fear memory (see section 4.2.2). Recip-
rocal glutamatergic connections between the PL and the basolateral nucleus of the amygdala
(BLA) underlie the formation, consolidation, recall and extinction of fear and anxiety associated
memories (Vidal-Gonzalez et al., 2006; Laviolette et al., 2005; Corcoran and Quirk, 2007). Sim-
ilar to the mPFC, LTP deficits accompanied by altered cellular excitability is observed in BLA
of juvenile Syngap1+/- rats (Toft, 2019). These excitability deficits might alter the maturation
dynamics of the prefrontal-amygdala connectivity and underlie the abnormal expression of fear
behaviour, making it a valid candidate circuit to study in the context of altered neural functional
connectivity in our model of ASD.
Altered functional connectivity observed in fMRI studies, typically results from altered
circuit activity. Mechanisms underlying circuit dysfunction range from alterations in the ex-
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pression or activity of ion channels to changes in neurotransmitters and receptors that affect
excitability at a cellular level (Contractor et al., 2015). One ion-channel rich neuronal com-
partment that influences cellular excitability is the axon initial segment (AIS). The AIS is a
plastic structure, modifying it’s morphology, particularly it’s length, over the course of normal
development (Fried et al., 2009; Cruz et al., 2009; Le Bras et al., 2014; Gutzmann et al., 2014),
in response to varying environmental stimuli (Schlüter et al., 2017; Gutzmann et al., 2014) and
in pathology (Ferreira et al., 2008; Schafer et al., 2009; Kaphzan et al., 2011; Kloth et al., 2017).
In vitro and in vivo studies in non-mammalian systems have shown that this adaptation of AIS
length and location along the axon is activity dependent and modifies the intrinsic excitability
of cells (Kuba et al., 2006; Kuba and Ohmori, 2009; Grubb and Burrone, 2010; Evans et al.,
2013; Chand et al., 2015; Evans et al., 2015). Preliminary data from the laboratory of Professor
Andreas Lüthi has found that upon fear conditioning in wild-type adult mice, the AIS of BA
cells that project to the PL elongate (personal correspondence).
Taken together, the alterations in cellular excitability previously noted in the prefrontal
cortex and basolateral amygdala in our rat models of Syngap1 haploinsufficiency, exaggerated
recall of mPFC-BLA circuit dependent fear memory in these animals coupled with impaired
and not exaggerated LTP and evidence of a role of non-synaptic AIS plasticity in fear memory
consolidation and recall, advocates for a closer inspection of AIS plasticity in a model that
presents with perturbed fear memory. The hypothesis tested in this chapter is that a reduction in
SynGAP protein levels results in altered development and experience-dependent changes in AIS
length. In order to test this hypothesis, first I analysed and compared AIS lengths in the PL and
the BLA, in adult versus juvenile Syngap1+/- rats to determine age-dependent alterations in AIS
length. Following this, I analysed the effects of fear-conditioning on AIS lengths in Syngap1+/-
and Syngap1+/∆gap rats in both the PL and the BLA. Finally, as the alterations in AIS length
following fear conditioning from the laboratory of Professor Andreas Lüthi is specifically in
BA cells that project to the mPFC, I analysed AIS lengths of the sub-population of cells that
project specifically from the BLA to the PL in Syngap1+/- rats. A further argument to look at
these specific sub-populations comes from previous work in the lab where in a rat model of
Fragile-X syndrome a decrease in AIS length is found specifically in PL cells that project to the
BLA (Jackson, 2016) (see appendix fig.S1). Given previous evidence of convergence between
mouse models of FXS and SYNGAP1-ID (Barnes et al., 2015), I also analysed AIS lengths of
cells of the mPFC that project to the BLA.
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4.2 Results
4.2.1 Age dependent changes to AIS length
Structural plasticity of AIS length with age have been previously reported in mice and mon-
keys. Data from wildtype (WT) mouse primary visual cortex showed an increase in AIS length
in adulthood (>P60) compared to juvenile (P28) animals (Gutzmann et al., 2014). In rhesus
macaque monkeys, the AIS of pyramidal neurons in the prefrontal cortex (PFC) shortened in
length during the first 6 post-natal months, as animals transitioned from childhood to adoles-
cence (Cruz et al., 2009). However, the AIS lengths of gephyrin-positive GABAergic chandelier
neurons in the same region and model showed marked shortening only during adolescence (2-3
years) (Cruz et al., 2009). Taken together these studies indicate that AIS lengths are dynamically
regulated during development as well as AISs of different cell types within the same brain region
undergo distinct developmental trajectories. Given this evidence of in vivo plasticity of AIS
morphology, I first analysed genotype specific differences in AIS length with age between adult
(P90-120) (Syngap1+/+) and Syngap1+/- rats in the pre-limbic (PL) region of the mPFC and the
basal and lateral nucleus of the amygdala (BLA). The AIS length measurements in the adults
were further compared to those obtained in juvenile (P28-32) rats of both genotypes in chapter 3.
These particular brain regions were chosen for their role in the ontogenesis of fundamental beha-
viours that are disrupted in SYNGAP1 haploinsufficiency linked ASD/ID (Hamdan et al., 2011;
Parker et al., 2015; Prchalova et al., 2017; Vlaskamp et al., 2019; Jimenez-Gomez et al., 2019)
such as threat learning (Deal et al., 2016; Akers et al., 2012; Rudy, 1993; Arruda-Carvalho et
al., 2017) and social interaction (Panksepp, 1981; Siviy and Panksepp, 2011).
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PL L2/3 and L5
As AIS lengths of both WT (Syngap1+/+) and Syngap1+/- rats at P28-32 were measured in
chapter 3, here I measured AIS lengths in the PL L2/3 and L5 in animals at P90-120 and analysed
the developmental trajectory and genotype differences between WT and HET (Syngap1+/-) rats
(figs. 4.1 & 4.2). Unlike previous data from the mouse cortex (Gutzmann et al., 2014), WT
animals did not show any significant difference in mean AIS length in cells of L2/3 (Syngap1+/+
P28-35= 28.75 ± 0.85 µm, P90-120= 31.55 ± 0.37 µm) or L5 (Syngap1+/+ P28-35= 28.99
± 0.55 µm , P90-120= 32.14 ± 0.65 µm) with age. Interestingly, in both layers the shortest
(minimum) measured AIS length was significantly increased in adult WT (P90-120) animals
compared to juveniles (P28-35) with no change in the longest (maximum) measured length
and a concomitant decrease in the range of measured AIS lengths. Changes in AIS length
with age in the mouse primary visual cortex shows that cells at the later age point, considered
functionally mature, have longer AISs (Gutzmann et al., 2014). Within this context, the increase
in minimum AIS length and decrease in range of AIS lengths without any change in average
or maximum measured AIS lengths in the PL of WT rats suggests that the population of cells
sampled at the juvenile age are at different stages of maturity while those in the adult animals
are more closely matched.
AIS lengths in PL L5 of Syngap1+/- rats followed similar alterations to the WT animals
with no age-dependent change in mean or maximum measured AIS length, increased minimum
measured AIS length, decreased range and a shift in the cumulative distribution towards longer
AIS lengths (see fig. 4.2 B, B’ & table 4.2), indicating that haploinsufficiency of SynGAP
does not affect developmental alterations in AIS length in PL L5. AIS lengths in cells of
PL L2/3 of Syngap1+/- rats did not show any difference in mean AIS length with age and,
similar to Syngap1+/+ rats, showed decreased range with increased minimum measured AIS
lengths. However, these cells did not follow the WT developmental trajectory of the shift in the
cumulative AIS lengths towards increased length which was further accompanied by decreased
maximum measured AIS length (see fig. 4.2 A, A’ & table 4.1).
Further, genotype specific analysis revealed a trend of reduced average AIS length (fig.4.1D
Syngap1+/+= 31.55± 0.37 µm n=4, Syngap1+/-= 29.05± 0.63 µm n=4 animals, p=0.0571) and
a significant difference in the cumulative distribution (fig.4.1E p=<0.0001 using a Kolmogorov-
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Smirnov test) of AIS lengths in L2/3 of Syngap1+/- rats compared to WT controls at P90-120.
No genotype specific change, however, was observed in L5 either at the level of average AIS
length (fig.4.1H Syngap1+/+= 32.14 ± 0.65 µm n=4, Syngap1+/-= 31.06 ± 0.49 µm n=4






P28-35 28.75 µm 28.73 µm
P90-120 31.55 µm 29.05 µm
Min
Length
P28-35 24.66 µm 25.24 µm
P90-120 30.59 µm 28.36 µm
Max
Length
P28-35 32.18 µm 33.11 µm
P90-120 32.39 µm 30.95 µm
Range
P28-35 7.52 µm 7.86 µm
P90-120 1.80 µm 2.59 µm





P28-35 28.99 µm 28.73 µm
P90-120 33.14 µm 31.06 µm
Min
Length
P28-35 25.57 µm 25.43 µm
P90-120 30.52 µm 30.29 µm
Max
Length
P28-35 31.43 µm 35.03 µm
P90-120 33.66 µm 32.43 µm
Range
P28-35 5.86 µm 9.60 µm
P90-120 3.13 µm 2.13 µm
Table 4.2: Comparison of AIS lengths in PL L5 at P28-35 and P90-120
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Figure 4.1: AIS lengths in PL L2/3 and L5 of P90-120 Syngap1+/+ and Syngap1+/- rats (A) Representative
image of the cortical stack acquired for analysis. Cell bodies visualised using NeuN (red) and AIS using AnkG
(green). White boxes demarcate the regions selected for analysis of L2/3 (left) and L5 (right). Representative single
AIS with arrows indicating the proximal and distal ends from Syngap1+/+ (L2/3 B, L5 F) and Syngap1+/- (L2/3
C, L5 G) rats. Scale bar=10 µm. (D, E) Trend of reduced average AIS length (Syngap1+/+= 31.55 ± 0.37 µm
n=4, Syngap1+/-= 29.05 ± 0.63 µm n=4 animals, p=0.0571) and significantly shifted cumulative distribution of AIS
lengths was observed in PL L2/3 of Syngap1+/- rats compared to controls p=<0.0001 using a K-S test. (H, I) No
change in average AIS length (Syngap1+/+= 32.14 ± 0.65 µm n=4, Syngap1+/-= 31.06 ± 0.49 µm n=4 animals) or
cumulative distribution of AIS lengths was observed in in PL L5 of Syngap1+/- rats compared to controls.
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Figure 4.2: Comparative AIS lengths between P28-35 and P90-120 Syngap1+/+ and Syngap1+/- rats in L2/3
and L5 of the mPFC Comparison of mean and cumulative distribution of AIS lengths across age and genotype
indicate that (A, A’) in cells of mPFC PL L2/3 Syngap1+/+ (WT) animals show no significant difference in average
AIS length but a shift in the overall distribution of AIS lengths towards longer AISs while AIS lengths of Syngap1+/-
(HET) rats do not exhibit a similar shift in AIS length distribution towards longer AISs (B, B’) Cells of PL L5
show no significant change in mean AIS length with age but both WT and HET animals show a shift in cumulative
distribution of AIS lengths towards longer AISs.
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BA and LA
Similar to the PL, AIS lengths across genotypes in both the LA and the BA in animals at
P90-120 (fig. 4.3 & 4.4) were measured and compared to changes observed at P28-32 (fig. 3.5).
In the LA of WT rats mean AIS length was significantly increased in adult animals compared
to juveniles (Syngap1+/+ P28-35= 24.43 ± 1.06 µm, P90-120= 29.13 ± 0.74 µm, p=0.0243).
This increase in average length appeared to be predominantly driven by increased minimum
measured AIS length at P90-120 as maximum measured AIS length was comparable across
ages (see table 4.3 & 4.4 A, A’). Similar to the results obtained in the WT animals, average AIS
length measured in the LA of Syngap1+/- rats was significantly increased (P28-35= 23.71 ±
0.96 µm, P90-120= 28.31 ± 0.75 µm, p=0.0389). This increase again was driven by increased
minimum measured length at P90-120 as maximum measured AIS length remain unchanged
with age (see table 4.3 & 4.4 A, A’). Following on from the interpretation of this data in the PL,
it would imply that cells in the LA in juvenile animals showed more heterogenous functional
maturity while those in the adult animals were more homogenous and a reduction in SynGAP
levels did not affect this maturation (Two-Way ANOVA, GenotypexAge F(1, 18)=0.002392,
p=0.9615; Age F(1, 18)=18.76, p=0.0004).
As with the LA, average AIS length (Syngap1+/+ P28-35= 33.21 ± 1.84 µm, P90-120=
40.07 ± 2.88 µm) and minimum measured AIS length was increased between P28-32 and P90-
120 in cells of the BA in WT rats. Interestingly however the maximum measured AIS length
was also increased with no change in range of lengths measured in WT animals at P90-120
compared to P28-32 (see table 4.4 & 4.4 B, B’). The overall increase in average AIS length
(Syngap1+/- P28-35= 30.94 ± 2.26 µm, P90-120= 38.42 ± 1.57 µm) and minimum measured
AIS length in BA cells of WT P90-120 rats (compared to P28-32 rats) extended to the Syngap1+/-
rats. However, maximum measured AIS length was unchanged with subsequent decrease in
range of AIS lengths measured across ages in these animals (see table 4.4 & 4.4 B, B’). The
interpretation of cells at P90-120 having longer AISs and being functionally more mature could
be extended to the BA of both WT and Syngap1+/- rats in that there is increased minimum
measured AIS length (Two-Way ANOVA, GenotypexAge F(1, 19)=0.01699, p=0.8977; Age
F(1, 19)=9.492, p=0.0062). However, the the unaltered range of AIS lengths measured in the
WT BA cells would imply that additional factors affect the AIS length of a cell. Given that AIS
structure, particularly length, is known to be dependent on synaptic input (Kuba et al., 2006;
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Fried et al., 2009) and that excitability of BA cells is dependent on its projection target (Paré and
Gaudreau, 1996), the unchanged range of AIS lengths measured in the WT rats at P90-120 can
be attributed to sampling a mixed population of cells that project to or receives projections from
different brain regions. Given that Syngap1 haploinsufficiency causes a reduction in the range
of AIS lengths measured, it might imply that AIS lengths of a particular sub-population are
differentially affected. Genotype specific differences in AIS lengths in one such sub-population
is elaborated on in section 4.2.3.
Lastly, no genotype specific changes were observed in average AIS length in the BA
(fig.4.3D Syngap1+/+= 40.07 ± 2.88 µm n=4, Syngap1+/-= 38.42 ± 1.57 µm n=4 animals)
or LA (fig.4.3I Syngap1+/+= 29.13 ± 0.74 µm n=4, Syngap1+/-= 28.31 ± 0.75 µm n=4 anim-
als), nor were there any changes to cumulative distribution of AIS lengths (fig. 4.3E, J) seen in





P28-35 24.43 µm 23.71 µm
P90-120 29.13 µm 28.31 µm
Min
Length
P28-35 20.33 µm 21.41 µm
P90-120 28.07 µm 26.60 µm
Max
Length
P28-35 30.48 µm 27.64 µm
P90-120 31.30 µm 29.88 µm
Range
P28-35 10.14 µm 6.23 µm
P90-120 3.28 µm 3.27 µm





P28-35 33.21 µm 30.94 µm
P90-120 40.07 µm 38.42 µm
Min
Length
P28-35 26.15 µm 24.86 µm
P90-120 31.53 µm 35.54 µm
Max
Length
P28-35 39.92 µm 41.40 µm
P90-120 43.69 µm 41.80 µm
Range
P28-35 13.77 µm 16.54 µm
P90-120 12.16 µm 6.26 µm
Table 4.4: Comparison of AIS lengths in LA at P28-35 and P90-120
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Figure 4.3: AIS lengths in BA and LA of P90-120 Syngap1+/+ and Syngap1+/- rats (A) Representative image of
the BA used for analysis. Cell bodies visualised using NeuN (red) and AIS using AnkG (green). Representative
single AISs with arrows representing the proximal and distal ends from BA and LA respectively of Syngap1+/+ (B,
G) and Syngap1+/- (C, H) rats. Scale bar=10 µm. (D, E) No change in average AIS length (Syngap1+/+= 40.07 ±
2.88 µm n=4, Syngap1+/-= 38.42 ± 1.57 µm n=4 animals) or cumulative distribution of AIS lengths was observed
in BA of Syngap1+/- rats compared to controls. (F) Representative image of the LA used for analysis. (I, J) No
change in average AIS length (Syngap1+/+= 29.13 ± 0.74 µm n=4, Syngap1+/-= 28.31 ± 0.75 µm n=4 animals) or
cumulative distribution of AIS lengths in LA L5 was observed in Syngap1+/- rats compared to controls.
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Figure 4.4: Comparative AIS lengths between P28-35 and P90-120 Syngap1+/+ and Syngap1+/- rats in the
BLA Comparison of mean and cumulative distribution of AIS lengths across age and genotype indicate that cells in
the (A, A’) LA, Two-Way ANOVA, GenotypexAge F(1, 18)=0.002392, p=0.9615; Age F(1, 18)=18.76, p=0.0004
and (B, B’) BA, Two-Way ANOVA, GenotypexAge F(1, 19)=0.01699, p=0.8977; Age F(1, 19)=9.492, p=0.0062
show increased mean length and a shift in cumulative distribution towards increased AIS lengths in both Syngap1+/+
(WT) and Syngap1+/- (HET) rats.
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4.2.2 Experience-dependent changes to AIS length
Experience-dependent plasticity of AIS morphology has been previously shown in neurons
of avian and murine sensory systems (Kuba et al., 2010; Gutzmann et al., 2014; Schlüter et al.,
2017). In chick embryos, auditory deprivation resulted in an elongation of AIS length, with
increased cellular excitability, in neurons of the cochlear nucleus magnocellularis (Kuba et al.,
2010). Similarly, dark rearing of mouse pups resulted in elongated AIS lengths and increased
cellular excitability in neurons of the mouse primary visual cortex (Gutzmann et al., 2014;
Schlüter et al., 2017). Additionally, preliminary work from the laboratory of Professor Andreas
Lüthi has found an increase in AIS length in basal amygdalar cells following an associative
learning (cued fear conditioning) paradigm. Unpublished results from our laboratory show
that rat models of Syngap1 haploinsufficiency have exaggerated recall of fear memory in an
associative learning/ cued fear conditioning paradigm. Given the potential of a role of non-
synaptic AIS plasticity in fear memory consolidation and recall, here I analysed AIS plasticity
in a model that presents with perturbed fear memory. As recall of fear memory is dependent
on the mPFC-BLA circuit (Song et al., 2015; Saha et al., 2018) and altered cellular excitability
has been noted in the prefrontal cortex and basolateral amygdala (Toft, 2019) in our rat models,
post-behaviour AIS analysis was limited to these two brain regions.
Fear memory in Syngap1+/- rats
For assessment of fear memory acquisition and recall, adult (P80-120) WT and Syngap1+/-
rats were subjected to classic pavlovian conditioning. Briefly, animals were habituated to the
testing ‘neutral’ context for 5 min on two non-consecutive days. 24h after the second day of
habituation animals were placed in a different context and subjected to a visually cued fear
conditioning paradigm where each animal received 6 presentations of a 10s flashing blue light
(the conditioning stimulus or CS) which co-terminated with a 1s 0.8 mA footshock (the uncondi-
tioned stimulus or US). During the conditioning phase, acquisition of fear memory was assessed
as percentage time spent by the animal in the ‘freezing’ behavioural state. Freezing state was
defined as a complete suppression of spontaneous locomotor activity, and of all movements
except those needed for respiration (S. Fanselow, 1984). Both WT and Syngap1+/-subjected to
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the CS-US pairings (referred to as fear-conditioned or FC) animals showed comparable levels
of freezing, which were significantly higher than control animals which were presented only
with the flashing blue light (CS) without pairing with the footshock (US) (referred to as CS
only) (fig.4.5A, Two-Way ANOVA CSx Genotype p=0.0001, F(15, 70)=3.673). Additionally,
rats of neither genotype showed evidence of generalised anxiety as % freezing prior to the
presentation of the first CS was negligible (Syngap1+/+= 0.093% ± 0.093, Syngap1+/-= 0.71%
± 0.234). These results concur with previous findings from the laboratory (S Till, unpublished)
and indicate that Syngap1 haploinsufficiency does not affect acquisition of fear memory.
Following conditioning, re-exposure to the CS induces conditioned fear ‘freezing’ response,
which represents a reliable measure of the learned association. Here, 24h after conditioning
animals were placed in the neutral context to which they were habituated and tested for re-call
and extinction of fear memory. During this phase, animals were presented with 12 iterations
of the CS for 30s with a 30s inter-trial interval (ITI) and % freezing over time was used as the
behavioural read-out. In a typical wild-type animal subjected to this paradigm, % freezing will
be highest in the initial three or four CS presentations and is classed as re-call or fear memory
(Pavlov, 1927). With subsequent presentations of the CS without US pairing, the % freezing
exhibited by the animal decreases as it forms a new association of the CS with the absence of
US. This is classed as extinction learning (for review see Shechner et al. (2014); Bouton (2004)).
Here, the average of % freezing exhibited during the first three CS presentations (CS1-3) was
classed as fear recall while the difference in average % freezing between the first three and last
three CS presentations (CS1-3 - CS10-12) was classed as extinction. Syngap1+/- FC rats re-
called at levels similar to WT rats (Fig.4.5B, Syngap1+/+= 59.78%± 9.70, Syngap1+/-= 65.21%
± 9.03) with animals of both genotypes showing significantly higher levels of freezing compared
to CS only controls (Two-Way ANOVA CSxGenotype p=<0.0001, F(36, 360)=3.084). Following
re-call, animals were subjected to further presentations of the CS to test for extinction learning.
While WT FC animals showed a reduction in freezing over the course of the CS presentations
(extinction = 28.11%± 8.76%), this was lower than the levels typically seen in literature (Chang
et al., 2009). Additionally, while ‘typical’ WT rodents would show modulation of the freezing
response during the inter-trial intervals (ITI), the WT FC rats in this behavioural cohort showed
a low degree of modulation of freezing response during the ITIs (fig. S3). In Syngap1+/- FC
rats, % freezing was reduced only modestly over the course of the CS presentations (extinction
= 11.54% ± 6.20%) with animals failing to show modulation of the freezing response during
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the ITIs (fig. S3). As with the conditioning, the animals of both genotypes did not show
a generalised anxiety response prior to the onset of the first CS (fig.4.5B pre-stim freezing
Syngap1+/+=16.08% ± 5.77%, Syngap1+/-= 32.88% ± 8.36%, Two-Way ANOVA p=0.6832).
In agreement with previous data from the lab, this would imply that haploinsufficiency of
SynGAP leads to exaggerated re-call of fear memory causing an attenuation of extinction
learning.
AIS lengths post fear conditioning in Syngap1+/- rats
Following behaviour, I analysed AIS lengths in the pre-limbic mPFC (PL) and basolateral
amygdala (BLA) of animals subject to the fear-conditioning paradigm and compared the results
obtained to CS only controls for both genotypes. The PL and BLA are known to play a funda-
mental role in the acquisition and re-call of fear memory (Herry and Johansen, 2014). Given
that Syngap1+/- rats show exaggerated fear re-call and AIS alterations in the BA have previously
been found post fear conditioning, the selection of these two brain regions was appropriate.
In PL L2/3, a trend of reduced average AIS length between WT FC and Syngap1+/- FC rats
(fig.4.5G, Syngap1+/+= 30.00 pm 0.49 µm n=7, Syngap1+/- = 27.98 pm 0.54 µm n=9 animals,
p=0.0595) while a shift towards shorter AIS lengths in the cumulative distribution was observed
in Syngap1+/- FC rats compared to WT FC rats (fig.4.5H). Further, no statistically significant
differences were observed in either WT or Syngap1+/- FC rats compared to the CS only controls
(Syngap1+/+ CS only= 29.82 ± 0.56 µm n=3, Syngap1+/- CS Only= 27.95 ± 0.74 µm n=4
animals).
In PL L5, no change in average AIS length or cumulative distribution of AIS lengths was
observed across rats of either genotype that were subjected to fear conditioning (FC) or in
comparison to CS only control animals (Fig.4.5M, N Syngap1+/+ CS only= 29.29 ± 0.79 µm
n=3, Syngap1+/+= 29.41 pm 0.47 µm n=8, Syngap1+/- CS Only= 29.26 ± 0.56 µm n=4 and
Syngap1+/-= 29.30 pm 0.42 µm n=9 animals). Similarly no change in average AIS length or
cumulative distribution of AIS lengths was found across genotype or condition (FC compared
to CS Only) in either the LA or the BA (LA fig.4.6E, F Syngap1+/+ CS only= 26.45 ± 0.15
µm n=3, Syngap1+/+= 26.38 pm 0.3 µm n=7, Syngap1+/- CS Only= 25.40 ± 0.69 µm n=4 and
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Figure 4.5: AIS lengths in mPFC PL L2/3 and L5 of fear conditioned Syngap1+/+ and Syngap1+/- rats (A)
Fear conditioning (FC) (Syngap1+/+ CS only n=5, Syngap1+/+ FC n=11, Syngap1+/- CS only n=6, Syngap1+/- FC
n=14) show that Syngap1+/- rats freeze at comparable levels to Syngap1+/+ levels (B) Fear Recall /Extinction shows
that Syngap1+/- FC rats recall at levels similar to Syngap1+/+ rats and significantly higher than CS only controls
(Two-Way ANOVA P=<0.0001).(C-F) Representative single AISs with arrows representing the proximal and distal
ends from PL L2/3 of Syngap1+/+ CS only (C), Syngap1+/+ (D), Syngap1+/- CS only (E) and Syngap1+/- (F) rats.
Scale bar=10 µm. (G, H) Trend of reduced average AIS length and cumulative distribution of AIS lengths was
observed in PL L2/3 of Syngap1+/- FC rats compared to Syngap1+/+ FC rats. (I-L) Representative single AISs with
arrows representing the proximal and distal ends from PL L5 of Syngap1+/+ CS only (I), Syngap1+/+ (J), Syngap1+/-
CS only (K) and Syngap1+/- (L) rats. Scale bar=10 µm. (M, N) No change in average AIS length or cumulative
distribution of AIS lengths in PL L5 was observed in rats of either genotype or condition.
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Syngap1+/- = 26.26 pm 0.52 µm n=8; BA fig.4.6K, Syngap1+/+ CS only= 40.18 ± 4.16 µm
n=3, Syngap1+/+= 37.17 pm 2.29 µm n=7, Syngap1+/- CS Only= 36.64 ± 2.57 µm n=4 and
Syngap1+/-= 38.30 pm 2.09 µm n=8).
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Figure 4.6: AIS lengths in LA and BA of fear conditioned Syngap1+/+ and Syngap1+/- rats (A-D) Represent-
ative single AISs with arrows representing the proximal and distal ends from the LA of Syngap1+/+ CS only (A),
Syngap1+/+ (B), Syngap1+/- CS only (C) and Syngap1+/- (D) rats. Scale bar=10 µm. (E, F) No change in average
AIS length (Syngap1+/+ CS only= 26.45 ± 0.15 n=3, Syngap1+/+= 26.38 pm 0.3 n=7, Syngap1+/- CS Only= 25.40
± 0.69 n=4 and Syngap1+/- = 26.26 pm 0.52 n=8 animals) or cumulative distribution of AIS lengths was observed
in rats of either genotype or condition. (G-J) Representative single AISs with arrows representing the proximal
and distal ends from the BA of Syngap1+/+ CS only (G), Syngap1+/+ (H), Syngap1+/- CS only (I) and Syngap1+/-
(J) rats. Scale bar=10 µm. (K, L) No change in average AIS length (Syngap1+/+ CS only= 40.18 ± 4.16 n=3,
Syngap1+/+= 37.17 pm 2.29 n=7, Syngap1+/- CS Only= 36.64 ± 2.57 n=4 and Syngap1+/-= 38.30 pm 2.09 n=8
animals) or cumulative distribution of AIS lengths was observed in rats of either genotype or condition
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Fear memory in Syngap1+/∆Gap rats
Patients with SYNGAP1-ID typically present with protein truncating mutations resulting in
haploinsufficiency (Hamdan et al., 2009; Krepischi et al., 2010; Klitten et al., 2011; Hamdan et
al., 2011; Carvill et al., 2013). The Syngap1+/- rats show haploinsufficiency of the full-length
protein in a fashion similar to these clinical patients, thus showing construct validity. However,
in addition to protein truncating mutations, seven pathogenic de novo missense mutations,
with three being in the catalytic GAP domain, have also been identified in the SYNGAP1
gene in patients presenting with ID (Berryer et al., 2013; O’Roak et al., 2014; Parker et al.,
2015; Mignot et al., 2016). These missense mutations result in the presence of enzymatically
inactive forms of the SynGAP protein, leading to a 50% reduction in GAP function without
a 50% reduction in total protein levels (Berryer et al., 2013). Further, SynGAP acts both in
a GAP-domain dependent and independent manner at the post-synaptic density to regulate
downstream signalling pathways and synaptic plasticity (Walkup et al., 2015, 2016, 2018).
Therefore, in order to further our understanding of the contributions of the various SynGAP
protein domains to SYNGAP1-ID pathophysiology with specific focus on the GAP domain, fear
memory acquisition and recall were assessed in a rat model containing a specific deletion of the
GAP domain (Syngap1+/∆Gap).
During the conditioning phase, Syngap1+/∆Gap rats (n=8) show fear memory acquisition
at a rate comparable to WT animals (Syngap1+/+, n=9) as measured by % freezing over the
course of the protocol (fig.4.7A, Two-Way ANOVA p=0.8250, F(5, 25)=0.4276). Animals of
both genotypes show significantly higher freezing than CS only controls (Two-Way ANOVA
CSxGenotype p=0.0045) and no evidence of generalised anxiety as indicated by low % freez-
ing levels prior to the on-set of the first CS-US pairing (Fig.4.7A, % freezing pre-stimulus
Syngap1+/+= 0.556% ± 0.55%, Syngap1+/∆Gap= 4.028% ± 1.44%, p=0.5447 Bonferroni’s
multiple comparisons test). Thus haploinsufficiency of the GAP domain, similar to haploin-
sufficiency of the full-length SynGAP protein, causes no impairments in acquisition of fear
memory.
During the recall phase, % freezing exhibited by an animal were measured across twelve
CS presentations and the inter-trial intervals. Syngap1+/∆Gap rats showed higher, but statistic-
ally non-significant, % freezing during the first three CS presentations compared to WT fear-
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conditioned (WT FC) rats (Fig.4.7B, Syngap1+/+= 67.78% ± 7.80%, Syngap1+/∆Gap= 81.11%
± 9.08%, Two-Way ANOVA p=>0.999) with fear conditioned (FC) animals of both genotypes
showing significantly higher % freezing compared to CS only controls (Fig.4.7A, Two-Way
ANOVA CSxGenotype p=<0.0001, F(36, 240)=2.891). Similar to the conditioning phase, neither
WT nor Syngap1+/∆Gap FC rats showed evidence of generalised anxiety as measured by % freez-
ing exhibited prior to the first CS presentation (Fig.4.7B pre-stim freezing Syngap1+/+= 1.67%
± 5.02%, Syngap1+/∆Gap= 33.96% ± 10%, p=0.4396 Bonferroni’s multiple comparisons test).
Over the course of the 12 CS presentations, WT FC animals showed progressively reduced %
freezing, which is measure classically used as evidence of extinction learning (Chang et al.,
2009). Here, ‘extinction’ was measured as the difference in % freezing exhibited by an animal
between CS1-3 and CS10-12 and for WT FC animals was 43.70%± 5.78%. Syngap1+/∆Gap FC
rats, however, showed significantly lower levels of ‘extinction’ compared to WT FC animals
(% freezing during CS1-3 - CS10-12= 10.28% ± 8.59, Two-Way ANOVA p=0.0148), mimick-
ing the exaggerated fear memory recall phenotype of the Syngap1+/- rats. Differing from the
phenotype of Syngap1+/- rats, the Syngap1+/∆Gap showed modulation of their freezing response
during inter-trial intervals (see appendix fig.S3).
AIS lengths post fear conditioning in Syngap1+/∆Gap rats
Given the similarly exaggerated fear recall in Syngap1+/∆Gap and Syngap1+/- FC rats, the
role of the medial prefrontal cortex (mPFC) and the basolateral amygdala in fear memory recall
(Herry and Johansen, 2014) and evidence of AIS plasticity in the basal amygdala post fear-
conditioning (A Lüthi), I analysed and compared AIS lengths in both these brain regions in
animals subjected to the fear-conditioning paradigm to CS only controls across both genotypes.
In the mPFC, average AIS lengths and cumulative distribution of AIS lengths was as-
sessed in L2/3 and L5 of the pre-limbic sub-region as this region has previously been shown
to be crucial for fear memory recall (Corcoran and Quirk, 2007). No difference in either av-
erage AIS length or cumulative distribution of AIS lengths in observed in cells of PL L2/3
between animals subjected to FC compared to CS only control animals, or between genotypes
(Fig.4.7G, H Syngap1+/+ CS only= 29.78± 1.41 µm n=2, Syngap1+/+= 29.59 pm 0.47 µm n=7,
Syngap1+/∆Gap CS Only= 27.81 ± 0.89 µm n=3 and Syngap1+/∆Gap = 30.06 pm 0.56 µm n=6
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animals). In cells of PL L5, increased average AIS length and altered cumulative distribution of
AIS lengths was observed in Syngap1+/∆Gap FC rats compared to Syngap1+/+ FC (Fig.4.7M, N
Syngap1+/+= 30.23 pm 0.32 µm n=7, Syngap1+/∆Gap= 31.62 pm 0.35 µm n=6 animals, p=0.04)
and CS only control rats (Fig.4.7M, N Syngap1+/∆Gap CS Only= 29.16 ± 0.50 µm n=3 and
Syngap1+/∆Gap= 31.62 pm 0.35 µm n=6 animals, p=0.0049).
In the lateral and basal nuclei of the amygdala, no changes in either average AIS length or cu-
mulative distribution of AIS lengths was observed between animals subjected to fear condition-
ing and CS only controls or between genotypes in either condition (LA fig.4.8E, F Syngap1+/+
CS only= 27.35 ± 1.84 µm n=2, Syngap1+/+= 27.82 pm 0.80 µm n=7, Syngap1+/∆Gap CS
Only= 27.59 ± 0.84 µm n=3 and Syngap1+/∆Gap = 28.35 pm 0.39 µm n=6; BA fig.4.8K, L
Syngap1+/+ CS only= 36.62± 7.01 µm n=2, Syngap1+/+= 35.59 pm 1.76 µm n=7, Syngap1+/∆Gap
CS Only= 36.69 ± 4.14 µm n=3 and Syngap1+/∆Gap = 38.04 pm 1.31 µm n=6).
Inevitably, within the cohorts of fear conditioned animals the % freezing exhibited during
CS presentations that was used to measure recall and extinction was varied. Given that plasticity
of AIS morphology is dependent on the experience of each individual animal, I wanted to assess
if the AIS lengths measured in a given brain-region were correlated with the amount of %
freezing exhibited by that animal during recall and extinction. Therefore, I ran a Spearman’s
correlation analysis of the measured AIS lengths in all four regions with the % freezing exhibited
by an animal during recall and extinction (fig.4.9). The analysis revealed that in WT FC animals
of both Syngap1+/- and Syngap1+/∆Gap cohorts, no significant correlations were found between
AIS lengths in any of the brain regions and % freezing exhibited during recall or extinction
(fig.4.9A, B). However, Syngap1+/- FC rats showed a significant, negative correlation between %
freezing exhibited during recall (r2=-0.934, p=0.002, n=8) and extinction (r2= -0.766, p=0.032)
and measured AIS lengths in PL L2/3. In Syngap1+/∆Gap FC rats, AIS lengths in the BA were
negatively and significantly correlated with % freezing exhibited by an animal during recall (r2=
-0.943, p= 0.017). Further, both Syngap1+/- and Syngap1+/∆Gap CS only control animals did
not show any significant correlations of AIS length and % freezing during recall or extinction,
ensuring that the correlations obtained were dependent on animal experience and could not be
explained by genotype (Syngap1+/- CS only recall-PL L2/3 r2= 0.316, p=0.667, extinction-PL
L2/3 r2= 0.800, p=0.333; Syngap1+/∆Gap CS only recall-BA r2=0.500, p=1.00).
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Figure 4.7: AIS lengths in mPFC PL L2/3 and L5 of fear conditioned Syngap1+/+ and Syngap1+/∆Gap rats (A)
FC shows that Syngap1+/∆Gap rats freeze at comparable levels to Syngap1+/+ levels (Syngap1+/+ CS only n=2,
Syngap1+/+ FC n=9, Syngap1+/∆Gap CS only n=5, Syngap1+/∆Gap FC n=8) (B) Fear Recall /Extinction shows that
Syngap1+/∆Gap FC rats recall at levels similar to Syngap1+/+ rats and significantly higher than CS only controls
(C-F) Representative single AISs with arrows representing the proximal and distal ends from PL L2/3 of Syngap1+/+
CS only (C), Syngap1+/+ (D), Syngap1+/∆Gap CS only (E) and Syngap1+/∆Gap (F) rats. Scale bar=10 µm. (G, H)
No change in average AIS length or cumulative distribution of AIS lengths was observed in PL L2/3 of rats of either
genotype or condition. (I-L) Representative single AISs with arrows representing the proximal and distal ends from
PL L5 of Syngap1+/+ CS only (I), Syngap1+/+ (J), Syngap1+/∆Gap CS only (K) and Syngap1+/∆Gap (L) rats. Scale
bar=10 µm. (M, N) Average AIS length and cumulative AIS lengths were significantly increased in Syngap1+/∆Gap
FC rats compared to Syngap1+/∆Gap CS only rats as well as Syngap1+/+ FC rats.
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Figure 4.8: AIS lengths in LA and BA of fear conditioned Syngap1+/+ and Syngap1+/∆Gap rats (A-D) Repres-
entative single AISs with arrows representing the proximal and distal ends from the LA of Syngap1+/+ CS only (A),
Syngap1+/+ (B), Syngap1+/∆Gap CS only (C) and Syngap1+/∆Gap (D) rats. Scale bar=10 µm. (E, F) No change in
average AIS length (Syngap1+/+ CS only= 27.35 ± 1.84 n=2, Syngap1+/+= 27.82 pm 0.80 n=7, Syngap1+/∆Gap CS
Only= 27.59± 0.84 n=3 and Syngap1+/∆Gap = 28.35 pm 0.39 n=6 animals) or cumulative distribution of AIS lengths
was observed in rats of either genotype or condition. (G-J) Representative single AISs with arrows representing the
proximal and distal ends from the BA of Syngap1+/+ CS only (G), Syngap1+/+ (H), Syngap1+/∆Gap CS only (I) and
Syngap1+/∆Gap (J) rats. Scale bar=10 µm. (K, L) No change in average AIS length (Syngap1+/+ CS only= 36.62
± 7.01 n=2, Syngap1+/+= 35.59 pm 1.76 n=7, Syngap1+/∆Gap CS Only= 36.69 ± 4.14 n=3 and Syngap1+/∆Gap =
38.04 pm 1.31 n=6 animals) or cumulative distribution of AIS lengths was observed in rats of either genotype or
condition
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Figure 4.9: Spearman’s correlation data of AIS lengths with fear recall and extinction in Syngap1+/- and
Syngap1+/∆Gap rats No significant correlation of AIS lengths in any of the brain regions analysed to %Recall or
%Extinction in WT FC rats from either the Syngap1+/- cohort, n=6 (A) or the Syngap1+/∆Gap cohort, n=7 (B) (C)
Statistically significant negative correlation was found between PL L2/3 AIS length with both %Recall (r2= -0.934,
p= 0.002) and %Extinction (r2= -0.766, p=0.032) in Syngap1+/- FC rats, n=8 (D) Statistically significant negative
correlation was seen between BA AIS length with %Recall (r2= -0.943, p= 0.017) in Syngap1+/∆Gap FC rats, n=6.
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4.2.3 Sub-Population Specific changes to AIS length
Reciprocal monosynaptic connectivity between the mPFC and the BLA (Bacon et al., 1996;
Verwer et al., 1996; Mcdonald et al., 1996; Krettek and Price, 1977; Gabbott et al., 2005; Hoover
and Vertes, 2007) is crucial for mediating fear-associated learning, memory consolidation and
emotional regulation (Burgos-Robles et al., 2017; Klavir et al., 2017; Davis and Whalen, 2001).
Disruption of this circuit has been implicated in a variety of anxiety-related disorders including
post-traumatic stress disorder (PTSD) (Burghy et al., 2012) and obsessive-compulsive disorder
(Sun et al., 2019). Altered anxiety states are a common comorbidity of ASD/ID (for review
see Kerns and Kendall (2012)), and perturbations in mPFC and BLA circuits in pre-clinical
models of these disorders has previously been reported (Markram et al., 2008; Rinaldi et al.,
2008; Testa-Silva et al., 2012; Selleck et al., 2018). Moreover, fear-conditioning in rodents
has specifically been shown to alter the intrinsic excitability of mPFC-BLA projection neurons
(Song et al., 2015) and a key regulator of intrinsic cellular excitability is the axon initial segment
(for review see (Kole and Stuart, 2012)). The AIS is known to regulate its length in an activity
dependent manner and in mice fear conditioning is shown to result in the elongation of the
AIS in BA-mPFC projection neurons. Further, in a rat model of Fragile-X syndrome that is
known to have impaired fear-associated learning (see appendix fig.S2), mPFC-BLA projection
neurons are shown to have shorter AISs compared to wildtype controls (see appendix fig.S1,
Jackson (2016)). Given that the rat models of Syngap1 haploinsufficiency present with altered
fear-memory and mouse models of FXS and SYNGAP1-ID have previously been shown to
have convergent cellular phenotypes, I hypothesized that AIS lengths specifically within mPFC-
BLA and BLA-mPFC projection neurons would be differentially altered at a baseline condition
(without being subjected to any learning paradigms) in our rat model.
In order to test this hypothesis, I used a retrograde tracing approach (fig.4.10A, fig4.11A).
Physiologically inert beads tagged with rhodamine fluorophores were stereotaxically injected
into the mPFC and BLA to study reciprocal connectivity within the same subject. ‘Red’ beads
(excitation wavelength 530nm) were injected into the mPFC of the right hemisphere (fig.4.10B,
C) while ‘green’ beads (excitation wavelength 460nm) were injected into the BLA of the
left hemisphere (fig.4.11B, C). Due to previously reported inter-hemispheric asymmetry in
amygdala size (Jung et al., 2018) and connectivity (Polli et al., 2009), the same hemispheres
were injected in all animals. AIS lengths in the BLA and mPFC of the ipsilateral hemisphere to
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the site of injection were measured.
AIS lengths in BLA-mPFC projection neurons
Injection of retrobeads into the mPFC showed that cells projecting to this region were found
predominantly in the basal nuclei of the BLA (fig.4.10A-D), as has previously been shown (Song
et al., 2015; McGarry and Carter, 2017; Sun et al., 2019). No change in average AIS length or
cumulative distribution of AIS lengths was observed in BLA-mPFC projection neurons in adult
(P90-120) Syngap1+/- rats compared to wildtype, littermate controls (fig.4.10G, Syngap1+/+=
42.20 ± 1.37 n=6, Syngap1+/-= 40.99 ± 1.03 n=8 animals). However, the sub-population of
BLA-mPFC projection neurons of both WT and Syngap1+/- rats showed differential distribution
of AIS lengths compared to those of the whole-population BA neurons. In WT animals, values
for mean, minimum and maximum measured AIS lengths showed a slight increase in BLA-
mPFC neurons accompanied by decreased overall range of AIS lengths (table. 4.5), however
the difference in mean AIS length values was not statistically significant (Two-way ANOVA
with Bonferroni’s correction for multiple comparisons, p=0.8092). Similar to WT animals,
BLA-mPFC projection neurons in Syngap1+/- rats showed slightly increased, but not statist-
ically significant (Two-way ANOVA with Bonferroni’s correction for multiple comparisons,
p=0.6722), average AIS lengths (table. 4.5). Minimum and maximum measured AIS lengths
were also increased in Syngap1+/- rats, similar to WT animals, while the range showed a ~2µm
increase than those measured in age-matched whole-population BA neurons of Syngap1+/- rats.
In both genotypes, mean AIS lengths of BLA-mPFC neurons were significantly higher than
whole-population LA neurons (Two-way ANOVA with Bonferroni’s correction for multiple
comparisons, p=<0.0001). Overall, the data indicates that within AIS lengths of BLA-mPFC
sub-population neurons was not significantly different from the general population of BA neur-
ons and that Syngap1 haploinsufficiency did not cause a sub-population specific alteration in
AIS length in BLA-mPFC neurons.
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Figure 4.10: AIS lengths in BLA-PL projecting neurons of Syngap1+/+ and Syngap1+/- rats (A) Schematic
showing the retrograde labelling strategy (B) Schematic of a coronoal section of the rat brain at AP = +3.00, DV =
±0.6 with the red region highlighting the region of the PL targeted by the stereotaxic injection (C) Example image
of injection site targetting the PL. Beads contain a 530 fluorophore, counter-stained with TOPRO (D) Representative
stitched imafe of the BLA used for analysis. White arrows identify successfully labelled cells and the white dashed
line denotes the external capsule. (E-F) Representative single AISs with arrows representing the proximal and
distal ends of Syngap1+/+ (E) and Syngap1+/- (F) rats. Scale bar=10 µm. (G, H) No change in average AIS length
(Syngap1+/+= 42.20 ± 1.37 n=6, Syngap1+/-= 40.99 ± 1.03 n=8 animals) or cumulative distribution of AIS lengths






BLA-mPFC 42.20 µm 40.99 µm
BA 40.07 µm 38.42 µm
LA 29.13 µm 28.31 µm
Min
Length
BLA-mPFC 37.14 µm 36.18 µm
BA 31.53 µm 35.54 µm
LA 28.07 µm 26.60 µm
Max
Length
BLA-mPFC 46.04 µm 45.11 µm
BA 43.69 µm 41.80 µm
LA 33.66 µm 32.43 µm
Range
BLA-mPFC 8.89 µm 8.93 µm
BA 12.16 µm 6.26 µm
LA 3.28 µm 3.27 µm
Table 4.5: Comparison of AIS lengths in BLA-mPFC projecting cells and whole-population BLA cells
AIS lengths in PL-BLA projection neurons
Injection of the retrobead into the BLA showed that cells of both PL L2/3 and L5 project
to the BLA (fig.4.11A-D), as has been previously shown (Hoover and Vertes, 2007). No
differences in either average AIS length or cumulative distribution of AIS lengths was observed
in Syngap1+/- rats compared to WT controls (fig.4.11G, H Syngap1+/+= 29.24 ± 0.73 µm
n=5, Syngap1+/-= 28.67 ± 0.41 µm n=8 animals). Compared to the measurements of AIS
length made in neurons of PL at a whole-population level in adult WT animals, PL-BLA
projection neurons showed significantly reduced mean AIS length compared to the mean in
PL L5 neurons (Syngap1+/+ PL-BLA= 26.80 ± 0.7306 µm, L2/3= 30.59 ± 0.3717 µm, L5=
30.52 ± 0.6533 µm, p=0.0206) but not PL L2/3 neurons (p=0.0931). This decrease in average
length was accompanied by decreased minimum measured AIS length in PL-BLA projection
neurons compared to neurons in both PL L2/3 and PL L5 while overall range of AIS lengths
was increased (see table.4.6). Similarly in Syngap1+/- rats, average AIS length of PL-BLA
projection neurons was significantly reduced in comparison to average length of PL L5 neurons
(Syngap1+/- PL-BLA= 28.67 ± 0.4140 µm, L2/3= 29.05 ± 0.6352 µm L5= 31.06 ± 0.4998
µm, p=0.0435) but not neurons of PL L2/3 (p=0.9959). Minimum and maximum measured AIS
length in PL-BLA neurons of Syngap1+/- rats also matched those of WT PL-BLA neurons and
were shorter than those measured in PL L2/3 or L5 whole-population neurons with an increased
range of measured AIS lengths. Overall the data indicates that Syngap1 haploinsufficiency did
not result in altered mean AIS length in PL-BLA projection neurons when compared to the
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same sub-population in wildtype littermate controls or when compared to mean AIS lengths of





PL-BLA 29.24 µm 28.67 µm
PL L2/3 31.55 µm 29.05 µm
PL L5 33.14 µm 31.06 µm
Min
Length
PL-BLA 26.80 µm 26.81 µm
PL L2/3 30.59 µm 28.36 µm
PL L5 30.52 µm 30.29 µm
Max
Length
PL-BLA 30.86 µm 29.84 µm
PL L2/3 32.39 µm 30.95 µm
PL L5 33.66 µm 32.43 µm
Range
PL-BLA 4.05 µm 3.02 µm
PL L2/3 1.80 µm 2.59 µm
PL L5 3.13 µm 2.13 µm
Table 4.6: Comparison of AIS lengths in PL-BLA projecting cells and whole-population PL cells
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Figure 4.11: AIS lengths in PL-BLA projecting neurons of Syngap1+/+ and Syngap1+/- rats (A) Schematic
showing the retrograde labelling strategy (B) Schematic of a coronoal section of the rat brain at AP = -3.00, DV
= ±5.2 with the green region highlighting the BLA targeted by the stereotaxic injection (C) Example image of
injection site targetting the BLA (outlined in white dotted line). Beads contain a 488 fluorophore, counterstained
with TOPRO (D) Representative column stack of the PL used for analysis with white arrows identifying successfully
labelled cells. (E-F) Representative single AISs with arrows representing the proximal and distal ends of Syngap1+/+
(E) and Syngap1+/- (F) rats. Scale bar=10 µm. (G, H) No change in average AIS length (Syngap1+/+= 29.24 ± 0.73
n=5, Syngap1+/-= 28.67 ± 0.41 n=8 animals) or cumulative distribution of AIS lengths was observed in Syngap1+/-
rats compared to controls
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4.3 Discussion
The chief hypothesis tested in this chapter is that reduction in SynGAP alters in vivo mor-
phological plasticity of the AIS. Specifically, analysis and comparison of genotype specific
changes in AIS morphology over development was undertaken in neurons of the mPFC PL and
the BLA. However, Syngap1 haploinsufficiency did not alter age-dependent changes to AIS
length in neurons of the LA, BA and PL L5, but showed a modest difference in age-dependent
changes in AIS lengths of PL L2/3 neurons.
Subsequently, adaptation of AIS length following a cued fear conditioning (FC) associative-
learning paradigm was analysed.The main results from this analysis revleaved that haploinsuffi-
ciency of SynGAP’s GAP domain is sufficient to drive exaggerated fear recall behaviour, which
in-turn is correlated with a reduction in AIS length, and haploinsufficiency of the full-length
protein and the GAP domain differentially alter AIS lengths post FC in PL L2/3 and L5.
Finally, cell-type specific alterations in AIS length between reciprocal mPFC-BLA projec-
tion neurons was undertaken but no genotype specific alterations in mean or distribution of AIS
lengths was observed in either sub-population.
4.3.1 Analysis of AIS lengths at different ages
Evidence of developmentally regulated plasticity of AIS length in vivo, with the consequent
fine-tuning of neuronal firing, have been seen on the time-scale of days (Kuba et al., 2015),
weeks (Gutzmann et al., 2014) and months (Cruz et al., 2009). Here, I examined AIS length over
the course of normal development in adult (P90-120) animals of Syngap1 haploinsufficiency and
compared the results across genotypes to those obtained in juvenile (P28-32) animals described
in chapter 3, with 4-6 week age difference between the animals. Reduction in SynGAP levels
results in an exaggerated freezing response on re-call of fear memory, formed in a cued fear
conditioning (FC) paradigm, with little to no extinction (ranging from 10.28-11.54% ± 6.20-
8.59%) of this response. The prefrontal- amygdala circuitry is crucial for the appropriate
formation and expression of fear and anxiety-related memories. Therefore, analysis was focused
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on neurons of the PL and the BLA, which are known to alter their excitability in response to
FC-induced learning.
Comparison of AIS lengths between juvenile and adult rats revealed two key findings. First,
the distribution of AIS lengths in WT animals at P90-120 in all regions examined show a signi-
ficant shift in AIS lengths towards longer lengths, without any statistically significant increase
in mean length in neurons of PL L2/3, L5 and the BA and with statistically significant increase
in the LA. Maturation of neuronal circuits with age results from altered synaptic and cellular
excitability with corresponding elongation in AIS length in the rodent cortex (Gutzmann et al.,
2014). The results from WT animals thus imply that in juvenile animals there is greater variab-
ility in AIS lengths due to differential maturation states of the neurons, while in adult animals
neuronal maturity, and AIS lengths, are more homogenous. Similar to the alteration seen in WT
animals, Syngap1+/- rats also show a shift in the cumulative distribution of AIS lengths towards
longer lengths in adult animals in all brain regions examined with the exception of neurons
in PL L2/3. Neurons of the PL have afferent projections to multiple targets, including the
hippocampus, BLA, the medial-basal forebrain, the midline thalamus and the monoaminergic
nuclei of the brain-stem (Hoover and Vertes, 2007; Song and Moyer, 2018). Depending on
their projection target, neurons exhibit differential excitability, which may be accompanied by
differences in AIS lengths (Senn et al., 2014; Yamashita et al., 2018). Thus, the failure of PL
L2/3 neurons of Syngap1+/- rats to show elongation with age similar to those observed in PL L5,
BA and LA could be attributed to altered cellular activity and AIS lengths of a sub-population
of neurons projecting to a specific target. The argument of different sub-populations of neurons
showing differential AIS length can also be extended to explain the high degree of variability
observed in both the average and cumulative AIS length distribution of neurons in the BA across
ages and genotypes. Similar to the mPFC, pyramidal cells the BA show afferent projections to
multiple brain-regions with neurons differentially controlling behaviour and cellular excitability
depending on the projection target (Verwer et al., 1996; Mcdonald et al., 1996; Arruda-Carvalho
et al., 2017). Given that plasticity of AIS length is known to be dependent on altered synaptic
stimuli (Kuba et al., 2015), the converse argument that AIS length of a neuron will be differ-
entially altered depending on site of origin of efferent projections is equally valid. Further, a
study by Beyeler et al. (2018) shows that anatomical organisation of the BLA affects cellular
function such that pyramidal neurons express different intrinsic excitability depending on its
location along the anterior-posterior axis of the BLA. Although the sections containing the
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BLA chosen for AIS analysis were matched by hippocampal size, this matching was visually
estimated allowing for errors. Therefore, another explanation for the increased variability in
AIS lengths measured from neurons in the BA could be neuron location along the AP axis.
AIS analysis within a specific sub-population
The experimental and analytical design of described above occludes the identification of
sub-population specific changes. Given the importance of reciprocal PL-BLA projections in
fear memory formation (Arruda-Carvalho and Clem, 2015) and the exaggerated recall of fear
memory upon reduction of SynGAP, I performed within subject examination of AIS lengths in
PL neurons projecting to the BLA and vice-versa. Results showed no significant alterations in
AIS length in either sub-population examined in Syngap1+/- rats compared to wildtype controls;
indicating that AIS lengths - and its mediated cellular excitability - are unaltered in these
neuronal sub-populations and do not underlie the exaggerated fear-memory recall phenotype
seen in this preclinical model of Syngap1 haploinsufficiency.
However, one technical reason for a lack of genotype specific alterations in AIS length in
PL-BLA projection neurons might be bleed-through between the channels in which the different
beads were imaged (fig.S7). The experiment was designed such that AIS lengths from both
PL-BLA neurons and BLA-mPFC neurons could be analysed within the same subject, reducing
inter-animal variability between sub-populations. Briefly, the contra-lateral hemisphere of the
PL analysed for AIS lengths was injected with the ‘red’ bead while the ipsilateral BLA was
injected with the ‘green’ bead. PL cortices of both hemispheres show extensive connectivity
(Vertes, 2004), therefore the presence of beads of both colours in the images PL section was
expected. Furthermore, neurons of the PL have previously been shown to project to more than
one target region (McGarry and Carter, 2017), therefore the presence of double labelled ‘yellow’
cells in the analysed sections was also expected. However, the high degree of spatial overlap
between fluorescent beads was suggestive of a technical issue (fig.S7B). To circumvent this
complication, I applied stringent filter-settings during image acquisition to minimise channel
bleed-through and restricted analysis of AIS lengths to only neurons show single-labelling with
‘green’ beads. A resulting caveat of this decision was that, in order to reach the minimum
required AIS lengths to perform statistical analysis, neurons used for AIS analysis were pooled
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across different cortical layers and along a wider rostro-caudal axis than used for any of the
other modes of analysis. Previous studies reporting differences in cellular activity of this sub-
population have restricted analysis to L5 neurons as pyramidal neurons from different cortical
layers have different electrical properties (Song and Moyer, 2018). A biological explanation of
the high-degree of spatial overlap seen in the doube-labelled cells could be bead sequestration.
Within the BA to mPFC sub-population, there was no evidence of double-labelled cells. Lastly,
while differences in the rostro-caudal axis of the injection site could result in labelling of
different sub-populations of projection neurons, injection volumes was kept deliberately small
and neurons from only those animals where the brain region of interest was successfully targeted
by injection were included in the final analysis (see appendix fig. S5, S6).
AIS length mediation is only one mode of control of neuronal excitability. Particularly,
alterations in learning and memory are associated with alterations in synaptic plasticity (Sehgal
et al., 2013). Reduction in SynGAP levels is associated with synaptic plasticity impairments
along with altered dendritic spine dynamics (Carlisle et al., 2008; Clement et al., 2012; Aceti
et al., 2015; Araki et al., 2015). Therefore, other factors that might underlie the altered fear
memory in the Syngap1+/- rat is AIS-independent alterations in cellular excitability and synaptic
plasticity including alterations in number, density and function of voltage-gated ion channels
and neurotransmitter receptors at dendritic spines and cell soma, number of functional synapses
and altered pre-synaptic release probability. Electrophysiological characterisation of these cells
should be undertaken to gain a better understanding of the underlying cellular and synaptic
alterations.
4.3.2 Activity dependent changes to AIS length upon loss of SynGAP
In vivo experience-dependent plasticity of AIS morphology have been established through
studies of sensory deprivation (Kuba et al., 2015; Gutzmann et al., 2014; Schlüter et al., 2017).
Further, preliminary data shows elongation of AIS length in BA-PL projection neurons in adult
wildtype mice 24 hours post fear conditioning (personal correspondence A L(̈u)thi). Whether
these changes in AIS-length are accompanied by alterations in cellular excitability are not yet
known. Given that we know BA-PL projection neurons show no alterations in AIS length in
Syngap1+/- rats and that these rats show exaggerated fear-memory recall, I hypothesized that
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following fear-conditioning, BA-PL projection neurons of Syngap1+/- rats would show altered
experience dependent alteration in AIS length compared to CS only controls and wildtype
animals subjected to FC. However, due to limitations of protocol severity set by the UKBA
Home Office in the project license under which these experiments were performed, I analysed
alterations in AIS length in whole population PL L2/3, L5 and BLA neurons. Specifically, both
surgeries for stereotaxic injection of retrobeads and fear-conditioning are classified as protocols
of ‘moderate’ severity. On the project license under which these experiments were performed
each animal could only be subjected to one moderate procedure, therefore to perform both
retrobead injections and fear conditioning on the same animal would have resulted in being in
breach of the license. To avoid being in breach a new project license application was made
to allow for two moderate procedures to be undertaken on the same animal, however license
approval was pending at the time these experiments were undertaken. Thus, both retrobead
injection and fear conditioning experiments were conducted on different cohorts of animals.
Post FC, both Syngap1+/- and Syngap1+/∆Gap rat models of SYNGAP1-ID show exagerrated
recall of fear memory. Despite this similarity in behaviour, distinct alterations in AIS lengths
were observed in these animals post FC. Syngap+/- rats show a significant shift in the cumu-
lative distribution of AIS lengths measured in PL L2/3 neurons towards shorter lengths. This
shift is reminiscent of the trend of shorter AIS length observed in PL L2/3 neurons of adult
Syngap+/- animals (in comparison to WT age-matched controls) not subjected to fear condition-
ing (table.4.1). While, Syngap1+/∆Gap rats show increased average AIS lengths with a shift in
cumulative distribution towards longer AIS lengths in neurons of PL L5 (when compared to
WT and CS only controls). Suggesting that haploinsufficiency of the GAP domain and the full
length protein might cause alterations in cellular excitability in a cell-type/ brain-region specific
manner despite exhibiting similar behavioural abnormalities. This idea is further supported by
correlational analysis run between the % freezing exhibited by an animal during recall and the
AIS length of neurons in the various sub-regions analysed. Syngap1+/∆Gap FC rats showed a
strong negative correlation of AIS length with % freezing exhibited by the during recall while
Syngap1+/- FC rats showed a significant, negative correlation between % freezing exhibited
during recall and AIS lengths measured in neurons of PL L2/3. Of note is the high percentage of
freezing seen in Syngap1+/- and Syngap1+/∆Gap CS Only animals towards the end of the recall
protocol (CS 8-12). While it was evident during analysis of behaviour that the animals had
fallen asleep, the time spent immobile still fulfilled the criteria set for a ‘freezing’ response, and
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thus the data was not discarded.
Interestingly, the data presented here shows that the plasticity of AIS length observed in
wildtype mouse basal amygdala following fear conditioning is not recapitulated in WT rats.
The evident reason for this lack of recapitulation is that their AIS analysis was conducted in
BA-PL projection neurons whereas my analysis was conducted at the whole population level.
However, species specific differences, as is seen in chapter 5, and difference in fear-conditioning
protocol (auditory vs visual cue) could influence AIS length alteration in these neurons. Notably,
unpublished work from the laboratory shows that Syngap1+/- rats subjected to an auditory cued
fear conditioning paradigm exhibit reduced, and not exaggerated, levels of freezing during recall
of fear memory.
The work under-taken in this chapter is part of an on-going project with additional ex-
periments underway. Specifically, analysis of AIS lengths in the PL and the BLA and their
sub-populations of adult Syngap1+/∆Gap rats, the effect of fear-conditioning and extinction on
the AIS lengths of PL-BLA and BLA-mPFC projecting neurons and neurons of the infralimibic
cortex of Syngap1+/∆Gap and Syngap1+/- rats are being carried out.
The data presented here provides the first evidence of Syngap1 haploinsufficiency causing
differential experience-dependent alterations in AIS-morphology. The similarities in results
from assessment of fear memory recall in Syngap1+/∆Gap and Syngap1+/- rats implies that hap-
loinsufficiency of GAP domain function is sufficient to cause an exaggerated recall phenotype.
Given that the neural circuits underlying fear memory formation in rodents also underlie, to a
degree, the development of threat and aggression related behaviours in humans (for review see
Arruda-Carvalho et al. (2017)), GAP domain haploinsufficiency may underlie the increased
aggression and threat-like behaviours exhibited by individuals with SYNGAP1-ID (Krepischi et
al., 2010; Klitten et al., 2011; Parker et al., 2015; Vlaskamp et al., 2019). Further, it presents
evidence of cell-type specific alteration of this AIS length plasticity depending on the nature
of the protein haploinsufficiency, suggesting different underlying biological mechanisms in
these disorders. Lastly, it is the first study to show age-dependent increase in AIS length in the
basal and lateral nucleus of the amygdala. Electrophysiological characterisation will need to be
undertaken to establish the altered cellular excitability of these neurons.
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Chapter 5
Convergence of AIS pathology across models of mono-
genic forms of ASD/ID
5.1 Introduction
Identification of low frequency de novo mutations and candidate gene loci in patients with
developmental disorders such as ASD/ID using exome sequencing and genome-wide association
studies (GWAS) have led to the prediction of hundreds of risk loci underlying sporadic cases
of disease (Iossifov et al., 2012; Devlin et al., 2012; O ’ Roak et al., 2012; Sanders et al., 2012;
Hormozdiari et al., 2015). This genetic heterogeneity notwithstanding, there is evidence that
candidate genes cluster into distinct subsets based on biological function and protein-protein
interaction (O’Roak et al., 2012; Allen et al., 2013; Gulsuner et al., 2013; Mitra et al., 2013;
Parikshak et al., 2013; Willsey et al., 2013). These clusters include genes encoding regulators of
transcription (MECP2, FOXP1) (Amir et al., 1999; Iossifov et al., 2014), chromatin modification
(CHD8, ARID1B) (De Rubeis et al., 2014; Sanders et al., 2015)), translation (FMR1, SYNGAP1,
PTEN) (Osterweil et al., 2010; Barnes et al., 2015; Hopkins et al., 2014; Myers et al., 1998),
proteasome mediated degradation (UBE3A) (Kishino et al., 1997; Louros and Osterweil, 2016),
synapse formation and maintenance (SHANK3, NLGN3, 4, NRX1, CNTNAP2) (De Rubeis et
al., 2018).
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Furthermore, a common feature of many of these mutations includes altered cellular and
circuit excitability, either as a result of excitation/inhibition (E/I) imbalance or impaired ho-
moeostasis (Rubenstein and Merzenich, 2003; Gogolla et al., 2010; Nelson and Valakh, 2015;
Bourgeron, 2015). E/I imbalance in ASD have been reported both as a consequence of in-
creased excitation, particularly the number of glutamatergic synapses in mouse models of
Syngap1 haploinsufficiency (Clement et al., 2012; Ozkan et al., 2014; Aceti et al., 2015) and
Neurofibromatosis-1 (Cui et al., 2008), as well as diminished GABA-ergic inhibition in mouse
models of FXS (Gibson et al., 2008) and Rett syndrome (Dani et al., 2005; Durand et al., 2012).
Altered cellular excitability may subsequently lead to long-term changes in synaptic efficacy,
manifesting as impaired or exaggerated LTP and LTD. Indeed, evidence of this is found in
multiple animal models of ASD. Exaggerated mGluR-LTD is found in the Fmr1 KO mouse
model of FXS (Huber et al., 2002), Syngap1 het mouse model of SYNGAP1-ID (Barnes et al.,
2015) and Ube3a KO mouse model of Angelman’s syndrome (hui Jiang et al., 1998). Impaired
LTD is found in mouse models of tuberous sclerosis complex (Tsc2 het) (Auerbach et al., 2011),
NLGN3 associated non-syndromic ID (Nlgn3 KO) (Baudouin et al., 2012) and Cowden syn-
drome (Pten KO) (Sperow et al., 2012). LTP is found to be impaired in models of FXS (Zhao et
al., 2005; Xu et al., 2012), BRAF and PTPN11 models of Noonan syndrome (Lee et al., 2014),
NF1 (Silva et al., 1997) and SYNGAP1-haploinsufficiency (Komiyama et al., 2002; Ozkan et al.,
2014)) while LTP is enhanced in the HRAS model of Costello syndrome (Manabe et al., 2000).
The observed alterations in excitability and synaptic plasticity do not occur throughout the
brain, but rather appear to be circuit specific (Varghese et al., 2017). Brain regions particularly
affected include the prefrontal cortex, sensory cortices, the dorsal hippocampus and the amy-
gdala Varghese et al. (2017). Volumetric analysis showing increased size of the dorsolateral
PFC and amygdala have been consistently reported in ASD diagnosed children aged 2-5 years
(Carper and Courchesne, 2005; Courchesne et al., 2011; Carper et al., 2002; Hazlett et al., 2012;
Schumann et al., 2009; Sparks et al., 2002)) while a reduction in the number of parvalbumin-
positive chandelier interneurons is reported in the medial PFC (Hashemi et al., 2017; Ariza et
al., 2018). In the visual cortex of individuals with ASD reduced GABAergic inhibition, with
preserved glutamatergic activity, is found resulting in weakened functions such as binocular
rivalry (Robertson et al., 2013, 2016; Freyberg et al., 2015). In the hippocampus, decreased
neuronal cell size and dendritic complexity have been reported with increased cell density in
individuals with ASD (Raymond et al., 1995). This increased cell density is specifically of
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calbindin-immunoreactive interneurons of the dentate gyrus whereas the CA1 and CA3 sub re-
gions of the hippocampus show increased density of parvalbumin-immunoreactive interneurons
(Lawrence et al., 2010). Anatomical studies in the amygdala have been less consistent with
some studies reporting decreased size with increased neuronal density in the medial, central,
and cortical amygdalar nuclei (Bauman and Kemper, 2005) while others have reported signific-
ant reductions in neuron numbers in all amygdalar nuclei in adults with ASD (Morgan et al.,
2014). Neuronal changes in specific amygdalo-sensory input pathways may account for these
discrepancies (Rausch et al., 2016).
As alterations in AIS length have previously been linked to altered cellular excitability as
well as ASD/ ID (Kaphzan et al., 2011; Kloth et al., 2017), particularly in the Fmr1-/y mouse
model of Fragile-X syndrome (Booker et al., 2019), in this chapter I analysed AIS lengths
in multiple brain regions including the mPFC, S1BF, V1, CA1, CA3, BA and LA, across 5
monogenic mutations that are either known to cause syndromic or non-syndromic ASD/ ID
or have been ranked ‘high-confidence, causative’ genes by the SFARI autism gene database
(https://gene.sfari.org/database/human-gene/). These models include Fmr1-/y, Nlgn3-/y, Nrx1+/-,
Cntnap2+/- and Pten+/-. The aim of this chapter is two-fold: First, to inspect if altered AIS
lengths is a common feature of the above stated models that show altered cellular excitabil-
ity and second to see if reported AIS alterations in the Fmr1 KO mouse translate to our rat
model. Presented below is a brief introduction to each model followed by the results from the
undertaken AIS analysis.
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5.2 Fragile-X Mental Retardation 1
The most commonly inherited form of intellectual disability affecting 1:4,000-6,000 men
and 1:6,000-11,00 women is Fragile-X Syndrome (De Vries et al., 1997; Coffee et al., 2009).
First described as a novel form of ID showing X-linked segregation, FXS results from an
expansion of a CGG trinucleotide repeat at the 5’ UTR of the fragile-X mental retardation
1 gene (FMR1) at Xq27.3 (Martin and Bell, 1943). The presence of >200 repeats causes
hypermethylation of the gene promoter (Naumann et al., 2009; Oberlé et al., 1991) resulting
in transcriptional silencing and loss of expression of the fragile-x mental retardation protein
(FMRP) (Wilmar Saldarriaga, Flora Tassone, Laura Yuriko González-Teshima, Jose Vicente
Forero-Forero, Sebastián Ayala-Zapata, 2014). FMRP is an RNA binding protein, regulating
RNA stability, subcellular transport and acts as a translation repressor of neural mRNAs that
code for proteins involved in synapse development and activity (Weiler et al., 1997; Antar et al.,
2004; Bassell and Warren, 2008; Chen et al., 2003; Darnell et al., 2011). FXS is associated with
a wide range of cognitive, behavioural and physical symptoms including ASD (50-66% of males
and 20% of females, (Lewis et al., 2006; Wang et al., 2010; Abbeduto et al., 2014)), anxiety
(86.2% of males and 76.9% of females, (Cordeiro et al., 2011)), seizures (45% in adolescents
and 24% in adults >20 years (Cowley et al., 2016; Sabaratnam et al., 2001)), abnormal sensory
processing resulting in hypersensitivities (Fagiolini and Leblanc, 2011) and attention disorders
(Royall et al., 2002).
EEG and fMRI studies in individuals with FXS indicate brain-region specific imbalances
in neuronal excitation. Castrén et al. (2003) found increased event-related potentials, implying
enhanced excitability, in the auditory cortex of children with FXS while other studies have
found decreased activation in the prefrontal cortex (Holsen et al., 2008) and fusiform gyrus
(Dalton et al., 2008) of adolescents with FXS. Still other studies have uncovered enlargement
and sensitisation of the hippocampus (Kates et al., 1997) and the amygdala in adolescent males
with FXS (Watson et al., 2008; Gothelf et al., 2008). Adults with FXS show enhanced theta
oscillations at the scalp, an indicator of abnormal information transfer between brain regions as
well as an imbalance in excitatory and inhibitory neuronal circuit activity (Van der Molen and
Van der Molen, 2013; Van Der Molen et al., 2014).
132
Generation of the Fmr1-/y (KO) mouse has been key to the investigation of FXS patho-
physiology, as it phenocopies the human disorder (Bakker et al., 1994) and has helped gain
multiple insights into the aberrant cellular processes underlying this syndrome. A defining
feature of FXS is ID accompanied with reduced cognitive ability (for review see Ciaccio et al.
(2017)). The predominant cellular mechanism underlying cognition and memory is synaptic
plasticity, the ability of a synapse to modulate its strength in an activity-dependent manner
(Hebb, 1949). In FXS, deficits in cognition and accompanying deficits in synaptic plasticity
have most extensively been studied in the hippocampus. Fmr1-/y mice show impairments in
hippocampal associated spatial and short-term memory tasks including novel object recognition
(Bhattacharya and Klann, 2012; King and Jope, 2013), reversal morris water maze (Gandhi
et al., 2014) and Y-maze (Bhattacharya and Klann, 2012; Lim et al., 2014). In the CA1 of
the hippocampus, long-term depression, a long-lasting decrease in synaptic strength, can be
mediated by activation of group 1 metabotropic glutamate receptors (mGluR) either chemically
or electrically and via NMDA receptor activation (Daoudal and Debanne, 2003). In the mouse
model of FXS mGluR-LTD, but not NMDAR-LTD, in hippocampal CA1 region results in en-
hanced synaptic depression compared to wildtype controls (Godfraind et al., 1996; Paradee et
al., 1999; Huber et al., 2002; Hou et al., 2006). However, no change in intrinsic membrane
properties have been observed in these cells.
FMRP is expressed early in both human and murine development (Agulhon et al., 1999;
Todd et al., 2003) with its loss resulting in altered critical-period plasticity in several sensory
cortices. This is highlighted in the somatosensory (S1), auditory and visual (V1) cortices
(Harlow et al., 2010; Dölen et al., 2007; Kim et al., 2013). In the S1, the critical period of
NMDAR-dependent LTP at the thalamocortical afferents onto layer 4 (L4) spiny stellate cells
occurs early in the first post-natal week (Crair and Malenka, 1995). In Fmr1-/y mice, this
critical period is delayed until the second postnatal week (Harlow et al., 2010) concomitant with
increased input resistance and neuronal hyper-excitability of these cells (Gibson et al., 2008).
Following the closure of the L4-LTP critical period and typically during the second postnatal
week, ascending connections from L4 to L2/3 pyramidal neurons develop (Weiler et al., 2008).
Fmr1-/y mice show reduced connection probability at this stage of development (Bureau et
al., 2008). However, both these changes in the S1 of Fmr1 KO mice appear to be transient,
normalising to WT levels by postnatal week 4, suggesting a delayed maturation of this cortical
circuit (Bureau et al., 2008). However, increased sensitivity and neuronal excitability in the S1
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in response to sensory stimuli was observed beyond the 4 week age point (Zhang et al., 2014).
The primary visual cortex also shows altered plasticity upon loss of FMRP. Juvenile Fmr1-/y
mice exhibit loss of LTP in L5 pyramidal cells of V1 (Wilson and Cox, 2007). This loss of
LTP may contribute to the ‘hyperplastic’ state of the V1 observed in Fmr1-/y mice. Typically, 3
days of monocular deprivation at postnatal day (P) 28 in wildtype mice results in depression of
deprived eye responses and potentiation of non-deprived eye responses in the binocular region
of V1 (Frenkel and Bear, 2004). In the case of Fmr1 KO mice, an immediate potentiation of
non-deprived eye responses is observed (Dölen et al., 2007) resulting in a ‘hyperplastic’ state.
Imaging studies in adult Fmr1-/y mice revealed anatomical hyperconnectivity within the V1 with
disproportionately low connectivity between the V1 and other neocortical circuits, suggesting
that this hyperplastic state observed in the V1 at P28 persists into adulthood (Haberl et al.,
2015).
In addition to sensory cortices, integrative cortices also show alterations in synaptic plasti-
city and cellular excitability in FXS. Of particular interest in FXS in the PFC, as individuals
with FXS present with deficits in PFC-associated behaviours including attention, inhibitory con-
trol and cognitive flexibility (Royall et al., 2002). Similar to the patients, Fmr1 KO mice exhibit
impaired performance in PFC-mediated tasks including acquisition of visuo-spatial discrimina-
tion task (Krueger et al., 2011) and extinction of an instrumental learning task (Sidorov et al.,
2014). Accompanying these behavioural deficits is abnormal synaptic plasticity, particularly
deficits in LTP, in several subregions of the PFC including the anterior cingulate cortex (ACC),
medial PFC (mPFC) and piriform cortex (Zhao et al., 2005; Meredith et al., 2007; Wang et al.,
2008).
Other behavioural anomalies noted in Fmr1-/y mice include deficits in amygdalar dependent
tasks including certain social behaviours, anxiety and fear conditioning (McNaughton et al.,
2008; Paradee et al., 1999; Spencer et al., 2008). Impaired fear learning in Fmr1 KO mice
(Paradee et al., 1999) is accompanied by deficits in group1 mGluR mediated LTP at thalamic
inputs to the LA (Suvrathan et al., 2010; Zhao et al., 2005), a nucleus of the amygdalar complex
which forms the first node of appropriate fear memory acquisition (Romanski and LeDoux,
1992; Tsvetkov et al., 2002). Following acquisition, the basal amygdalar nucleus serves in
the storage and expression of fear memory (Gale et al., 2004; Anglada-Figueroa and Quirk,
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2005). Inhibitory signalling at the BA is impaired in Fmr1-/y mice, which could also contribute
to the deficits observed in amygdala-mediated behaviours (Olmos-Serrano et al., 2010, 2011;
Kratovac and Corbin, 2013; Martin et al., 2014; Vislay et al., 2013).
Booker et al. (2019) have found that despite the lack of altered membrane properties in
pyramidal cells of the CA1 in Fmr1-/y mice, these cells show increased firing. This increased
firing is accompanied by an increase in length of the axon initial segment. Given that the AIS
has previously been shown to regulate cellular excitability, that cellular deficits found in the
Fmr1-/y mouse are conserved in another Fmr1-/y rat model of FXS (Till et al., 2015; Asiminas
et al., 2019) and a decrease in AIS length is observed in prelimbic PFC cells that project to the
BLA in adult Fmr1-/y rats (Jackson, 2016), here I investigate if any AIS alterations are found in
various brain regions in juvenile rats in a novel rat model of FXS.
5.2.1 Results
As mentioned above, synaptic and cellular deficits have been observed in the medial PFC,
the primary somatosensory cortex S1 and the primary visual cortex V1 in the Fmr1-/y mice.
Here, I assess alterations in AIS length upon loss of FMRP in these brain regions using a novel
rat model of FXS (fig. 2.1, Asiminas et al. (2019)).
In the prelimbic mPFC, average AIS lengths and the cumulative distribution of AIS lengths
were comparable between genotypes in L2/3 (fig.5.1B, B’ Fmr1+/y= 25.92 µm ± 0.51 µm n=6,
Fmr1-/y= 27.08 µm ± 0.75 µm n=6 animals). However, in layer 5, the average length was
significantly increased (fig.5.1D Fmr1+/y= 25.80 µm ± 0.60 µm n=6, Fmr1-/y= 28.84 µm ±
1.10 µm n=6 animals, p=0.001) with the cumulative AIS length distribution showing a shift
towards longer AIS lengths in Fmr1-/y rats compared to wildtypes (fig.5.1D’).
Similar to the mPFC, no change in average AIS length or cumulative distribution of AIS
lengths was seen between genotypes in S1 L2/3 (fig.5.1F, F’ Fmr1+/y= 29.29 µm ± 0.47 µm
n=6, Fmr1-/y= 29.50 µm ± 0.35 µm n=6 animals) whereas a significantly increased average
length (fig.5.1J Fmr1+/y= 28.80 µm ± 0.39 µm n=6, Fmr1-/y= 31.39 µm ± 0.59 µm n=6
animals, p= 0.010) with a shift towards longer AIS lengths in cumulative distribution (Fig.5.1J’)
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was observed in S1 L5 cell of Fmr1-/y rats compared to controls. Given that cellular excitability
changes have also been noted in L4 of the S1 in Fmr1 KO mice, I also examined AIS lengths
in this layer but found no changes in either average or cumulative distribution of AIS lengths in
our KO rats compared to controls (fig.5.1H,H’ Fmr1+/y= 22.92 µm ± 0.48 µm n=6, Fmr1-/y=
21.62 µm ± 0.81 µm n=6 animals).
Unlike results from the other two cortical regions, no changes were observed in average
length or cumulative AIS length distribution in cells of either L2/3 or L5 of the visual cortex
(V1 L2/3 fig.5.1L, L’ Fmr1+/y= 27.44 µm ± 0.80µm n=6, Fmr1-/y= 27.77 µm ± 0.64 µm n=6
animals; V1 L5 fig.5.1N, N’ Fmr1+/y= 31.63 µm ± 0.51 µm n=6, Fmr1-/y= 31.98 µm ± 0.55
µm n=6 animals).
The elongated AIS and its mediated alterations in cellular excitability phenotype of the
Fmr1-/y mouse was observed in the CA1 sub-region of the dorsal hippocampus. Here, I in-
spected both the CA1 as well as the CA3 sub-region of the hippocampus as the CA3 projects
extensively to the CA1 (Hannula and Duff, 2017). Contrary to results obtained in the mouse, I
saw no alterations in average AIS length and cumulative AIS length distributions in the Fmr1-/y
rat compared to controls (fig.5.2B, B’ Fmr1+/y= 30.76 µm ± 0.55 µm n=6, Fmr1-/y= 30.90 ±
0.69 µm n=5 animals). While surprising, the data fits well with the electrophysiological char-
acterisation of the CA1 in this rat model as no changes in cellular firing or intrinsic membrane
properties have been observed in the CA1 pyramidal cells at this age (P28-32) (Jackson, 2016).
Similar to the CA1, no changes were seen between genotypes in the average or cumulative
distribution of AIS lengths in the CA3 (fig.5.2D, D’ Fmr1+/y= 37.45 µm ± 0.54 µm n=6,
Fmr1-/y= 37.13 µm ± 0.76 µm n=5 animals).
Previous characterisation of cellular excitability in the LA and BA of juvenile Fmr1-/y
rats revealed no changes in either firing properties or membrane properties in pyramidal cells
of the LA (Jackson, 2016). However, pyramidal cells of the BA were hyperexcitable showing
increased firing with increased input resistance (Jackson, 2016). In agreement with these results,
I found no change in the average or cumulative distribution of AIS lengths in the LA of juvenile
Fmr1-/y rats compared to wildtype controls (fig.5.2F, F’ Fmr1+/y= 22.09 µm ± 1.11 µm n=6,
Fmr1-/y= 22.12 µm ± 0.70 µm n=5 animals). I did, however, observe a significant increase in
average AIS length with a shift in cumulative distribution towards longer AIS lengths in neurons
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Figure 5.1: AIS lengths in cortical regions of Fmr1-/y rats (A-A’, C-C’, E-E’, G-G’, I-I’,K-K’,M-M’) Repres-
entative single AIS from Fmr1+/y and Fmr1-/y rats respectively from the PL (L2/3 A-A’, L5 C-C’), S1 (L2/3 E-E’,
L4 G-G’, L5 I-I’) and V1 (L2/3 K-K’, L5 M-M’). No change in avg AIS length or cumulative distribution of AIS
lengths was observed in PL L2/3 (B-B’), S1 L2/3 (F, F’), S1 L4(H-H’), V1 L2/3 (L-L’) and V1 L5 (N-N’) of Fmr1-/y
rats compared to controls. AIS lengths were found increased in Fmr1-/y rats in PL L5 (D-D’, p= 0.001) and S1 L5
(J-J’, p= 0.010) compared to controls.
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of the basal amygdala (BA) (fig.5.2H, H’ Fmr1+/y= 34.20 µm ± 1.08 µm n=6, Fmr1-/y= 36.16
µm ± 0.40 µm n=5 animals, p=0.046).
Overall, the data indicates that loss of FMRP results in elongation of AIS lengths in the
‘output’ layers of the brain regions analysed including L5 of the PL and S1BF and the BA
(Hoover and Vertes, 2007; Krettek and Price, 1977; Denardo et al., 2015). This increased
AIS length maybe responsible for the increased cellular excitability observed in atleast 2 of
these brain-regions (Jackson, 2016) and may be one of the underlying mechanisms of circuit
hyperexcitability that has been noted in pre-clinical models of this disorder (Contractor et al.,
2015). Further, the data suggest species specific differences in AIS length adaptation upon
loss of FMRP as the AIS phenotype observed in the CA1 of the mouse model of FXS did not
translate to our rat-model.
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Figure 5.2: AIS lengths in sub-cortical regions of Fmr1-/y rats (A-A’, C-C’, E-E’, G-G’) Representative single
AIS from Fmr1+/y and Fmr1-/y rats respectively from the hippocampus (CA1 A-A’, CA3 C-C’) and the BLA (LA
E-E’, BA G-G’). No change between Fmr1-/y and Fmr1+/y rats in avg AIS length or cumulative distribution of
AIS lengths was observed in the CA1 (B-B’), CA3 (D, D’) or the LA (F-F’). AIS lengths were found increased in
Fmr1-/y rats in the BA (H-H’, p= 0.046) compared to controls.
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5.3 Neuroligin 3
Neuroligins are family of post-synaptic cell adhesion molecules (CAMs), that bind to the
pre-synaptic neurexins (Ichtchenko et al., 1996; Song et al., 1999) to form a complex that
triggers synapse formation, axon specialisation (Scheiffele et al., 2000) and influences post-
synaptic differentiation (Rao et al., 2000). In the human genome, 5 genes (NLGN1-4, 4Y)
encode this family of CAMs (Jamain et al., 2003) of which mutations in NLGN3, located at
chromosomal locus Xq13, and those in NLGN4, located at Xp22.3, have been associated with
Asperger’s syndrome, ID and ASD (Jamain et al., 2003; Laumonnier et al., 2004; Levy et al.,
2011; Sanders et al., 2011; Yuen et al., 2017). Neuroligin proteins are composed of a large
extracellular neurexin-binding non-catalytic acetylcholinesterase homology domain (EF-hand
domain) (Tsigelny et al., 2000), a transmembrane domain and a short cytoplasmic tail that
contains a PDZ binding domain. This PDZ binding domain enables association of neuroli-
gins with PSD-95, a key post-synaptic scaffolding molecule (Irie et al., 1997). Neuroligins
are composed of multiple isoforms that show distinct localisation and alterations of synaptic
function. Neuroligin 1 is found exclusively at excitatory glutamatergic synapses (Song et al.,
1999), neuroligin 2 is found exclusively at GABAergic inhibitory synapses (Varoqueaux et al.,
2004; Graf et al., 2004) while neuroligin 3 is found at both (Budreck and Scheiffele, 2007) and
neuroligin 4 is found at glutamatergic and glycinergic synapses (Graf et al., 2004; Hoon et al.,
2011). In line with this differential isoform localisation, in vitro over-expression of neuroligin 1
results in enhanced excitatory postsynaptic transmissions, that of neuroligin 2 enhances inhibit-
ory postsynaptic transmissions (Levinsoni et al., 2005) while over-expression of neuroligin 3
also results in increased inhibitory transmission (Etherton et al., 2011).
NLGN3, is a category 1 ‘high confidence’ gene thought to be causative for non-syndromic
ID (SFARI database). A R451C mutation in NLGN3 was first identified in a pair of Swedish
brothers presenting with Asperger’s syndrome and typical autism (Jamain et al., 2003). This
mutation, found to be maternally inherited, impairs proper protein folding in the EF-hand do-
main required for binding to pre-synaptic neurexins (Nguyen and Südhof, 1997) and reduces
surface neuroligin 3 expression due to increased retention in the endoplasmic reticulum (Co-
moletti et al., 2004; De Jaco et al., 2010; Ulbrich et al., 2016). In addition to this point mutation,
large-scale sequencing and GWAS studies have found de novo copy number variations res-
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ulting in a premature stop codon and complete loss of neuroligin 3 protein to be linked with
autism (Levy et al., 2011; Sanders et al., 2011; Yuen et al., 2017). Clinical presentation of
NLGN3 associated NSID is highly variable, ranging from severe non-verbal autistic disorder
to specific language impairment, Aspergers syndrome and Tourette’s syndrome (Persico and
Napolioni, 2013). Controversially, multiple studies have found no association between muta-
tions in NLGN3/4 and autism (Ylisaukko-oja et al., 2005; Gauthier et al., 2005; Wermter et al.,
2008; Liu et al., 2013; Vincent et al., 2004; Xu et al., 2014). However, these studies were per-
formed in high-functioning autistic individuals whereas mutations in NLGN3/4 have typically
been associated with low-functioning cases. A further resolution to this controversy is offered
from findings in animal studies which show that manifestation of ASD-like symptoms upon
introduction of the human NL3 R451C mutation is dependent on the background strain of the
animal (Jaramillo et al., 2014, 2018), suggesting that these mutations might be more debilitating
in some populations than other.
The functional consequence of pathological mutations in NLGN3 have been explored in two
mouse models. The first is a gain of function (knock-in) NL3 R451C mutation, resulting in a
90% loss of neuroligin 3 from the whole mouse brain (Tabuchi et al., 2007), that was identified
by Jamain et al. (2003) and the second is a full protein knock out that mimics NLGN3 CNV
mutations linked with autism (Sanders et al., 2011).
Behavioural analysis of independently generated NL3 R451C mice have shown discrepan-
cies in results obtained from social and spatial learning tasks. Tabuchi et al. (2007), using a
3-chamber sociability task, found impaired social interaction with enhanced spatial learning in
a reversal morris water maze in NL3 R451C mice compared to wildtypes. On the other hand,
Chadman et al. (2008) found no difference between the NL3 R451C and wildtype mice in either
a juvenile reciprocal social interaction task, an adult social approach task or enhanced learning
in a reversal Morris water maze. These differences in behaviour were later uncovered to be due
to the differing background strains on which the mutations were generated. The background
mouse strain in the paper by Tabuchi et al. (2007) was a hybrid C57BL6/J/129S2/SvPasCrl
while the strain used in the Chadman et al. (2008) study was a pure C57BL6/J. Findings from
Tabuchi et al. (2007) were replicated when the NL3 R451C mutation was generated on in mice
with 129S2/SvPasCrl background strain (Jaramillo et al., 2014) but not when the mutation was
generated on the C57BL6/J (Jaramillo et al., 2018), supporting the results obtained in Chadman
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et al. (2008) study. Additional minor differences have also been noted between the NL3 R451C
and Nlgn3 knock-out (KO) mice, particularly with respect to locomotion and olfaction. Nlgn3
KO mice show increased locomotion in open field, elevated plus maze and locomotion box
test with reduced olfaction (Radyushkin et al., 2009) and olfactory discrimination (Bariselli et
al., 2018) while no such alterations are noted in the NL3 R451C mice (Chadman et al., 2008;
Jaramillo et al., 2018). NLgn3 KO mice also showed decreased overall brain volume, which
was not found in the NL R451C mice (Radyushkin et al., 2009).
Consistent findings across NL3 R451C and Nlgn3 KO mice include reduced sensitivity to
acoustic stimuli, as measured by reduced acoustic startle response to high-decibel tones without
any irregularities in sensorimotor gating (Chadman et al., 2008; Radyushkin et al., 2009), re-
duced ultra-sonic vocalisations upon female approach (Chadman et al., 2008; Radyushkin et
al., 2009; Fischer and Hammerschmidt, 2011; Kalbassi et al., 2017), a feature that is remin-
iscent of human pathology of reduced linguistic abilities (Persico and Napolioni, 2013), and
improved motor co-ordination when measured using an accelerating rotarod (Chadman et al.,
2008; Rothwell et al., 2014) compared to wildtype controls. Rothwell et al. (2014), argued that
this enhanced performance on the rotarod is a proxy for heightened acquisition of repetitive
behaviours, a feature that forms part of the core diagnostic criteria for ASDs (ICD-10). The
same study found that selective knock-down of neuroligin 3 from dopamine receptor-1 (D1)
expressing medium spiny neurons in the nucleus accumbens of wild-type mice increases inhibi-
tion onto these cells and is sufficient to recapitulate the enhanced rotarod performance exhibited
by the NL3 R451C and Nlgn3 KO mice (Rothwell et al., 2014). Another common manifestation
of ASD-like repetitive behaviours in mice is exaggerated grooming. Selective knock-down of
neuroligin-3 using siRNA in the dorsal striatum of wildtype mice results in increased grooming
behaviour (Lee et al., 2018). Another core ASD-diagnosis criterion is impaired social com-
munication and sociability preference. While neither NL3 R451C mice nor Nlgn3 KO mice
show impairments in sociability, both show a markedly reduced preference for social novelty
(Radyushkin et al., 2009; Bariselli et al., 2018; Cao et al., 2018). Further, selective knockdown
of neuroligin 3 from dopaminergic neurons of the ventral tegmental area in wildtype mice,
causing inhibition of neuronal activity, mimics the phenotype of Nlgn3 KO mice resulting in
a loss social novelty preference in wildtype animals (Bariselli et al., 2018). This data sup-
ports the altered E/I balance hypothesis of ASD (Rubenstein and Merzenich, 2003; Nelson and
Valakh, 2015) and suggests a shift towards increased inhibition upon loss of neuroligin 3. This
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increased inhibition hypothesis is supported by additional studies. Notably, L2/3 pyramidal
neurons of the somatosensory barrel cortex of P13-16 NL3 R451C mice showed 50% increased
frequency of miniature inhibitory synaptic events (Tabuchi et al., 2007). In the same cells an
independent study found accelerated spine tunrover of PSD-95 affiliated excitatory synapses but
not gephyrin-associated inhibitory synapses suggesting that abnormal functioning of neuroligin
3 at excitatory synapses may drive reduced excitation (Isshiki et al., 2014). Recordings from
the CA3 sub-region of the hippocampus of P4-9 NL3 R451C mice showed increased frequency
of GABAA, and not glutamate, mediated giant depolarising potentials along with increased
frequency of miniature GABAA-mediated postsynaptic currents (mGPSC) starting at P4 until
adulthood (Pizzarelli and Cherubini, 2013). Given that in the first post-natal week the effects of
GABAA are depolarising and excitatory and the increased mGPSCs show reduced attenuation
upon application of the GABAA antagonist TPMPA, this may indicate that the R451C mutation
alters presynaptic GABAA release. This could perhaps account for the increased inhibition
observed at later time-points in NL3 R451C mice. Lastly, EEG inspection of sleep/wake cycle
in NL3 R451C mice show increased power of delta oscillations during non rapid-eye movement
(NREM) sleep (Liu et al., 2017). Delta oscillations are generated by the thalamocortical net-
work (McCormick and Bal, 1997) and regulated by GABA inhibitory transmission (Kopp et al.,
2004), with administration of GABA agonist diazepam resulting in decreased delta oscillations,
therefore the gain-of-function R451C mutation might result in decreased delta power due to
increased GABA-ergic transmission. In the primary visual cortex of NL3 R451C mice, an in-
crease in GAD-65 positive GABA-ergic interneuron number is observed, suggesting increased
inhibition in this brain region as well (Verma et al., 2019).
This increased inhibition, however, was found to be circuit specific. While the S1 L2/3
cells showed increased inhibition, CA1 cells of P13-16 NL3 R451C mice showed altered ex-
citation with about ~1.5 fold increase in frequency of AMPAR-mediated excitatory synaptic
transmission, a ~2 fold increase in NMDAR-mediate LTP and greater dendritic branching (Eth-
erton et al., 2011). However, EEG studies showed a reduction in hippocampal mediated theta
oscillations, which are suppressed due to increased GABA-ergic transmission (Liu et al., 2017).
These differences may arise from both differences in age of experimental animals as well as
different wake/sleep states of these animals. Gamma and theta oscillations in the mPFC are key
in modulating social behaviours. In the mPFC of NL3 R451C mice, a reduction in gamma oscil-
lations is observed along with reduced excitability of fast-spiking parvalbumin-immunoreactive
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interneurons, suggesting increased excitation in this brain region as opposed to increased in-
hibition (Cao et al., 2018). Lastly, synaptic plasticity deficits are also observed in upon loss
of neuroligin 3, particularly impaired LTD in the dorsal striatum (Martella et al., 2018) and
impaired mGluR1 mediated LTD, which was reversed upon re-expression of neuroligin 3, in
the cerebellum (Baudouin et al., 2012).
Given the synaptic and excitability deficits observed in the Nlgn3 mutant mice, particularly
in the sensory cortices and convergent pathway of mGluR mediated LTD deficits similar to the
Fmr1-/y mice, I analysed AIS lengths in multiple brain regions in a loss of function knock-out
rat model of Nlgn3 (Nlgn3-/y).
5.3.1 Results
In juvenile (P28-32) rats modelling NLGN3-NSID, and similar to the analyses performed in
the rat models of SYNGAP1-ID (chapter 3) and FXS (above), I examined changes in AIS lengths
in three cortical regions including the mPFC PL, the S1 barrel cortex and the visual cortex. No
changes in average AIS length or cumulative distribution of AIS lengths was observed in either
L2/3 (fig.5.3B, B’ Nlgn3+/y= 29.28 µm ± 0.92 µm n=6, Nlgn3-/y= 29.10 µm ± 1.03 µm n=6
animals) or L5 (fig.5.3D, D’ Nlgn3+/y= 29.88 µm ± 1.35 µm n=6, Nlgn3-/y= 29.22 µm ± 1.25
µm n=6 animals) of the mPFC PL of the Nlgn3-/y rats compared to wild-type, aged-matched,
littermate controls. This finding is consistent with unpublished results from electrophysiological
recordings in our laboratory which show no changes in intrinsic cellular excitability or firing
properties in PL L5 pyramidal cells from P26-32 Nlgn3-/y rats compared to wildtype controls.
Reduced sensitivity to sensory stimuli and the increased inhibitory transmission observed
in L2/3 cells of the S1 of Nlgn3 KO mice could be a result of altered intrinsic excitability of
these cells. However, no changes in intrinsic membrane properties or firing properties of these
neurons were observed in NL3 R451C mice or Nlgn3 KO mice (Tabuchi et al., 2007; Etherton
et al., 2011). Consistent with these findings, no change in average or cumulative distribution
of AIS lengths was observed in L2/3, L4 or L5 neurons of Nlgn3-/y rats compared to controls
(L2/3 fig.5.3F, F’ Nlgn3+/y= 28.38 µm ± 0.15 µm n=6, Nlgn3-/y= 27.32 ± 0.58 n=6 animals;
L4 fig.5.3H, H’ Nlgn3+/y= 25.01 µm ± µm 0.81 n=6, Nlgn3-/y= 23.29 µm ± 0.66 µm n=6
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animals; L5 fig.5.3J, J’ Nlgn3+/y= 29.43 µm ± 0.36 µm n=6, Nlgn3-/y= 29.56 µm ± 0.26 µm
n=6 animals).
Similar to the other two cortical regions studied, no changes were observed in average
or cumulative distribution of AIS lengths in L2/3 or L5 of the visual cortex of Nlgn3-/y rats
compared to wildtype littermate controls (L2/3 fig.5.3L, L’ Nlgn3+/y= 25.28 µm ± 0.04 µm
n=2, Nlgn3-/y= 26.64 µm± 1.07 µm n=2 animals; L5 fig.5.3N, N’ Nlgn3+/y= 29.01 µm± 1.19
µm n=2, Nlgn3-/y= 29.62 µm ± 1.17 µm n=2 animals). However, due to the low n in these
experiments, conclusions are preliminary.
In the NL3 R451C mice, altered synaptic plasticity is observed in pyramidal cells of CA1
and CA3 regions of the hippocampus (Etherton et al., 2011; Pizzarelli and Cherubini, 2013).
While altered plasticity does not always imply altered intrinsic excitability of the neuron, this
maybe a contributing factor. Further, given the evidence of convergent cellular physiology
between mouse models of FXS and NLGN3-NSID (Baudouin et al., 2012), the increased AIS
length in the CA1 sub-region in the mouse model of FXS, and impairments in hippocampal-
dependent spatial memory in mouse models of NLGN3 -NSID, here I analysed AIS length in the
CA1 and CA3 sub-regions of the dorsal hippocampus. In our rat model of Nlgn3-/y, no genotype
specific changes in average AIS length or cumulative distribution of AIS lengths is observed in
either the CA1 or the CA3 of the Nlgn3-/y compared to controls (CA1 fig.5.4B, B’ Nlgn3+/y=
35.76 µm ± 1.40 µm n=6, Nlgn3-/y= 32.99 µm ± 1.31 µm n=6 animals; CA3 fig.5.4D, D’
Nlgn3+/y= 42.38 µm ± 2.54 µm n=6, Nlgn3-/y= 40.00 µm ± 1.98 µm n=6 animals). The lack
of change in AIS length in the CA1 is consistent with the lack of changes in cellular excitability
found in electrophysiological recordings of age-matched Nlgn3-/y rats compared to wild-type
littermate controls (N Anstey, unpublished).
Laslty, Nlgn3 KO mice show reduced levels of anxiety in amygdala-dependent contextual
and cued fear conditioning paradigms (Radyushkin et al., 2009). Additionally, in our Nlgn3-/y
rat model, these animals also show preferential activation of a ‘flight’ over ‘freeze’ response
strategy in a cued fear conditioning paradigm (N Anstey et al., unpublished), suggesting further
amygdalar circuit dysfunction. Altered amygdalar function is further corroborated by findings
of impaired LTP of thalamocotical inputs into the basolateral amygdala of juvenile Nlgn3-/y rats,
similar to Syngap1+/- and Fmr1-/y rats (Toft, 2019). Given that AIS morphology-dependent
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Figure 5.3: AIS lengths in cortical regions of Nlgn3-/y rats(A-A’, C-C’, E-E’, G-G’, I-I’,K-K’,M-M’) Represent-
ative single AIS from Nlgn3+/y and Nlgn3-/y rats respectively from the PL (L2/3 A-A’, L5 C-C’), S1 (L2/3 E-E’,
L4 G-G’, L5 I-I’) and V1 (L2/3 K-K’, L5 M-M’). No change in avg AIS length or cumulative distribution of AIS
lengths was observed in PL L2/3 (B-B’), PL L5 (D-D’), S1 L2/3 (F, F’), S1 L4(H-H’), S1 L5 (J-J’), V1 L2/3 (L-L’)
and V1 L5 (N-N’) of Nlgn3-/y rats compared to controls.
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alterations in cellular excitability might drive these plasticity changes, I analysed AIS lengths in
the both the BA and LA neurons of juvenile Nlgn3-/y rats. No changes in either average length
or cumulative distribution of lengths was found in P28 Nlgn3-/y rats compared to controls in
either the lateral or the basal amygdala (LA fig.5.4F, F’ Nlgn3+/y= 26.65 µm ± 1.50 µm n=4,
Nlgn3-/y= 26.70 µm ± 1.31 µm n=4 animals; BA fig.5.4H, H’ Nlgn3+/y= 35.50 µm ± 3.56 µm
n=5, Nlgn3-/y= 37.58 µm ± 2.46 µm n=5 animals).
Overall, the data suggests that in our model, loss of Nlgn3 results in no alterations in AIS
length or intrinsic cellular physiology (N Anstey, upublished, Toft (2019)) in any of the brain
regions studied but does result in AIS-independent alterations in synaptic plasticity in the BLA
(Toft, 2019). This the lack of genotype specific modulation of AIS-length in Nlgn3-/y rats is
consistent with the findings in the Syngap1+/- (see chapter 3) but differs from those obtained in
the Fmr1-/y rats.
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Figure 5.4: AIS lengths in sub-cortical regions of Nlgn3-/y rats (A-A’, C-C’, E-E’, G-G’) Representative single
AIS from Nlgn3+/y and Nlgn3-/y rats respectively from the hippocampus (CA1 A-A’, CA3 C-C’) and the BLA (LA
E-E’, BA G-G’). No change between Nlgn3-/y and Nlgn3+/y rats in avg AIS length or cumulative distribution of AIS
lengths was observed in the CA1 (B-B’), CA3 (D, D’), LA (F-F’) or BA (H-H’).
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5.4 Neurexin 1α
Neurexins are the presynaptic binding partners of post-synaptic ligands including neurlo-
ligins (Ichtchenko et al., 1995; Graf et al., 2004), neurexophilin (Missler and Südhof, 1998)
and leucine-rich repeat transmembrane neuronal proteins (LRRTMs) (Siddiqui et al., 2010).
Encoded by the 1.1Mb long NEUREXIN 1-3 (or NRX1-3) gene located on chromosome 2p16.3,
neurexins were first identified in the rat brain as receptors for the black-widow venom α-
latrotoxin (Ushkaryov et al., 1992). Neurexins have since been shown to act predominantly as
cell adhesion molecules, influencing synapse formation and transmission through trans-synaptic
association with post-synaptic ligands (Südhof, 2008; Reissner et al., 2013). Neurexins are also
critically involved in Ca2+ dependent vesicular neurotransmitter release (Missler et al., 2003;
Geppert et al., 1998; Kattenstroth et al., 2004; Reissner et al., 2013).
Arising from independent promoters, two major subclasses of neurexins exist: A highly
evolutionarily conversed α-neurexin and a less conserved β -neurexin (Missler and Südhof,
1998). Both sub-classes share transmembrane C-terminal domains and cytoplasmic tails but
differ critically in the composition of their extracellular N-terminal domain. α-Neurexin con-
tains six LNS (Laminin A G domain/ Neurexin / Sex hormone globulin) repeats interspersed
with epidermal-growth factor-like domains while the shorter β -neurexin only contains one LNS
repeat (Missler and Südhof, 1998). In addition to the two major isoforms the presence of six
alternative splice sites on Nrx1-2 and five on Nrx3 yield an extraordinary 4000 protein variants
(Ullrich et al., 1995; Tabuchi and Südhof, 2002), impacting inter-molecular pairing affinities
(Ichtchenko et al., 1995; Craig and Kang, 2007; Chih et al., 2006; Boucard et al., 2005; Graf et
al., 2006).
Interest in NRX1 as a gene important in neuropsychiatric disorders emerged in 2006 when a
study by Friedman et al. (2006), using oligonucleotide microarray analysis, identified a deletion
in 2p16.3 in a 7 year old boy with borderline-ID IQ of 74 and attention deficit disorder. Large-
scale genome analysis studies and individual case reports alike have since identified mutations
in NRX1 and NRX2 linked to ASD (Szatmari et al., 2007; Zahir et al., 2008; Marshall et al.,
2008; Kim et al., 2008; Bucan et al., 2009; Ching et al., 2010; Pinto et al., 2010; Glessner et al.,
2009; Gregor et al., 2011; Wiśniowiecka-Kowalnik et al., 2010; Harrison et al., 2011; Curran
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et al., 2013; Schaaf et al., 2012; Imitola et al., 2014; Duong et al., 2012; Onay et al., 2016)
and schizophrenia (Kirov et al., 2008; Vrijenhoek et al., 2008; Rujescu et al., 2009; Need et al.,
2009; Gauthier et al., 2011; Levinson et al., 2011; Rees et al., 2014; Todarello et al., 2014; Li
et al., 2016).
Most individuals with NRX1 associated NDDs contained heterozygous exonic structural
variation in α-Neurexin with only 11 patients, till date, presenting a bi-allelic loss of NRX1
(Castronovo et al., 2019). Phenotypic presentations of individuals with NRX1-deletions is highly
variable and includes moderate to severe intellectual disability (77-92%, (Dabell et al., 2013;
Gregor et al., 2011; Béna et al., 2013)), ASD (43-70%; (Dabell et al., 2013; Gregor et al., 2011;
Béna et al., 2013; Gonzalez-Mantilla et al., 2016; Al Shehhi et al., 2019)) developmental and
speech delay (69%, (Ching et al., 2010; Sahoo et al., 2011; Curran et al., 2013; Brignell et
al., 2018)), ADHD (9-41%, (Lowther et al., 2017; Schaaf et al., 2012)), epilepsy (14-53%,
(Dabell et al., 2013; Harrison et al., 2011; Béna et al., 2013; Schaaf et al., 2012; Gonzalez-
Mantilla et al., 2016)) and muscle hypotonia (38-47%, (Schaaf et al., 2012; Béna et al., 2013)).
The putative effects of dysfunctional CAMs, such as NRXN1, on neural circuitry support
pathophysiological ‘two hit’ hypothesis of neurodevelopmental disorders. In particular, the
variability in clinical presentation associated with NRXN1 deletions, ranging from unaffected
carrier status to severe neurodevelopmental phenotypes, suggests that individual mutations
in this gene may confer disease risk rather than play a causal role (Castronovo et al., 2019).
Incomplete penetrance may be further be explained by secondary and independently segregating
genetic risk factors, as supported by enhanced frequencies of additional pathogenic CNVs in
cohorts of patients carrying NRXN1 deletions (Béna et al., 2013; Girirajan et al., 2013) or
exposure to environmental factors (Bölte et al., 2019; Persico and Merelli, 2015).
Pre-clinical models to understand the biological mechanisms of NRX1 deletions have used
both null (Nrx1-/-) (Missler et al., 2003; Dudanova et al., 2006; Etherton et al., 2009; Grayton et
al., 2013; Esclassan et al., 2015; Twining et al., 2017) and heterozygous (Nrx1+/-) (Laarakker et
al., 2012; Grayton et al., 2013; Dachtler et al., 2015) mouse and rat models. (Missler et al., 2003)
first generated the α-neurexin triple knock-out (KO) mice lacking Nrx 1α , 2α and 3α . This
loss of α-neurexins was lethal, with triple KO animals showing marked difficulties in breathing
and zero percent survival beyond post-natal day 1. However, gross brain anatomy in these triple
KOs was found to be normal, with no evidence of defects in axonal path-finding, increased
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apoptosis or altered distribution of synaptic proteins. Functionally; recordings from neocortical
cultures, hippocampal cultures, acute brain stem slices and acute pituitary gland slices found a
>50% deficit in spontaneous and evoked Ca2+-triggered neurotransmitter release in adult double
KOs (Nrx1α -/-;Nrx2α -/-) and newborn triple KOs (Missler et al., 2003; Dudanova et al., 2006).
This reduction in neurotransmitter release was attributed to reduced numbers of functional Ca2+
channels, as absolute numbers of surface-expressed Ca2+ channels remained unaltered in both
the double and triple KO animals (Missler et al., 2003; Dudanova et al., 2006).
Behavioural phenotyping of rat and mouse models of Nrx1α deletions have found stark
differences between species, sexes and between heterozygous and homozygous models of
NRX1 associated ID (Etherton et al., 2009; Laarakker et al., 2012; Grayton et al., 2013; Dachtler
et al., 2015; Esclassan et al., 2015). Behaviourally, Nrx1-/- male mice were found to show no
deficits in the hippocampal-dependent Morris water maze spatial learning task (Etherton et al.,
2009; Grayton et al., 2013), while Nrx1+/- male mice showed impaired hippocampal dependent
long-term (24h interval) object discrimination memory (Laarakker et al., 2012). This deficit in
object discrimination memory, however, was not reproduced in later studies in the same model
(Dachtler et al., 2015). In a rat model of NRX1-ID ,Nrx1-/- rats show impaired performance in a
hippocmapal-dependent spatial discrimination task with impairment being more pronounced in
Nrx1-/- females (Esclassan et al., 2015). Similar to the mouse model of FXS, Nrx1-/- mice also
display sensorimotor gating abnormalities as shown by decreased pre-pulse inhibition (PPI)
with an exaggerated startle response (Etherton et al., 2009) whereas Nrx1+/- mice (Dachtler et
al., 2015) and Nrx1-/- rats display no change in PPI, despite an exaggerated startle response in
the rats (Esclassan et al., 2015). Contradictory results are also seen in measures of repetitive
grooming behaviour with studies finding both increased (Etherton et al., 2009) and no alteration
in grooming in Nrx1-/- (Grayton et al., 2013) and Nrx1+/- (Dachtler et al., 2015) male mice.
Another behavioural discrepancy within Nrx1-/- mice is seen in locomotor activity. Where
Etherton et al. (2009) and Dachtler et al. (2015) found no alterations in locomotor behaviour
in Nrx1-/- and Nrx1+/- mice, studies by Laarakker et al. (2012) and (Esclassan et al., 2015)
found hyperactivity of Nrx1-/- mice and rats, while still other studies found reduced locomotor
activity in Nrx1-/- mice (Grayton et al., 2013). Anxiety-related disorders are a common co-
morbidity in individuals with ASD. Inspection of anxiety-like behaviours in the Nrx1-/- and
Nrx1+/- mice also yielded conflicting results with Etherton et al. (2009) and Dachtler et al.
(2015) finding no change in anxiety-like behaviour in Nrx1-/- and Nrx1+/- mice in tasks such
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as the elevated plus maze (EPM), forced swim test and tail suspension test while Grayton et
al. (2013) found elevated anxiety in Nrx1-/- mice using EPM and light/dark box task. Nrx1-/-
rats showed no alteration in innate anxiety upon examination using EPM (Twining et al., 2017).
The most consistent behavioural finding in the pre-clinical NRX1 models, however, is the lack
of deficits in sociability in Nrx1-/- and Nrx1+/- mice and rats (Etherton et al., 2009; Grayton et
al., 2013; Dachtler et al., 2015; Esclassan et al., 2015), though some studies observe a weaker
discrimination of social novelty in Nrx1+/- mice (Dachtler et al., 2015) and increased preference
for sociability in Nrx1-/- male mice (Grayton et al., 2013).
Further, independent studies have shown impairments in various aspects of cognition. Not-
ably, Dachtler et al. (2015) found that in a passive avoidance task, female Nrxn1α+/- mice
showed an impairment in cognition, traversing back to the box where they received an aversive
stimuli faster than wildtype controls. While Esclassan et al. (2015), found impairments in
associative learning (instrumental conditioning) and attention (impaired latent inhibition) and
Twining et al. (2017) found impairments in social-cued fear conditioning in Nrx1-/- rats.
Underlying behavioural and cognitive abnormalities are alterations in intrinsic cellular excit-
ability and synaptic plasticity (Daoudal and Debanne, 2003). Therefore, in order to understand
the biological mechanisms of impaired behaviour observed in the various models of NRX1 as-
sociated ASD/ID, here I have analysed differences in the length of the axon initial segment, a
neuronal compartment known to regulate cellular excitability via alterations in its length with
these alterations being further shown to underlie excitability alterations in other mouse models
of ASD/ID (Kaphzan et al., 2011; Leterrier, 2018; Booker et al., 2019). As majority of NRX1-
mutations linked with ASD/ID are heterozygous, AIS lengths in various behaviourally relevant
brain regions were examined in a Nrx1α heterozygous rat model (Nrx1-/-).
5.4.1 Results
Previously, Nrx1-/- rats exhibited severe impairments in the acquisition of an mPFC-dependent
(Ostlund and Balleine, 2005) associative learning operant task (Esclassan et al., 2015), showing
little evidence of learning after 10 days of training. Intrinsic cellular excitability of neurons in
the PL region of the mPFC in rodents have been shown to alter following training in associ-
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ative learning tasks (Hayton et al., 2011). Therefore, one underlying mechanism of impaired
acquisition in the Nrx1-/- rats, might be the inability to alter the intrinsic excitability of the
PL neurons. Given that the AIS is known to regulate its length and alter cellular excitability
in an activity-dependent manner (for review see Kuba (2012)), I hypothesized that in our rat
model of NRX1-associated ASD/ID, the AIS length in PL L2/3 and L5 neurons would be altered
compared to control animals. Upon examination, no alterations in average AIS length or cumu-
lative distribution of AIS lengths was observed in either PL L2/3 or L5 neurons of Nrx1+/- rats
compared to wildtype, littermate controls at P28-32 (L2/3 fig.5.5B, B’ Nrx1+/+= 29.07 µm ±
0.71 µm n=8, Nrx1+/-= 28.69 µm ± 0.70 µm n=8 animals; L5 fig.5.5D, D’ Nrx1+/+= 30.02
µm ± 1.22 µm n=8, Nrx1+/-= 29.67 µm ± 1.13 µm n=8 animals).
Similar to preclinical models of FXS (Contractor et al., 2015), NLGN3-ID (Tabuchi et al.,
2007) and SYNGAP1-ID (Guo et al., 2009), Nrx1-/- rats also show disrupted sensory perception
(Esclassan et al., 2015). As altered cellular excitability is shown to underlie disrupted sensory
processing in models of ASD (Robertson and Baron-Cohen, 2017), I analysed AIS length
changes in two sensory cortices, the somatosensory barrel cortex as well as the visual cortex, in
the Nrx1+/- rats. No changes in average AIS length or cumulative distribution of AIS lengths
in found in either L2/3, L4 or L5 of the of the S1 barrel cortex in these animals compared to
wildtype controls (L2/3 fig.5.5F, F’ Nrx1+/+= 29.99 ± 0.37 n=6, Nrx1+/-= 29.98 µm ± 0.62
µm n=6 animals; L4 fig.5.5H,H’ Nrx1+/+= 22.65 µm ± 0.48 µm n=6, Nrx1+/-= 23.07 ± 0.29
n=6 animals; L5 fig.5.5J,J’ Nrx1+/+= 29.20 µm ± 0.38 µm n=6, Nrx1+/-= 28.74 µm ± 0.57
µm n=6 animals). Similar to the barrel cortex, no changes were observed in either average AIS
length or cumulative distribution of AIS lengths in L2/3 and L5 of the primary visual cortex in
Nrx1+/- juvenile rats compared to controls (L2/3 fig.5.5L, L’ Nrx1+/+= 26.72 µm ± 4.06 µm
n=2, Nrx1+/-= 25.52 µm ± 1.04 µm n=3 animals; L5 fig.5.5N, N’ Nrx1+/+= 29.34 µm ± 3.74
µm n=2, Nrx1+/-= 28.91 µm ± 1.72 µm n=3 animals). However, due to the low n in these
experiments, conclusions are preliminary.
Further, Nrx1-/- rats showed impairments in hippocampal-dependent spatial navigation tasks,
including spatial discrimination and reversal and rewarded alternation T-maze, and disruption in
the CA1-dependent (Puga et al., 2007) latent inhibition task, where pre-exposure to a stimulus
inhibits subsequent associations with that stimulus (Esclassan et al., 2015). Electrophysiolo-
gically, Nrx1-/- mice show decreased frequency of miniature excitatory post-synaptic currents
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Figure 5.5: AIS lengths in cortical regions of Nrx1+/- rats (A-A’, C-C’, E-E’, G-G’, I-I’,K-K’,M-M’) Repres-
entative single AIS from Nrx1+/+ and Nrx1+/- rats respectively from the PL (L2/3 A-A’, L5 C-C’), S1 (L2/3 E-E’,
L4 G-G’, L5 I-I’) and V1 (L2/3 K-K’, L5 M-M’). No change in avg AIS length or cumulative distribution of AIS
lengths was observed in PL L2/3 (B-B’), PL L5 (D-D’), S1 L2/3 (F, F’), S1 L4(H-H’), S1 L5 (J-J’), V1 L2/3 (L-L’)
and V1 L5 (N-N’) of Nrx1+/- rats compared to controls.
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(EPSCs) and input-output relation of evoked potentials in the CA1 (Etherton et al., 2009).
Although mEPSCs are an action-potential independent measure of excitability, with altered
resulting in a shift in the excitatory/inhibitory balance of individual CA1 pyramidal neurons
to favor decreased excitatory input. The AIS is known homeostatically regulate its length and
distance from cell soma to compensate for differences in input (Kuba et al., 2010; Gulledge and
Bravo, 2016). However, no changes in average AIS length or cumulative distribution of AIS
lengths was observed in either the CA1 or the CA3 or Nrx1+/- rats compared to controls (CA1
fig.5.6B, B’ Nrx1+/+= 34.84 µm ± 0.47 µm n=7, Nrx1+/-= 35.19 µm ± 0.81 µm n=7 animals;
CA3 fig.5.6D, D’ Nrx1+/+= 41.70 µm ± 0.55 µm n=7, Nrx1+/-= 42.40 µm ± 1.30 µm n=7
animals).
Finally, Twining et al. (2017) found chemogenetically reversible deficits in a amygdala-
dependent social cued fear conditioning paradigm in the Nrx1-/- rats. Accompanying this deficit
was increased firing activity in neurons of the medial but not the lateral amygdala nucleus.
In keeping with the lack of altered cellular firing in the LA of Nrx1-/- rats, no alterations in
average AIS length or cumulative distribution of AIS lengths was observed in either the LA of
Nrx1+/- rats compared to controls (fig.5.6F, F’ Nrx1+/+= 29.24 µm ± 0.76 µm n=8, Nrx1+/-=
27.73 µm ± 0.53 µm n=7 animals). Further, as social-cued fear conditioning also involves
the basal amygdala , I examined AIS lengths in neurons from this region as well but found no
change in average legnth or cumulative distribution of AIS lengths in BA neurons of Nrx1+/-
rats compared to controls (fig.5.6H, H’ Nrx1+/+= 41.76 µm ± 1.77 µm n=7, Nrx1+/-= 38.94
µm ± 2.01 µm n=6 animals).
In keeping with results obtained from juvenile Syngap1+/- and Nlgn3-/y rats, heterozygosity
of Nrx1, does not result in altered AIS lengths in any of the brain regions analysed here.
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Figure 5.6: AIS lengths in sub-cortical regions of Nrx1+/- rats (A-A’, C-C’, E-E’, G-G’) Representative single
AIS from Nrx1+/+ and Nrx1+/- rats respectively from the hippocampus (CA1 A-A’, CA3 C-C’) and the BLA (LA
E-E’, BA G-G’). No change between Nrx1+/- and Nrx1+/+ rats in avg AIS length or cumulative distribution of AIS
lengths was observed in the CA1 (B-B’), CA3 (D, D’), LA (F-F’) or BA (H-H’).
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5.5 Contactin-associated protein-like 2 (Cntnap2)
First identified in 1999, the Contactin-associated protein-like 2 or Cntnap2 gene is 2.3Mb
long, located in chromosomal region 7q35 in humans (chromosome 6 in mice and rats), com-
posed of 24 exons and encodes a transmembrane protein of the neurexin super-family of cell ad-
hesion molecules (Poliak et al., 1999; Nakabayashi and Scherer, 2001). Functionally, Cntnap2
mediates K+ channel clustering in mature complex peripheral neurons via a contactin-2/TAG-1
complex at the juxtaparanodes of myelinated axons (Poliak et al., 2003) and localisation of
Kv1.2 channels in the distal axon initial segment of central pyramidal neurons (Rasband et al.,
2002; Inda et al., 2006). In the developing brain, Cntnap2 affects dendritic arborisation, spine
development and stabilisation of newly formed synapses (Anderson et al., 2012).
CNTNAP2-related neuronal disorder was first reported by Verkerk et al. (2003) in a family
carrying a heterozygous translocation at intron 8. Behavioural manifestations of this mutation
included Gilles de la Tourette syndrome, ID and obsessive-compulsive disorder Verkerk et al.
(2003)). In 2006, Strauss et al. (2006) reported a homozygous loss of function point-mutation in
CNTNAP2 in 13 pro-bands of old-order Amish descent presenting with cortical-dysplasia-focal
epilepsy (CDFE), language regression, hyperactivity and intellectual disability. Temporal-lobe
specimens from these individuals showed abnormal neuronal migration with reduced CNTNAP2
(or CASPR2) expression. Homozygous loss-of-function deletions in CNTNAP2 have also been
found in individuals with Pitt-Hopkins like ID (Zweier et al., 2009). Since then, heterozygous
disruptions arising from gene dosage, rare mutations and common variation in CNTNAP2 have
been associated with various forms of NDDs including ID, ADHD, epilepsy and schizophrenia
(Rodenas-Cuadrado et al., 2014). Currently, the SFARI Gene database classifies CNTNAP2 as
a ‘strong-causative candidate’ for syndromic ASD/ ID.
To date, pre-clinical studies on loss-of Cntnap2 have focused on the homozygous loss-
of-function mutation, despite most reported cases of CNTNAP2 disruptions in humans being
heterozygous in nature. Cntnap2-/- mice show deficits in the core ASD-like behaviour including
repetitive stereotypy and social deficits as well as hyperactivity and seizures (Peñagarikano et
al., 2011). Using a juvenile play test, Peñagarikano et al. (2011) show that Cntnap2-/- mice
spend significantly less time interacting with a conspecific animal while showing increased
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stereotyped behaviours like grooming and digging. Social deficits were also observed upon
loss of Cntnap2, where Cntnap2-/- mice when places in a 3-chamber task showed no preference
for sociability. Additionally, upon examination of nesting behaviour, which can act as an
indicator or home-cage sociability, Cntnap2-/- mice showed decreased nesting (Peñagarikano et
al., 2011). Sociability is known to be mediated by the mPFC (Yoon et al., 2018) and in Cntnap2-/-
mice Selimbeyoglu et al. (2017) showed that optogenetically shifting the excitatory/inhibitory
balance towards increased inhibition in the mPFC of these animals restores their preference
for social novelty. The same study also found inherently different PV interneuron activity in
the mPFC of Cntnap2-/- mice as, upon social interaction, PV interneuron activity showed no
signs of increase, as was would be expected in wildtype animals (Selimbeyoglu et al., 2017).
Further, Cntnap2-/- mice also show fewer PV interneurons in L4 of the somatosensory cortex
(Vogt et al., 2018). Pyramidal cells of S1 L2/3, that receive feed-forward information from S1
L4 (Feldmeyer et al., 2013), show increased E/I conductance ratio in Cntnap2-/- mice (Antoine
et al., 2019) while in vivo two-photon Ca2+ imaging showed asynchronous firing in S1 L2/3
cells of Cntnap2-/- mice compared to wildtypes (Peñagarikano et al., 2011). A reduction in
PV interneurons was also observed in the hippocampus of Cntnap2-/- mice, accompanied by
deficits in hippocampal dependent behavioural tasks (Peñagarikano et al., 2011) including
reduced cognitive flexibility, with Cntnap2-/- mice failing to perform the reversal phase of the
Morris water maze task and showing significantly reduced alternation in the spontaneous T-
maze test (Peñagarikano et al., 2011). Lastly, elevated levels of social anxiety (Peñagarikano
and Geschwind, 2012) are a common clinical feature in individuals with mutations in CNTNAP2.
However, Cntnap2-/- mice show no elevation in anxiety-like behaviours in a light-dark box test
(Peñagarikano and Geschwind, 2012).
This focus on the homozygous model is partly explained by the evidence of deleterious
heterozygous mutations being identified in unaffected controls in studies (Strauss et al., 2006)
as well as the general population (Bakkaloglu et al., 2008), lending weight to the argument
that type of mutation and genetic background affects the translation of disruption into disorder.
Given the above observed phenotypes, AIS length analysis in this chapter is focused on a
heterozygous loss-of-function pre-clinical rat model of Cntnap2 (Cntnap2+/-) in the mPFC PL,
S1BF, CA1, CA3, BLA and V1.
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5.5.1 Results
In the mPFC, no change in average AIS length or cumulative distribution of AIS lengths
was observed in either PL L2/3 or L5 of juvenile Cntnap2+/- rats compared to controls (L2/3
fig.5.7B, B’ Cntnap2+/+= 28.46 µm ± 0.69 µm n=5, Cntnap2+/-= 30.03 µm ± 0.20 µm n=5
animals; L5 fig.5.7D, D’ Cntnap2+/+= 29.70 µm ± 0.47 µm n=5, Cntnap2+/-= 31.39 µm ±
0.50 µm n=5 animals).
Given the altered excitability of neurons in the S1BF of Cntnap2-/- mice, I examined AIS
lengths in various layers of the S1 in order to determine if alterations in AIS lengths could
be a contributing factor to altered cellular excitability. No change in average AIS length or
cumulative distribution of AIS lengths were observed in any of the superficial or deep layers
of the S1BF in P28-35 Cntnap2+/- rats compared to littermate controls (fig.5.7F, F’ S1 L2/3
Cntnap2+/+= 29.03 µm ± 1.06 µm n=5, Cntnap2+/-= 28.14 µm ± 0.44 µm n=5; H, H’ S1
L4 Cntnap2+/+= 23.19 µm ± 0.95 µm n=5, Cntnap2+/-= 22.54 µm ± 0.25 µm n=5; J, J’ S1
L5 Cntnap2+/+= 29.62 µm ± 0.39 µm n=5, Cntnap2+/-= 28.48 µm ± 0.76 µm n=5 animals).
Further, AIS legnths were measured in primary visual cortex of Cntnap2+/- rats, to analyse if
lengths were affected in another sensory region was altered. No difference in either average
AIS length or cumulative distribution of AIS lengths was observed in either V1 L2/3 or L5 of
juvenile Cntnap2+/- rats compared to controls (L2/3 fig.5.7L, L’ Cntnap2+/+= 26.87 µm ± 0.97
µm n=5, Cntnap2+/-= 26.27 µm ± 0.89 µm n=5 animals; L5 fig.5.7N, N’ Cntnap2+/+= 31.05
µm ± 0.37 µm n=5, Cntnap2+/-= 30.26 µm ± 0.47 µm n=5 animals).
Individuals with CNTNAP2 mutations exhibit severe temporal lobe epilepsy and language
impairments while Cntnap2-/- mice and rats exhibit spontaneous seizures (Peñagarikano et
al., 2011; Thomas et al., 2017). Epileptiform activity is suggestive of increased network and
cellular excitability (Tuchman et al., 2010; Samra et al., 2017) with alterations in AIS length
and composition being implicated in temporal lobe epilepsy (Wimmer et al., 2010). Thus, here I
examined AIS lengths in the CA1 and CA3 subregion of the hippocampus, where focal seizures
originate (Scheffer et al., 2017). However, similar to results obtained in other brain regions,
average and cumulative distribution of AIS lengths in both CA1 and CA3 were comparable
across genotypes (fig.5.8B CA1 Cntnap2+/+= 34.68 µm ± 1.32 µm n=4, Cntnap2+/-= 35.17
µm ± 0.97 µm n=5; D CA3 Cntnap2+/+= 42.02 µm ± 1.06 µm n=4, Cntnap2+/-= 42.64 µm
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Figure 5.7: AIS lengths in cortical regions of Cntnap2+/- rats (A-A’, C-C’, E-E’, G-G’, I-I’,K-K’,M-M’) Repres-
entative single AIS from Cntnap2+/+ and Cntnap2+/- rats respectively from the PL (L2/3 A-A’, L5 C-C’), S1 (L2/3
E-E’, L4 G-G’, L5 I-I’) and V1 (L2/3 K-K’, L5 M-M’). No change in avg AIS length or cumulative distribution of
AIS lengths was observed in PL L2/3 (B-B’), PL L5 (D-D’), S1 L2/3 (F, F’), S1 L4(H-H’), S1 L5 (J-J’), V1 L2/3
(L-L’) and V1 L5 (N-N’) of Cntnap2+/- rats compared to controls.
160
± 0.98 µm n=5 animals).
Although pre-clinical models of CNTNAP2 associated ID donot present with over anxiety-
deficits, in keeping with the comparison of looking at the basolateral amygdala in the other
monogenic rat models of ASD/ID, I examined AIS lengths in the BLA of juvenile Cntnap2+/-
rats. As expected, there were no genotype specific differences in either average AIS length or
cumulative distribution of AIS lengths in either the LA or the BA (LA fig.5.8F, F’ Cntnap2+/+=
26.09± 0.65 n=4, Cntnap2+/-= 26.07 µm± 0.22 µm n=4 animals; BA fig.5.8H, H’ Cntnap2+/+=
37.01 µm ± 3.06 µm n=4, Cntnap2+/-= 32.85 µm ± 3.05 µm n=5 animals).
Overall, the data here matches the findings from juvenile Syngap1+/-, Nlgn3-/y and Nrx1+/-
rats and suggests that reduction in Cntnap2/ Caspr2 levels does not affect AIS length in any of
the brain regions analysed.
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Figure 5.8: AIS lengths in sub-cortical regions of Cntnap2+/- rats (A-A’, C-C’, E-E’, G-G’) Representative
single AIS from Cntnap2+/+ and Cntnap2+/- rats respectively from the hippocampus (CA1 A-A’, CA3 C-C’) and
the BLA (LA E-E’, BA G-G’). No change between Cntnap2+/- and Cntnap2+/+ rats in avg AIS length or cumulative
distribution of AIS lengths was observed in the CA1 (B-B’), CA3 (D, D’), LA (F-F’) or BA (H-H’).
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5.6 Phosphatase and tensin homolog
A canonical tumour suppressor, the phosphatase and tensin homolog (PTEN) gene maps to
human chromosome 10q23.3 (Nelen et al., 1996; Feilotter et al., 1999) and was first identified as
a Cowden syndrome and cancer susceptibility gene in 1996-7 (Nelen et al., 1996; Marsh et al.,
1997b,a). Since then, multiple germline mutations in PTEN have been identified in individuals
with Cowden’s syndrome, Bannayan-Riley-Ruvalcaba syndrome and Proteus Syndrome (Zori
et al., 1998; Goffin et al., 2001; Butler et al., 2005). Together, these mutations were dubbed
PTEN hamartoma tumour syndromes (PHTS) (Mester et al., 2011). A characteristic of PHTS,
reported to occur in as high as 94% in some studies (Mester et al., 2011), includes a greater than
2 standard deviation increase from mean in occipital-frontal circumference for given height, sex
and ethnicity, or macrocephaly, a phenotype that is also commonly observed in individuals with
autism spectrum disorder (Dementieva et al., 2005; Chaste et al., 2013).
The first case study of PTEN mutation with autism was reported by Goffin et al. (2001), in a
proband with maternal diagnosis of Cowden syndrome. While the mother did not show altered
social function or evidence of intellectual disability the child showed progressive macrocephaly
with hallmark signs for ASD including severe speech delay, short attention span, lack of interest
in social contacts and stereotyped behaviours like hand-flapping (Goffin et al., 2001). Following
this initial case report, heterozygous germline mutations in PTEN associated with ASD and
macrocephaly have been reported in over 11 studies (Butler et al., 2005; Buxbaum et al., 2007;
Herman et al., 2007; Orrico et al., 2009; Varga et al., 2009; McBride et al., 2010; Klein et al.,
2013; Hobert et al., 2014; Marchese et al., 2014). Other common co-morbidities present in
these patients include intellectual disability Tan et al. (2011), delayed language development
(Frazier et al., 2015), increased cortical white matter (Vanderver et al., 2014; Frazier et al.,
2015), poor working memory (Frazier et al., 2015; Tilot et al., 2014, 2015) and increased
seizure susceptibility with cortical dysplasia (Child and Cascino, 2013; Cheung et al., 2014;
Elia et al., 2012; O’Rourke et al., 2012; Conti et al., 2012; Tilot et al., 2015).
PTEN encodes a phosphatase with four major domains: An N-terminal tail responsible for
its nuclear versus cytoplasmic localisation and mediating binding of phosphatidylinositol4,5-
bisphosphate (PIP2) (Gil et al., 2006; Denning et al., 2007; Walker et al., 2004), the pro-
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tein phosphatase catalytic core domain (Li et al., 1997), a membrane binding C2 domain
and a PDZ-domain containing C-terminal tail (Li et al., 1997; Jurado et al., 2010). The
PDZ-binding domain allows PTEN to bind to scaffolding proteins such as PSD-95, result-
ing in localisation at the post-synaptic density (Li et al., 1997; Jurado et al., 2010). In
its capacity as a phosphatase, PTEN hydrolyses phosphatidylinositol (3,4,5)-trisphosphate
(PIP3) to phosphatidylinositol4,5-bisphosphate (PIP2) thus antagonising the phosphatidylin-
ositol 3-phosphate kinase (PI3K)/protein kinase B (PKB/AKT) / mammalian target of rapamy-
cin (mTOR) pathway (Li et al., 1997; Maehama and Dixon, 1998; Worby and Dixon, 2014).
Through these downstream signalling cascades PTEN modulates cellular proliferation, differ-
entiation and death during development (Kwon et al., 2006; Stiles et al., 2004) and in adults
(Gregorian et al., 2009; Amiri et al., 2012; Chow et al., 2009). The PI3K/AKT/mTOR pathway
is of particular interest within the ASD community as another model of ASD, tuberous sclerosis,
results from mutations in genes encoding the tuberous sclerosis complex, an inhibitor of the
mTOR pathway (Inoki et al., 2002).
Full knock-down of Pten is embryonic lethal, therefore various conditional knock-out lines
have been created to study the underlying biological changes occurring upon reduction in
PTEN levels (Kwon et al., 2001; Backman et al., 2001; Kwon et al., 2006; Kazdoba et al.,
2012; Lugo et al., 2014; Amiri et al., 2012). Loss of ~50% of PTEN protein results in various
cytoarchitectural alterations particularly hyperproliferation of neuronal precursor cells (Kazdoba
et al., 2012), defective migration and cortical lamination (Kwon et al., 2001; Backman et al.,
2001; Wen et al., 2013) and neuronal hypertrophy resulting in macrocephaly (Kwon et al.,
2001, 2006; Rademacher and Eickholt, 2019). However, given the focus on AIS in this thesis, I
summarize here the ASD-like behavioural phenotypes, synaptic and intrinsic cellular excitability
deficits observed in various mouse models of Pten haploinsufficiency.
Altered social behaviours and communication form one half of the ASD diagnostic criteria.
Selective loss of Pten from adult neuronal populations in the cerebral cortex and hippocampus
(Kwon et al., 2006), neuronal precursor cells (Amiri et al., 2012) and granule neurons of the
cerebellum and hippocampus (Lugo et al., 2014) results in reduced social behaviour with a loss
of preference for sociability in Pten heterozygous mice, as measured using a three-chamber task.
However, a knock-in germline mutant of Pten, resulting in increased cytoplasmic localisation
of the protein, exhibits increased sociability (Tilot et al., 2014). Further, germline Pten knock-
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down heterozygous (Pten+/-) mice (Clipperton-Allen and Page, 2014) as well as mice in which
Pten has selectively been knocked down from hippocampal dentate granule cells results in
increased repetitive behaviours measured by marble burying and increased grooming (Lugo et
al., 2014). Additional PTEN-ASD co-morbidities that are recapitulated in these mouse models
include increased incidence of seizures (Backman et al., 2001) with lowered threshold for
induction of audiogenic seizures (Kwon et al., 2006; Ogawa et al., 2007), increased sensitivity
to acoustic stimuli with impaired sensorimotor gating (Kwon et al., 2006) and balance and
gait abnormalities as measured using an accelerating rota-rod test (Tilot et al., 2014). There is
also come evidence of impaired hippocampal dependent spatial memory, as Pten+/- mice with
protein selectively knocked down from post-mitotic neurons of the hippocampus and cerebral
cortex show increased latency with a slower learning curve to finding a platform in the Morris
water maze (Kwon et al., 2006). Hyperactivity and anxiety-like behaviours upon loss of Pten
appear to be specific to the conditional knock-out as some models show elevated anxiety with
hyperactivity (Page et al., 2009; Clipperton-Allen and Page, 2014; Kwon et al., 2006) while
others show reduced anxiety (Lugo et al., 2014).
Underlying these behaviours are various intrinsic excitability and synaptic plasticity changes
(Daoudal and Debanne, 2003). In a model where Pten has been selectively knocked down from
cells of the medial ganglionic eminence, the region where somatostatin-positive GABAergic
interneuons arise, an increase in parvalbumin/somatostatin ratio with lowered E/I ratio and im-
paired social behaviours is found (Vogt et al., 2015). Conversely, Pten deletion from developing
hippocampal excitatory neurons , but not those of the mature amygdala and auditory cortex
Sperow et al. (2012); Haws et al. (2014); Xiong et al. (2012), causes cellular hyper-excitability
as measured by increased numbers of synapses with an excess of excitatory inputs and increased
frequency of mEPSCs (Sperow et al., 2012; Xiong et al., 2012; Williams et al., 2015; Pun et
al., 2012; Skelton et al., 2019). Conditional single-copy deletion of PTEN increases expression
of small-conductance calcium-activated potassium channels with a reduction in pyramidal cell
excitability, evidenced by decreased frequency of action potential firing, lowered membrane
resistance and increased after-hyperpolarisation (Garcia-Junco-Clemente et al., 2013). Synaptic
plasticity alterations upon loss of PTEN, particularly LTP, are animal-age and brain region de-
pendent. Neuron-specific deletion of PTEN enhances dentate gyrus granule cell theta burst-LTP
in adult (8-12 week) mice, whereas it impairs theta burst-LTP in both the dentate gyrus and
CA1 neurons of aged mice (20-30 weeks) (Takeuchi et al., 2013). Comparably, at CA3-CA1
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synapses NMDAR-LTP in 8 week-old mice lacking PTEN is decreased (Sperow et al., 2012;
Fraser et al., 2008) while mice at both ages show impaired NMDAR- and mGluR-LTD (Sperow
et al., 2012; Takeuchi et al., 2013). Interestingly, pharmacological blockade of PTEN lipid
phosphatase activity results in impaired NMDAR- but not mGluR-LTD or LTP (Jurado et al.,
2010). Together, these results indicate developmental loss of Pten can result in altered cellular
excitability and connectivity whereas selective loss in mature neurons results in altered synaptic
plasticity (Rademacher and Eickholt, 2019).
Given this evidence of altered cellular excitability, particularly in the hippocampus, amyg-
dala and auditory sensory cortex, and the presence of impairments in hippocampal, prefrontal
cortex and sensory-behaviours here I have analysed AIS lengths in a rat model of Pten haploin-
sufficiency.
5.6.1 Results
While our laboratory has found a gross increase in brain size, with enlarged ventricles,
in the Pten+/- rats (A Sharma, unpublished), no change in average AIS length or cumulative
distribution of AIS lengths is observed in either L2/3 or L5 of the PL of juvenile (P28-32) Pten+/-
rats compared to wildtype, littermate controls (L2/3 fig.5.9B, B’ Pten+/+= 29.00 µm ± 0.99
µm n=5, Pten+/-= 28.91 µm ± 0.60 µm n=5 animals; L5 fig.5.9D, D’ Pten+/+= 29.32 µm ±
1.33 n=5, Pten+/-= 30.14 ± 1.25 µm n=5 animals). Similarly, no change is observed in average
or cumulative AIS lengths in L2/3, L4 or L5 of the somatosensory barrel cortex of Pten+/- rats
compared to controls (L2/3 fig.5.9F, F’ Pten+/+= 26.76 ± 1.13 n=5, Pten+/-= 27.35 µm ± 1.22
µm n=5 animals; L4 fig.5.9H, H’ Pten+/+= 22.21 µm ± 0.37 µm n=5, Pten+/-= 22.37 µm ±
0.96 µm n=5 animals; L5 fig.5.9J, J’ Pten+/+= 28.62 µm ± 0.47 µm n=5, Pten+/-= 30.10 µm
± 0.67 µm n=5 animals). Due to poor tissue quality of sections containing the primary visual
cortex was severely degraded and could not be collected.
The hippocampus is where majority of the excitability deficits in Pten heterozygous mouse
models are observed. Here however, no statistically significant differences were seen in average
AIS length or cumulative AIS lengths between Pten+/- and wildtype control animals in either the
CA1 or the CA3 (CA1 fig.5.10B, B’ Pten+/+= 34.69 µm± 1.43 µm n=4, Pten+/-= 37.82 µm±
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Figure 5.9: AIS lengths in cortical regions of Pten+/- rats (A-A’, C-C’, E-E’, G-G’, I-I’) Representative single
AIS from Pten+/+ and Pten+/- rats respectively from the PL (L2/3 A-A’, L5 C-C’) and S1 (L2/3 E-E’, L4 G-G’, L5
I-I’). No change in average AIS length or cumulative distribution of AIS lengths was observed in PL L2/3 (B-B’),
PL L5 (D-D’), S1 L2/3 (F, F’), S1 L4(H-H’) or S1 L5 (J-J’) of Pten+/- rats compared to controls.
167
0.89 µm n=3 animals; CA3 fig.5.10D, D’ Pten+/+= 40.69 µm ± 1.07 µm n=3, Pten+/-= 46.91
µm ± 2.30 µm n=3 animals). Similarly, no alterations in average or cumulative distribution
of AIS lengths was observed in either the LA or the BA of the Pten+/- animals compared to
controls (LA fig.5.10F, F’ Pten+/+= 27.13 µm ± 0.50 µm n=5, Pten+/-= 29.29 µm ± 1.14 µm
n=3 animals; BA fig.5.10H, H’ Pten+/+= 40.20 µm ± 2.72 µm n=5, Pten+/-= 34.52 µm ± 4.76
µm n=3 animals). Due poor tissue quality of the sections containing the CA1, CA3, BA and
LA, the power of these experiments is low and the results are preliminary.
Overall, AIS length data from Pten+/- rats matched those obtained from Syngap1+/-, Nlgn3-/y,
Nrx1+/- and Cntnap2+/- rats in that no genotype specific alterations were found in any brain
region analysed.
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Figure 5.10: AIS lengths in sub-cortical regions of Pten+/- rats (A-A’, C-C’, E-E’, G-G’) Representative single
AIS from Pten+/+ and Pten+/- rats respectively from the hippocampus (CA1 A-A’, CA3 C-C’) and the BLA (LA
E-E’, BA G-G’). No change between Pten+/- and Pten+/+ rats in avg AIS length or cumulative distribution of AIS
lengths was observed in the CA1 (B-B’), CA3 (D, D’), LA (F-F’) or BA (H-H’).
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5.7 Discussion
Alterations in cellular excitability have been noted in multiple models of ASD/ID (Con-
tractor et al., 2015; Nelson and Valakh, 2015). However, variation in experimental design
across studies in brain region, cell type, age of experimental animal and choice of physiolo-
gical methods complicates the identification of common cellular, synaptic and circuit deficits
in these models (Antoine et al., 2019). Given recent findings that AIS length is differentially
regulated in models of ASD/ID (Kaphzan et al., 2011; Kloth et al., 2017; Booker et al., 2019), I
hypothesized that alteration in AIS length may be a point of convergence in ASD/ID that under-
lies this altered cellular excitability. In comparison to electrophysiological techniques, such as
patch-clamping, measuring differences in AIS lengths as a proxy measurement for difference
in cellular excitability is more high-throughput; thus allowing for rapid analysis across multiple
brain regions to select one for further investigation. Taking advantage of this high-throughput
read-out, I conducted a systematic analysis of AIS lengths across six different brain regions
in five novel monogenic rat models of ASD/ID. As ASD/ID is a developmental disorder and
altered cellular excitability in preclinical models is shown to underlie sensory hypersensitivities
in these models, the juvenile age (P28-35) of experimental animals was chosen to coincide with
the critical period of experience-dependent plasticity of the visual cortex (De Villers-Sidani et
al., 2008; Fagiolini and Leblanc, 2011).
Of the five rats models analysed in this chapter, and six in this thesis, genotype specific
changes in AIS length at P28 was observed only in the PL L5, S1 L5 and BA of the Fmr1-/y rats
with AIS lengths in all other brain regions and models being comparable to wildtype littermate
controls. Thus suggesting that alterations in AIS length of pyramidal cells in the selected brain
regions is not a node of convergence and does not contribute to the excitability pathophysiology
observed in these models. However, this result does not preclude additional factors, such as
altered circuit excitability, being a convergent node in the pathophysiology of these models.
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5.7.1 Altered AIS length in Fmr1-/y rats
The only model to show genotype specific alterations in AIS length was the Fmr1-/y model
of FXS, making it an interesting candidate for further study. Specifically, increased AIS lengths
were noted in neurons of of PL L5, S1BF and the BA. Given that in the Fmr1-/y mouse model,
increased AIS length in the CA1 is shown to underlie cellular hyperexcitability (Booker et al.,
2019) and increased AIS length in the BA was coupled with increased cellular firing (Jackson,
2016), loss of FMRP results in AIS length mediated alterations in cellular excitability in a brain-
region and layer-specific. All the layers shown to have increased AIS length are known to have
long-range projections (Hoover and Vertes, 2007; Krettek and Price, 1977; Denardo et al., 2015),
with local excitatory connectivity of these neurons being highly correlated with their long range
targets (Brown and Hestrin, 2009). Of particular interest is the ~11% increased length in PL L5,
as previous work in the laboratory has found that a ~20% reduction in AIS length in PL-BLA
projection neurons of adult (>P60) Fmr1-/y rats accompanied by cellular hypoexcitability (see
appendix figS1, Jackson (2016)). This would further suggest sub-population specific alterations
in AIS length upon loss of FMRP or sub-population specific adaptation of AIS length during
development in this model. PL-BLA projection neurons are imperative for the appropriate
consolidation and retrieval of fear related memory (Arruda-Carvalho and Clem, 2015; Akers
et al., 2012). Assessment of acquisition and recall of fear memory in rodents is performed
using cued or contextual fear conditioning (Akers et al., 2012), a form of associative memory
that is found to be impaired in the Fmr1-/y rats (see appendix fig.S2). In a visually cued-fear
conditioning task, similar to the one used in chapter 4, Fmr1-/y rats show freezing rates com-
parable to WTs during the conditioning phase. 24 hours after conditioning, when recall of fear
memory is assessed, Fmr1-/y rats showed markedly reduced freezing upon re-exposure to the
exposed to the conditioned stimulus, indicating impaired formation of fear-associated memory.
This behavioural phenotype is opposed to that observed in the Syngap1+/- and Syngap1+/∆Gap
rats, where the animals showed an exaggerated freezing response during re-call of fear-memory
(figs. 4.5B, 4.7B). Future experiments should assess if differential alterations in AIS lengths in
PL-BLA projection neurons are observed between Fmr1-/y, Syngap1+/- and Syngap1+/∆Gap rats
post fear conditioning.
Overall, the data suggests that alterations in AIS length may be one of the underlying
mechanisms of circuit hyperexcitability noted in pre-clinical models of FXS (Contractor et al.,
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2015) with species specific differences, as the elongated AIS phenotype observed in the CA1
of the mouse model of FXS did not translate to our rat-model.
5.7.2 Additional factors underlying ASD pathophysiology
Additional factors known to be causative of ASD include altered chromatin function and im-
paired transcriptional control (Sullivan et al., 2019), perturbed synapse formation and function
(Gilman et al., 2011; Krumm et al., 2014) and altered neuronal signalling pathways (Krumm
et al., 2014; Pinto et al., 2014). Gene expression studies comparing post-mortem brains from
individuals with ASD and matched unaffected controls highlight the role of impaired epigen-
etic/transcriptional regulation in ASD (for review see Sullivan et al. (2019); Quesnel-Vallières
et al. (2019)). Given that alternative splicing occurs more frequently in the brain than in any
other tissue (Melé et al., 2015) and abnormal patterns of RNA splicing and isoform usage have
been identified in brains of individuals with ASD (Gandal et al., 2018), transcriptional dysregu-
lation may have a particular impact on brain development and physiology. However, as protein
products of none of the mutations studied in this chapter are known to affect transcriptional
regulation or chromatin remodelling, disruptions in these processes is unlikely to be the causat-
ive pathophysiology these models. Further, although FMRP and PTEN are known to regulate
various signalling pathways, all the mutations studied in this thesis occur in synaptic proteins.
Therefore, a core convergent process likely to be causative of ASD in these models is perturbed
synaptic development and functional maturation (Gilman et al., 2011).
The fundamental function of a neurons is the transformation of synaptic input, beyond a
certain threshold, into output signals usually in the form of all-or-none reversal of membrane
potential polarity and is defined as the excitability of a cell. This integration of synaptic input
occurs in dendritic spines, the cell soma and the AIS, with the latter also being the site for
AP initiation, which together determine this threshold for AP generation. Development of
cellular excitability is a key regulator of neuronal networks, disruption of which results altered
neural circuit activity and is implicated in various neurodevelopmental disorders (Rubenstein
and Merzenich, 2003), with neuronal hyperexcitability being a proposed model for ASD/ID
pathophysiology (Contractor et al., 2015). While the focus of this thesis has been on alteration
of AIS morphology driven changes in cellular excitability, synaptogenesis and dendritic spine
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dynamics including spine number, morphology and expression of voltage-gated ion channels
play a key role in determining synpatic weight and efficiency, and regulating cellular excitability
(Van Spronsen and Hoogenraad, 2010; Yuste, 2011). Within models of ASD, disruptions in
synaptogenesis, synaptic pruning, spine-turnover and alterations in the expression or activity
of ion channels at dendritic spines and cell soma and altered neurotransmitter release could all
be contributing mechanisms for neuronal hyperexcitability. Alteration of intrinsic properties of
neurons as a result of these perturbation can result in altered synaptic plasticity, exaggerated
neuronal firing, abnormally high synchrony of neural networks, and exaggerated sensory-evoked
activity. Thus investigation at multiple levels (i.e., molecular, synaptic, cellular, network) is
necessary to determine both the pathophysiological effects of different genetic mutations and
their resultant ASD phenotype.
5.7.3 Limitations in experimental design
Although the AIS length data from the rat models is fairly conclusive, some decisions of
experimental design may contribute to the lack of alterations observed here. These include:
Age of experimental animals The ‘ideal’ age of the experimental animal depends on the
question being investigated and is intrinsically linked to mutation and specific circuit/brain
region being studied. Cells in different brain regions show differential excitability over de-
velopment, depending on the developmental trajectory of the neuronal circuit of which it is a
part (Tau and Peterson, 2010). Notably, in Nlgn3-/y mice altered cellular excitability in CA3
pyramidal neurons is observed from P4-9 and not at P14, while in Pten+/- mice alterations in
cellular excitability of CA1 pyramidal cell only occur in animals aged 8 weeks and older. The
decision to use juvenile animals for these experiments was chosen to coincide with develop-
mental critical period of experience-dependent alterations in cellular excitability in most of the
brain regions studied (De Villers-Sidani et al., 2008; Fagiolini and Leblanc, 2011; Ehrlich et
al., 2012). Additionally, the study which found increased AIS length in the CA1 pyramidal
neurons of Fmr1-/y mice as causative for cellular hyperexcitability was conducted in juvenile
animals (P28-32). However, increased AIS length and cellular hyperexcitablity in CA1 pyram-
idal neurons of the mouse model of Angelman’s syndrome was observed in adult (8-12 week)
mice. Thus, while the age chosen for analysis was optimised for the brain regions being studied,
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given the cellular excitability phenotypes observed analysis of AIS lengths at different ages and
adaptation of AIS length with age might be more appropriate depending on the model.
Selection of brain regions A two tiered rationale was used to select the brain-regions where
alterations in AIS were analysed. First, these brain regions were behaviourally relevant, with
impairments in behavioural assessments involving these brain regions being observed in other
pre-clinical models of the genetic mutations studied here. Second, cellular excitability and
synaptic plasticity have been widely studied in these brain-regions in the context of neurodevel-
opmental disorders (for review see Takarae and Sweeney (2017)). However, most studies focus
on characterisation of cellular deficits in a single brain-region, whereas I have chosen to per-
form within subject systematic analysis of AIS length across multiple brain-regions reported
with altered excitability in autism (for review see Takarae and Sweeney (2017)). Consequently,
brain-regions that have been disrupted in the individual models were excluded. For example,
sociability deficits observed in Nlgn3-/y mice was shown to be dependent on dopaminergic
neurons of the dorsal striatum (Lee et al., 2018), while social novelty deficits were found to be
dependent on dopaminergic neurons of the ventral tegmental area (Bariselli et al., 2018).
Further, AIS analysis in this thesis was largely restricted to pyramidal cells. Höfflin et al.
(2017) characterised AIS morphology and distance from soma in a variety of cortical cell types
including excitatory pyramidal neurons and different sub-type of interneurons. Based on their
classification, the AISs measured in this thesis belonged to excitatory pyramidal cells as all
measured AISs were of somatic origin, with a minimally discernible gap between the AIS and
the soma and followed near perpendicular trajectory to the cell soma. Inhibitory signalling
in the BA of Fmr1-/y mice is impaired, as is the excitability of fast-spiking inter-neurons in
the mPFC of Nlgn3-/y mice. Thus, literary evidence suggests future investigation of altered
AIS lengths and excitability of interneurons in our rat models of ASD/ID and brain regions of
interest might be of value.
Nature of mutations Genome-wide association studies published in parallel to the under-
taking of this project found no association between mutations in some of the genes studied
in this chapter and ASD. Notably, rare heterozygous mutations in CNTNAP2 were not found
to be substantially different between cohorts of psychiatric patients and the general control
population (Murdoch et al., 2015; Toma et al., 2018). Congruent with these studies, behavioural
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and electrophysiological studies performed by members of the lab found no genotype specific
differences between Cntnap2+/- and control rats. Thus, the lack of alteration in AIS length
observed in all brain regions in Cntnap2+/- is unsurprising. However, homozygous mutations
in CNTNAP2 are still associated with ASD (Poot, 2015), with pre-clinical models of Cntnap2-/-
showing evidence of cellular hyperexcitability (Antoine et al., 2019). Given that Cntnap2/
Caspr2 is expressed at the AIS (Poliak et al., 1999; Nakabayashi and Scherer, 2001), alterations
in AIS morphology should be analysed in a loss of function model.
Environmental factors External environmental factors such as home-cage enrichment,
mixed genotype housing and maternal care have been shown to influence the expression of
ASD-like behaviours. A 2017 study showed that the decision to co-house single or mixed geno-
type animals in the home cage critically influenced the development of behavioural phenotypes
upon loss of Nlgn3. They found that mixed genotype housing of Nlgn-/y KO mice with wild-
type littermates resulted in reduced vocalisation by the WTs and disrupted home-cage social
hierarchies, measured using tests of dominance, compared to single-genotype housed animals,
while re-expression of Nlgn3 specifically in PV-immuno reactive interneurons ameliorated these
alterations (Kalbassi et al., 2017). Further, enrichment of the home-cage with objects that allow
the animal to isolate itself into micro-environments and experience different textures or materi-
als, such as presence of nesting materials and wooden blocks that engage fine-motor movement,
are known to boost social interaction and mitigate anxiety like behaviours in laboratory rodents
(Hutchinson et al., 2005). A third environmental factor that is known to influence stress levels,
adaptive and problematic behaviours in individuals with ASD is maternal warmth and respons-
iveness (Greenberg et al., 2012; Robinson et al., 2016; Smith et al., 2016). While there is no
current evidence of altered maternal care upon introduction of any of these mutations in rodents,
anecdotal evidence of Syngap1 heterozygous female mice being less attentive to pups has been
reported (Biological and Vetrinary services, University of Edinburgh). The animals used in this
study were mix genotype housed, both wildtype and heterozygous mutant females were used for
mating and animals were kept in moderately enriched cages containing small wooden chewing
blocks, nesting tissues and cardboard rolls. The above discussed environmental factors could
therefore have played a role in the social and cognitive development in these animals, though
the exact mechanisms of environmental enrichment on AIS length alterations is unknown.
175
5.8 Conclusion
The results detailed in this chapter, cause me to reject my hypothesis that alterations in
AIS length would be a point of convergence in ASD/ID, underlying observed alterations in
cellular excitability. In doing so, my results do validate the null hypothesis. Moving forward,
results from both mouse and rat studies will help us gain a more complete understanding of the





6.1 Summary of results
Characterisation of AIS lengths in juvenile models of ASD/ID. The data presented in
this thesis here provides the first systematic characterisation of AIS lengths across behaviourally
relevant brain regions in juvenile rat models of monogenic forms of ASD/ID. This undertaking
revealed a baseline increase in AIS length, indicative of increased cellular excitability (Kuba et
al., 2014), in layer 5 of the prelimbic and somatosensory barrel cortices and the basal amygdala
in the Fmr1 knock-out model of Fragile-X syndrome (FXS). However, no difference in AIS
length was observed in any of the brain regions in any of the other models, which included
Syngap1, Nlgn3, Nrx1, Cntnap2 and Pten mediated ASD/ID (table 6.1).
Species specific differences in AIS deficits in models of Fragile-X Syndome. The results
from the Fmr1 model are of particular interest, as the findings are indicative of species specific
differences in AIS length within the preclinical models of the same syndrome. In a mouse model
of FXS, Booker et al. (2019) show that knock-out animals exhibit increased AIS length and
cellular hyper-excitability in pyramidal cells of the CA1 sub-region of the dorsal hippocampus,
but this increased is not observed in the prelimbic, visual or somatosensory barrel cortices. In my
work, no increase in AIS length was observed in neurons of the CA1 regions in Fmr1-/y animals.
Concurrent with these results, ex vivo intracellular recordings from the CA1 neurons in these
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animals showed no alterations in cellular excitability (Jackson, 2016). Increased AIS length
was, however, observed in the juvenile Fmr1-/y rats in pyramidal neurons of layer 5 pre-limbic
medial prefrontal cortex (PL) and somatosensory barrel cortex (S1BF) as well as in principal
neurons of the basal amygdala (BA). This increase in AIS length in the BA was accompanied
by cellular hyper-excitability (Jackson, 2016) in these animals. Similar to the work performed
in Jackson (2016), whole-cell patch clamp recordings should be undertaken to complement the
present AIS study and characterise alterations in intrinsic cellular excitability of PL and S1BF
L5 neurons in juvenile Fmr1-/y rats. Divergent phenotypes across pre-clinical models of the
same neurodevelopmental disorder (NDD) have been widely reported (Eltokhi et al., 2018; Till
et al., 2015; Homberg et al., 2016; Guo et al., 2020), including across models of Fragile-X
Syndrome (Till et al., 2015). Given the rich interplay of genetic and environmental factors
that affect the developmental trajectory of NDDs, an emerging theory argues for a move away
from a single endophenotype model to more integrative ‘poly-phenotype’ models (Homberg et
al., 2016). Using multiple model systems of the same disorder ranging from in vitro induced
pluripotent patient stem cell lines to mouse and rat models will thus allow for better dissection
of unique and shared biomarkers for each model system, working in conjunction to extend
our understanding of disease pathophysiology. Recent unpublished work by Dr. Sam Booker
(personal correspondence) bears testament to this, as CA1 neurons in adult Fmr1-/y rats show
hyperexcitabliity despite no observed difference in cellular excitability in these neurons in
juvenile animals. This result would argue for re-assessment of AIS lengths in the CA1 neurons
in older animals, and assess if age-dependent plasticity of the AIS is impaired in this model of
FXS.
Assessment of morphological plasticity of the AIS in models of SYNGAP1-ID. Further,
this thesis aimed to characterise the morphological plasticity of the AIS and how this maybe
perturbed in a rat model of Syngap1 haploinsufficiency. This entailed analysis of age and ex-
perience dependent plasticity (table 6.2). This study is the first to show an show age-dependent
increase in AIS length in the BA and lateral nucleus of the amygdala (LA) of wildtype rats.
Secondly, in Syngap1+/- rats, age-dependent elongation of AIS length does not occur in cells of
PL L2/3, while this process is unaffected in cells of PL L5, BA and LA. Furthermore, I provide
evidence that the nature of SynGAP protein haploinsufficiency differentially affects AIS plas-
ticity. Using a fear-conditioning paradigm to assess experience-dependent alterations in AIS
length revealed that despite haploinsufficiency of the full-length or GTPase activating (GAP)
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domain of SynGAP resulting in similarly exacerbated re-call of fear memory, only animals
haploinsufficient for the GAP domain showed an increase AIS length post fear conditioning and
only in PL L5 neurons. This difference in AIS modulation would suggest that SYNGAP1-ID
patients with mutations resulting in loss of GAP domain activity may have distinct biological











Syngap1+/∆Gap Syngap1+/- Fmr1-/y Nlgn3-/y Nrx1+/- Cntnap2+/- Pten+/-
AIS Length AP Firing AIS Length AP Firing AIS Length AP Firing AIS Length AP Firing AIS Length AP Firing AIS Length AP Firing AIS Length AP Firing
PL L2/3 - N/A - N/A - N/A - N/A - N/A - N/A - N/A
PL L5 - - - - ↑ N/A - - - - - N/A - N/A
CA1 - - - - - - - - - ↓ - N/A - N/A
CA3 - N/A - N/A N/A - N/A - N/A - N/A - N/A
LA - - - ↑ - - - ↑ - N/A - - - N/A
BA - ↓ - - ↑ ↑ - ↑ - N/A - - - N/A
S1BF L2/3 - N/A - N/A - N/A - N/A - N/A - N/A - N/A
S1BF L4 - N/A - N/A - N/A - N/A - N/A - N/A - N/A
S1BF L5 - N/A - N/A ↑ N/A - N/A - N/A - N/A - N/A
V1 L2/3 - N/A - N/A - N/A - N/A - N/A - N/A - N/A
V1 L5 - N/A - N/A - N/A - N/A - N/A - N/A - N/A
Table 6.1: Summary table comparing genotype specific differences in juvenile animals (P28-32). AIS lengths across all 6 ASD/ID models and the corresponding electrophysiological
results are summarized above. ‘↑’ indicates an increase in length or intrinsic excitability, ‘↓’ indicates a decrease in length or intrinsic excitability, ‘-’ indicates no change in the animals
containing the mutation compared to littermate wild-type controls. N/A indicates results are not available. Electrophysiological recordings performed by A. Toft, N. Anstey, A. Jackson, L.
Mizen.
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Plasticity of the AIS (average AIS length)
Syngap1+/+ Syngap1+/-
P 28-35 P 90-120 Fear Sub-pop P28-35 P90-120 Fear Sub-pop








PL L2/3 28.75 µm 31.55 µm 29.82 µm 30.00 µm PL =⇒ BLA
26.80 µm
28.73 µm 29.05 µm, * 27.95 µm 27.98 µm, * PL =⇒ BLA
26.81 µmPL L5 28.99 µm 33.14 µm, ↑ 29.29 µm 29.41 µm 28.73 µm 31.06 µm,↑ 29.26 µm 29.30 µm
LA 24.43 µm 29.13 µm, ↑ 26.45 µm 26.38 µm BLA =⇒ PL
42.20 µm
23.71 µm 28.31 µm, ↑ 25.40 µm 26.26 µm BLA =⇒ PL
40.99 µmBA 33.21 µm 40.07 µm, ↑ 40.18 µm 37.17 µm 30.94 µm 38.42 µm, ↑ 36.64 µm 38.30 µm
Table 6.2: Summary table showing AIS plasticity in a rat model of Syngap1 haploinsufficiency Table shows the average AIS length at two developmental time points P28-35
(juveniles) and P90-120 (adults), post fear conditioning (FC) as well as in two distinct sub-populations: PL neurons that project to the BLA (PL =⇒ BLA) and BLA neurons that project to
the PL (BLA =⇒ PL). ‘↑’ indicates significantly increased AIS length within the same genotype with age, ‘*’ indicates significantly altered AIS length across genotypes. For statistics and
complete results see chapter 4.
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6.2 Translational implications for ASD/ID research: Convergence,
divergence and homeostatic platicity
Across models for distinct genetic causes of ASD/ID, phenotypic convergence and diver-
gence have been reported at cellular, molecular and behavioural levels. For example, elevated
rates of de novo protein synthesis have been reported in mouse models of Fragile-X syndrome
and SYNGAP1 haploinsufficiency (Barnes et al., 2015) whereas decreased levels of protein
synthesis have been observed in mouse models of Tuberous sclerosis complex (Auerbach et al.,
2011). Similarly, metabotropic glutamate receptor (mGluR) mediated long-term depression is
found to be exaggerated in models of Fragile-X syndrome and SYNGAP1 haploinsufficiency
(Barnes et al., 2015) whereas mGluR mediated long-term potentiation is disrupted in mouse
models of Neuroligin 3 mediated non-syndromic ID (Baudouin et al., 2012). Such studies have
resulted in the postulation of certain celluar and molecular process as ‘nodes’ of convergence
across the various models, allowing for the focussing of drug discovery and other therapeutic
approaches. Cellular hyper-excitability has widely been regarded as one such node (Contractor
et al., 2015), and the work of this thesis has focused on determining if changes in AIS morpho-
logy maybe a direct pathophysiological consequences of the genetic mutations causing ASD/ID
and under-pin the observed cellular hyper-excitability. However, the ASD phenotype is also
comprised of pleiotropic compensatory changes in addition to direct pathophysiological effects
(Nelson and Valakh, 2015; Contractor et al., 2015; Antoine et al., 2019). Examples of these
compensatory changes can be found at the molecular level, where in a mouse model of Fragile-
X syndrome shown to excessively translate mRNAs, some of these candidates corrected, rather
than exacerbated, the pathological changes observed in FXS (Thomson et al., 2017). Another
recent example in four mouse models of ASD/ID showed that increased neuronal activity and
E/I conductance ratio served to homeostatically stabilize, rather than drive, network hyperexcit-
ability (Antoine et al., 2019). The study proposes that ASD symptoms in these animals arises
as a result of imperfect homeostasis, for example, the increased E/I ratio observed here impairs
the ability of these cells to compensate for future strong inputs (Ramocki and Zoghbi, 2008;
Antoine et al., 2019). However, delineating pathogenicity of these mutations on network activity
from maladaptive homeostatic compensation is complicated by the activity-dependent plasticity
of neuronal and network excitability (Nelson and Valakh, 2015). The focus thus far has been on
understanding the biophysical changes in post-synaptic cellular and sub-cellular compartments
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with alterations in pre-synaptic processes, such as altered rates of synaptic vesicle re-cycling
(Bonnycastle, 2018) being overlooked. However, structural plasticity of the AIS, and its corres-
ponding control of intrinsic cellular excitability, is homeostatically regulated and depends on
incoming synaptic inputs (Kuba et al., 2006; Kole and Stuart, 2012). Therefore, perturbations
in pre-synaptic processes coupled with a lack of alterations in AIS morphology could result in
impaired homoeostasis and underlie the pathology in our models of ASD/ID.
6.3 Future Directions: Differential approaches to understanding AIS
deficits in SYNGAP1-ID and Fragile-X Syndrome
Moving forward, experiments should focus on delineating the exact fear-experience induced
morphological plasticity of the AIS and how these might be distinctly regulated in the present
rat models of Syngap1-ID and FXS. The visual cued fear conditioning paradigm described in
this thesis is an adaptation of the classical pavlovian associative memory paradigm (Pavlov,
1927) and as such composes of three distinct stages:
• Acquisition and consolidation of associative memory, wherein an initially neutral flash-
ing light cue signals an aversive foot-shock and induces expression of fear-behaviours
such as freezing
• Re-call of fear memory such that sole presentation of the cue induces the expression of
fear behaviour
• Extinction of the acquired fear-behavioural response when the cue ceases to denote an
aversive outcome
As shown in chapter 4, rat models of Syngap1 haploinsufficiency exhibit no deficits in
fear memory acquisition, displaying freeing levels comparable to their wild-type counterparts.
However, these animals display exaggerated fear re-call with limited extinction, displaying sus-
tained levels of freezing behaviour despite repetitive presentations of the cue unaccompanied
by the aversive foot-shock stimulus. Similar to the Syngap1+/- animals, Fmr1-/y animals also
show no deficits in conditioning, freezing to similar levels as the wild-type littermates. Unlike
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the Syngap1+/- animals, the Fmr1-/y animals show decreased levels with rapid extinction of
freezing behaviour when tested for fear-memory re-call. This diametrically opposite behavi-
oural response within the same paradigm maybe suggestive of opposing deficits in cellular
excitability within the same neural circuit. The pre-limbic cortex and basolateral amygdala
reciprocal network is crucial for fear memory consolidation and re-call (Vidal-Gonzalez et al.,
2006; Laviolette et al., 2005; Corcoran and Quirk, 2007). Additionally, preliminary data from
the laboratory of Professor Andreas Lüthi has shown that in BA cells that project to the PL,
AIS lengths increased following fear learning in wildtype mice. Therefore, investigation of
alterations in intrinsic cellular excitability as well changes in AIS lengths post fear conditioning
specifically in the BA to PL and PL to BLA projecting neurons in both the Syngap1+/- animals
and the Fmr1-/y animals should be undertaken. However, experiments exploring AIS changes
specifically in the PL-BLA, BLA-Pl circuit presents with some limitations due to the under-
lying assumption that the observed abnormal freezing behaviours occur as a consequence of
perturbed memory consolidation and recall. In case of Syngap1+/- animals, the exaggerated
freezing response might be a consequence of impaired extinction learning while in the Fmr1-/y
animals the reduced freezing behaviour might be because the animals choose to express fear
memory as a ‘flight’ rather than the classical ‘freeze’ response (Roelofs, 2017). In order to
distinguish between these possibilities, a more methodical approach must be employed. For
SynGAP haploinsufficient animals, an additional behaviour experimental day should be added
to assess extinction re-call levels followed by investigation of AIS lengths in the infra-limbic
(IL), rather than pre-limbic, cortex as the IL is crucial for fear extinction learning (Do-Monte et
al., 2015). It would also be prudent to assess alterations in AIS length in the PL-BLA network of
Syngap1+/- animals following conditioning with a more brief re-call protocol. For the Fmr1-/y
animals, analysis of cellular excitability and AIS lengths could be undertaken in the central
amygdala (CeA) and periaqueductal gray (PAG), as these brain regions lie downstream of the
BLA-mPFC circuit and determine the expression of fear-induced behaviour as either ‘fight’,
‘flight’ or ‘freeze’ (Roelofs, 2017). Another possible underlying mechanism contributing to the
altered fear-memory mediated behaviours in these models might disrupted ‘engram’ formation.
Engrams are cell ensembles that serve as the neural substrate for storing and re-calling memor-
ies (Herry et al., 2008; Josselyn and Tonegawa, 2020) and are composed of the same sub-set
of cells that are activated during memory formation and memory re-call. Engram cells are
most easily identified by their expression of early gene markers, such as c-Fos and Arc mRNA
(Kramer et al., 2018). Thus, an altogether non-circuit specific method to dissect the perturbed
185
cellular mechanisms in fear memory formation in our ASD/ID models would be use a viral
tracing approach to record the intrinsic cellular properties and analyse AIS lengths specifically
in the engram cells.
Finally, a fundamental question that arises from the assessment of AIS lengths and genotype
specific differences in models of ASD/ID is ‘What does the magnitude of change mean for the
individual cell?’ Would a 4 µm alteration in AIS length in a cell with baseline AIS length of
40 µm alter cell function to the same extent as a 4 µm alteration for a cell with baseline AIS
length of 20µm? Given that AIS length is determined as a consequence of neuronal input, this
question might best be answered using a computational model. In order to build the model,
experimental data could be obtained by performing dye-fills, to assess dendritic architecture and
spine density, when recording cellular intrinsic excitability with the cells being post-hoc stained
for the AIS. This would allow for a more definite determination of the functional consequences
of a 10 or 20% change in AIS length in our models, as well as answering the question if a lack





Figure S1: Axon initial segment is significantly shorter in adult Fmr1 KO rat PL-BLA projection neurons
These experiments were performed by Dr. Adam Jackson (Thesis: A Jackson 2016) (A) Confocal image of bead
labelled soma showing immunocytochemistry for axon initial segment (AIS) specific Ankyrin-G (green) and NeuN
(blue). (B) AIS length is significantly increased in Fmr1 KO rats (WT: 30.90 ± 1.30µm; n=4 animals; KO: 24.60 ±
0.72µm; n=4 animals; p=0.03) (C) Cumulative distribution of AIS length data. (D) No difference between genotypes
was observed in AIS distance from soma (WT: 2.79 ± 0.20µm; n=4 animals; KO: 2.82 ± 0.45µm; n=4 animals;
p=0.95). (E) Cumulative distribution of AIS distances from soma.
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Figure S2: Fmr1 KO rats show impaired fear recall These experiments were performed by Dr. Sally Till (A)
Using the same visual-cued fear conditioning paradigm as outlined in chapter 2, both Fmr1 KO and WT rats
show comparable levels of fear memory acquisition on training/ conditioning as witnessed by increased %freezing
compared to both WT and Fmr1 KO control animals that were only presented with the CS without the aversive
footshock (B) However, when testing recall Fmr1 KO rats showed significantly reduced re-call. The re-call protocol
used in this figure is different to the one used in this thesis such that animals in this figure were subjected to 3x2min
CS presentations interleaved by 2 min ITI.
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Figure S3: Fear re-call data with inter-trial interval in Syngap1+/- and Syngap1+/∆Gap rats (A) During re-call
of fear memory both Syngap1+/+ and Syngap1+/- show reduced modulation of freezing response during the ‘light
off’ inter-trial intervals for the first 8 CS presentations, following which WT rats show greater modulation of fear
response than Syngap1+/- rats (Syngap1+/+ CS only n=5, Syngap1+/+ FC n=11, Syngap1+/- CS only n=6, Syngap1+/-
FC n=14) (B) Wildtype Syngap1+/+ and Syngap1+/∆Gap show greater modulation of freezing response during ITIs
than Syngap1+/- rats (Syngap1+/+ CS only n=2, Syngap1+/+ FC n=9, Syngap1+/∆Gap CS only n=5,
textitSyngap1+/∆Gap FC n=8).
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Figure S4: AIS Distance from cell soma measurements in Nlgn3-/y and Nrx1+/- rats No significant difference
in distance from cell soma in mPFC L2/3 (A, A’ Nlgn3+/+ =1.787 ± 0.4156, N=4, Nlgn3-/y= 1.888 ± 0.5305,
N=5, Nrx1+/+= 1.718 ± 0.5381, N=8, Nrx1+/-= 1.800 ± 0.5319, N=8), L5 (B, B’Nlgn3+/+= 2.171 ± 0.2439, N=4,
Nlgn3-/y= 2.290 ± 0.3499, N=5, Nrx1+/+= 2.036 ± 0.3484, N=8, Nrx1+/-= 2.135 ± 0.9229, N=8), S1 L2/3 (C,
C’Nlgn3+/+= 1.386 ± 0.1972, N=6, Nlgn3-/y= 1.383 ± 0.1796, N=6, Nrx1+/+= 1.316 ± 0.2464„ N=6, Nrx1+/-=
1.317 ± 0.3588, N=6), S1 L4 (D, D’Nlgn3+/+= 0.9332 ± 0.2735, N=6, Nlgn3-/y= 1.052 ± 0.2726, N=6, Nrx1+/+=
1.224 ± 0.1788, N=6, Nrx1+/-= 1.255 ± 0.3075, N=6) and S1 L5 (E, E’Nlgn3+/+= 1.136 ± 0.3181, N=6, Nlgn3-/y=
1.197 ± 0.2735, N=6, Nrx1+/+= 1.832 ± 0.3815, N=6, Nrx1+/-= 1.867 ± 0.6089, N=6) in Nlgn3-/y and Nrx1+/- rats
compared to wildtype littermate controls.
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Figure S5: Injection sites into the mPFC This figure shows the retrobead injection sites into the mPFC from all
the animals included in AIS analysis in chapter 4. Beads are shown in red and counter-stained with either NeuN
(green) or TOPRO (blue) Scale bar= 500 µm.
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Figure S6: Injection sites into the BLA This figure shows the retrobead injection sites into the BLA from n-2
animals included in AIS analysis in chapter 4. 2 animals are not shown due to damage to the injection site during
tissue handling. Beads are shown in green and counter-stained with either NeuN (red) or TOPRO (blue) Scale bar=
500 µm.
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Figure S7: Three channel image showing overlap between retrobead expression in the mPFC (A) Represent-
ative image of the PL stack acquired showing the high degree of overlap between the red and green retrobeads,
indicated using the yellow arrow. Some only green-bead expressing cells were also see, indicated by the green arrow,
and these were the ones measured in chapter 4. Slices were counter-stained with NeuN pseudo-coloured in blue
Scale bar = 50 µm. (B) Magnified image of a single ‘yellow’ cell showing the overlap between red and green beads.
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